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Abstract
Distal Hydrogen-Bonding Effects and Cofacial Bimetallic Salen
Architectures for Oxygen Activation Chemistry
By Jenny Yue-fon Yang
Submitted to the Department of Chemistry
on April 18, 2007 in partial fulfillment of
the requirements for the degree of
Doctor of Philosophy in Inorganic Chemistry
Abstract
Two distinct structural scaffolds elaborated from Schiff-base macrocycles were designed
to study the proton-coupled electron transfer chemistry of 0-0 bond forming and
activation chemistry. The "Hangman" architecture is composed of hydrogen-bonding
functionalities poised over a redox active manganese salophen or salen platform. The
complexes proved to be proficient catalase mimics (disproportionation of hydrogen
peroxide to water and oxygen). Detailed spectroscopic, computational, and structure-
function relationship studies elucidated the key redox, steric, and secondary coordination
sphere effects for optimal catalytic ability. The incorporation a chiral backbone into the
macrocycle led to catalysts that perform enantioselective epoxidation of unfunctionalized
olefins. A macrocycle with an amide, imine, and bisphenolic functionalities was also
incorporated as the redox platform in the Hangman framework; the manganese complex
also performed catalytic oxygen atom transfer to olefins. The second framework, dubbed
"Pacman", is composed of two salen platforms linked cofacially by rigid pillars xanthene
or dibenzofuran. A series of bimetallic complexes, including chromium, iron, manganese,
cobalt, copper, and zinc were generated. Mossbauer spectroscopy was used in the
characterization of the iron salen complexes, which were also examined for photolytic
oxidation chemistry.
Thesis supervisor: Daniel G. Nocera
W. M. Keck Professor of Energy and Professor of Chemistry
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Chapter 1
Introduction
1.1 Proton Coupled Electron Transfer in Nature
The principal theme of the research presented is the elucidation of mechanistic details in
the coupled transport of both protons and electrons in bond-making and bond-breaking
catalysis. 1-4 This is a recurring theme throughout a broad range of natural systems that
encompass a diverse range of reactivity. Consummate examples are the four electron
oxidation of water to oxygen by Photosystem II (PSII), 5-9 and its microscopic reverse, the
reduction of oxygen to water by cytochrome c oxidase (CcO),'o -17 which highlights our
interests in 0-0 bond chemistry.
While electron transfer at active sites is typically regulated via a transition metal platform
or cluster, proton transfer is mediated through non-covalent hydrogen-bonding
interactions in the secondary coordination sphere. A prototypical example of the dual
importance of electron and proton control by structure and function can be found in
heme-dependent hydroperoxidases.1 8-22 A ferric protoporphyrin IX prosthetic group is
found at the active site of peroxidases, catalases, and the cytochrome P450
monooxygenases, as shown in Figure 1.1. Structurally oriented acidic or basic amino acid
residues and/or locally hydrogen bonded water assist 0-0 bond cleavage of hydrogen
peroxide in peroxidases and catalases, and oxygen in the cytochrome P450
monooxygenases. These interactions on the distal oxygen, frequently characterized as the
"pull effect",18-22 promote heterolytic bond cleavage to form the two electron oxidized
Compound I intermediate, 20-24 as opposed to the one electron oxidized Compound II
Figure 1.1 Representation of the active sites (a) peroxidases, (b) catalases, and (c)
cytochrome P450 monooxygenases highlighting the proposed roles distal residues play
in O-O bond cleavage. Adapted from reference 67.
species that results from homolytic bond cleavage. The reactivity of the of Compound I
species in these subclasses then diverge; peroxidases tend to behave as one electron
oxidants, 22,'25,26 while catalases are selective in their reactivity towards the two electron
oxidation of hydrogen peroxide,22' 26-28 and cytochrome P450 monoxygenases perform
two electron oxygen atom transfer chemistry to a variety of substrates. 19 The tuned
microenvironment guides proton and electron delivery within the active site, assisting in
O-0O bond activation, and the subsequent chemistry of the oxidizing intermediate.
The importance of this microenvironment has successfully been demonstrated by
modifying natural enzymes. By adjusting the distance and position of distal residue(s)
over the heme environment in the oxygen carrier myoglobin (Mb), peroxidase, catalase,
or enantioselective monooxygenase activity is observed.18,29-47 Additionally, the effect of
the redox environment has been studied independently by inserting unnatural redox
cofactors to generate artificial metalloenzymes. 48-64 Alternatively, these individual factors
can be analyzed in greater detail using a synthetic system which incorporates the key
factors that mediate reactivity in the natural systems we are targeting.
1.2 Proton Coupled Electron Transfer in Synthetic Systems
The complexity of tuning the precise factors which dictate PCET in biological systems
has led to the use of molecular models to elucidate important non-covalent interactions in
oxidation catalysis. A minimalist secondary coordination sphere is constructed onto a
ligand platform which can support metals in a wide range of oxidation states, as shown in
Scheme 1.1. This Hangman architecture in effect "hangs" an acid-base functional group
over the redox platform using a rigid scaffold.65 Synthetic methods can be used to tune
the redox properties of the metal, while the scaffold can be modified to specify the spatial
Scheme.1.1
location and pKa of the distal group. This allows structure-function relationships to be
probed using more direct methods.
The initial redox platform incorporated into this architecture was a porphyrin macrocycle
with a carboxylic acid functionality (HPX-CO 2H), as shown in Figure 1.2.6568 The iron
porphyrin platform faithfully reproduces many of the essential features of heme-
dependent hydroperoxidases, including a ferric hydroperoxide and Compound I and
Compound II type intermediates. Additionally, crystallographic characterization of the
ferric hydroxide complex reveals a water molecule oriented by the acid and bound
hydroxide. This is reminiscent of water molecules situated by distal amino acid residues
in heme peroxidases. 66 The effect of the hanging group is highlighted in the reactivity of
the Hangman complexes. The iron Hangman complexes are effective catalase mimics,
generating turnover numbers (TON) more than two orders of magnitude over the
unfunctionalized redox platform (Figure 1.2).67,68 Stop-flow spectroscopic studies of the
reaction using the oxidant m-CPBA found the presence of the hanging group both
accelerated peroxy acid ligation and exclusively favored the proton-coupled two-electron
0-0 bond heterolysis to form a Compound I-like intermediate, as opposed to a less
oxidizing Compound II-like intermediate. 69 In the presence of olefin substrate and
Figure 1.2. Proposed catalytic cycle of the catalase-like disproportionation of
hydrogen peroxide by iron (HPX-CO2H), and epoxidation by manganese (HPX-
CO 2H). Adapted from reference 67.
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hydrogen peroxide, the manganese Hangman complexes catalyzed epoxidation at
improved TON over the manganese porphyrin lacking the hanging group. 67 In both cases,
the exceptional improvement in catalytic activity due to the hanging acid group is due to
the proton mediated formation of the more oxidizing high valent M=O species.
1.3 Photolytic Generation of Metal Oxo Species
In Nature, O-0O bond formation is performed by the oxygen evolving complex (OEC) in
Photosystem II. In the proposed mechanism, 0-0 bond formation is initiated via a
nucleophilic hydroxide or water attack onto an electrophilic manganese oxo. 6' 9 Initially,
we are interested in studying the formation and electrophilic character of high valent
metal oxo species. Both of these factors can be probed by their reaction with a variety of
electron rich substrates. (Analogous to the use of olefin epoxidation in investigating high
valent oxo formation in the manganese hangman porphyrins described above.) This
approach has been successful in the cofacial bimetallic "pacman" porphyrin system that
has also been explored in this research program. 70-77 The Fe-O bond in diiron p-oxo
pacman porphyrin complexes can be photolytically cleaved to expose an iron(IV) oxo
Figure 1.3. Proposed catalytic cycle for the photolytic oxidation catalysis performed
by diiron pacman porphyrin complexes, and summary of substrates and turnover
numbers observed.78 82
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capable of oxidation chemistry.78-82 Detailed mechanistic studies resulted in ligand
architecture modifications that dramatically increased turnover numbers. 81' 82 This was
coupled with the use of electron withdrawing groups on the porphyrin to increase the
electrophilic nature of the iron oxo intermediate and thus the ability to oxidize more
difficult substrates, as shown in Figure 1.3. The photolytic generation of a high valent
metal oxo from a thermally inert diiron i-oxo complex to perform oxidation chemistry
using molecular oxygen as the oxidant was an additional avenue of reactivity that we
were interested in expanding.
1.4 Schiff-base Macrocycles as Redox Platforms
The use of porphyrin macrocycles to support the redox platform in Hangman and Pacman
porphyrin architectures was very successful in producing effective catalysts for oxidation
chemistry. Furthermore, modulating functional groups around the porphyrin platform
allowed tuning of the steric, redox, and photophysical properties in order to expand the
scope of substrate and catalytic conditions. While synthetic preparation of variously
functionalized porphyrins is well established, most procedures still require lengthy, multi-
step synthesis, particularly in order to allow attachment to the xanthene and dibenzofuran
spacers in constructing the Hangman and Pacman ligands. Alternatively, the replacement
of the porphyrins with Schiff-base macrocycles as the redox platform in our architectures
engenders several advantages. Firstly, they are easily assembled via condensation of two
salicylaldehydes with a diamine, as shown in the retrosynthesis in Chart 1. lb. Secondly, a
large variety of functionalized salicylaldehydes exists commercially and in the literature,
Chart 1.1
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and can typically be prepared in one or two steps. 83-87 The 3 and 5 positions are
highlighted in Chart 1.1lb as they are activated and thus the easiest positions to
functionalize. Combined with the scope of aliphatic and aromatic diamines that can be
used, this constitutes a modular approach to a wide range of macrocycles with tunable
steric and redox properties. Additionally, given the rich oxidation chemistry displayed by
the porphyrin hangman and pacman complexes, one of the features that would be
appealing to add to the catalytic chemistry is enantioselectivity. Although some
metalloporphyrins catalysts have, through elaborate synthetic pathways, incorporated
asymmetric functional groups to promote chiral induction of substrates, the enantiomeric
excess (ee) of the products tend to be poor, and the scope of substrates limited.88-95 This is
partly due to the lack of sp 3 carbons near the metal center; addition of chiral
functionalities has to occur on the perimeter of the macrocycle (Chart 1.1a). As shown in
Chart 1.1.b, an aliphatic diamine provides a location for enantioselective induction
proximate to the reactive metal center. Macrocycles of this type have already
demonstrated excellent stereochemical communication to a wide variety of substrates in
organic transformations.96-105 We are interested in integrating these features into the
catalysts that we have studied thus far.
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Chapter 2
Hangman Salophen Mediated Activation
of 0-0 Bonds: Mechanistic Insights
Portions of the work presented in this chapter have been published:
Liu, S.-Y.; Soper, J. D.; Yang, J. Y.; Rybak-Akimova, E. V.; Nocera, D. G. lnorg. Chem.
2006, 45, 7572-7574.
2.1. Motivation and Specific Aims
The Hangman ligand architecture, which incorporates an acid functionalized scaffold
over a metal-ligand platform, is expanded by replacing the previously studied porphyrin
ligand platform with a salophen macrocycle. This modification permits a more facile
synthetic introduction of functional groups to the phenolic arms of the salophen, thereby
permitting the steric and redox environment of the metal center to be varied more easily.
The manganese Hangman salophen compounds are successful catalase mimics, and their
reactivity can be tuned by varying the redox properties of the salophen macrocycle. In
order to determine the basis for the enhanced activity for the dismutation of hydrogen
peroxide, stopped-flow spectroscopic techniques using the peroxyacid m-CPBA to probe
intermediates in the catalytic cycle and the kinetics of their formation. This includes
heterolysis of the O-0O bond to form a putative Mn(V) oxo. Stopped-flow studies help
define the electronic effects that perturb the kinetics of the Mn(V) oxo formation.
Conditions to independently generate the Mn(V) salophen oxo using hydrogen peroxide
have also been discovered. By comparing our results to those of manganese salophen
platforms lacking the acid functionalized scaffold and Hangman porphyrins, insight into
the mechanism of catalase activity by manganese salophens is gained.
2.2. Background
Chart 2.1
S1 control of acid-base properties
X I PCET
control of redox properties
HSX
Expanding upon the work on the Hangman Porphyrin ligand, HPX' -4 (discussed in
Chapter 1), a series of Hangman Salophen compounds were assembled (HSX, shown in
Chart 2.1). 5 The modular synthesis of salophen compounds allows for easy synthetic
modification in the functionalities of the 5 and 5' position along the phenolic arms
(indicated by X) of the macrocycle. This position exerts a particularly strong influence on
the redox properties of the metal center.6 Within the HSX framework, PCET catalysis
was explored in the activation of O-O bonds by studying the disproportionation of
H20 2.
catalase
2 H20 2  2 H20 + 02 (1)
This catalase reaction is an important PCET process that is catalyzed by a variety of
enzymes. 7-1 1 In the case of manganese(III) chloride HSX compounds where X = tert-
butyl, the turnover number (TON) for oxygen production upon addition of hydrogen
peroxide is dramatically higher with the acid functionalized xanthene (4372 TON/hour)
compared to the ester analogue (98 TON/hour), which lacks the acidic proton. The
control experiment with the redox only manganese salophen platform (lacking the
xanthene scaffold) shows a similarly low activity (86 TON/hour). 5 Thus, an enhancement
of catalase activity is observed by positioning a carboxylic acid group over a redox
platform. This enhanced reactivity is also observed for iron(III) Hangman porphyrin
compounds when compared to iron(III) tetramesityl porphyrin (TMP). 3 While similar
reactivity is also observed for Hangman salophen and porphyrin platforms, the former is
synthetically much easier to modify. The meso-positions of the porphyrins are not
available for modification because they are needed to incorporate steric protection to
prevent formation of inactive diiron pt-oxo dimers. 12 To this end, a series of HSX analogs
Table 2.1. Redox potential of manganese (HSX) chloride compounds with varying X
functionalities in the 5 and 5' position, observed LMCT band in the UV-visible
spectrum, and the amount of time after injection that half of 4388 equivalents of H2 0 2
was measured to be consumed by monitoring the amount of oxygen evolved.5'13
X Ei/2(Mn"/Mn"') kmax(nm) t (50%) (sec)
OMe -0.36 511 560
Br -0.5 490 860
H 0.0 486 970
t-Bu 0.14 476 1760
NO2 0.44 460 -
with X = OMe, Br, H, t-Bu, and NO2 were synthesized. This family of manganese(III)
Hangman salophen compounds shows an increase in oxidation potential as the electron
with-drawing ability of groups in the 5 and 5' position (shown in Table 2.1) is
increased.5 '13 The redox potential of the manganese(II/III) couple can be varied from 0.37
V, with the introduction of electron donating methoxy groups to 0.44 V with the
introduction of electron withdrawing nitro groups. 5"' 3 The electronic perturbation of
substituent groups is reflected in a low energy absorption band, 14 which exhibits a red-
shift from 511 nm to 460 nm along the series of increasing electron-donating ability of
the substituent. This trend is consistent with a salophen ligand-to-metal charge transfer
parentage of the absorption band. Variations in redox potential and electron density at the
metal site are directly correlated with the rate of catalase activity as measured by the rate
of H20 2 consumption (shown in Table 2.1 and Figure 2.1). We can also measure
reactivity by comparing the amount of time it takes for half of the H2 0 2 equivalents to be
dismutated into oxygen and water. We can also measure reactivity by comparing the
amount of time it takes for half of the H20 2 equivalents to be dismutated into oxygen and
water. The Hangman salophen with X = NO2 displays very little reactivity and only
achieves a TON of 81, or 2% conversion over the hour the reaction was monitored,
whereas the methoxy substituted congener is the most successful catalase mimic. There is
only a moderate correlation between the initial rates of reaction and the Gpi constant and
the sensitivity parameter (p = -0.3) is quite low, which suggests there are little changes in
the transition state of the rate-limiting step of the reaction. 13 It is likely that under the
biphasic reaction conditions used in these studies, the diffusion of H20 2 is an important
factor in the rate-determining step for the initial reactivity and this result in the low
observed p value.
2.3. Results and Discussion
2.3.1. Synthesis
The compounds that are the focus of this Chapter are shown in Chart 2.2. The acid
functionalized manganese Hangman salophen (1) was synthesized as described
previously.5 The synthesis of the corresponding methyl ester is outlined in Scheme 2.1.
The functionalized xanthene precursor 75 was condensed with two equivalents of 3-tert-
butyl-2-hydroxy-5-methoxy-benzaldehyde to give the ligand 8, which was refluxed with
Scheme 2.1
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7 8: H2[HSX(OMe)-COOMe] 2: Mn[HSX(OMe-COOMe)]CI
manganese(II) acetate in air, followed by an aqueous sodium chloride wash to give the
Mn(III) complex 2. Manganese salophen complex 3 was synthesized for the purposes of
performing control experiments; it was prepared by the stepwise condensation of two
equivalents of 3-tert-butyl-2-hydroxy-5-methoxybenzaldehyde with 1,2,-
phenylenediamine followed by the same metalation procedure described for 2.
2.3.2. Stopped-flow Spectroscopy
Chart 2.2
OMe
MO
t-Bu
MeO
1: Mn[HSX(OMe)-COOH]CI, R = H
2: Mn[HSX(OMe)-COOMe]CI, R = Me 3: Mn(salophen(OMe)]CI
In order to understand the role the hanging functionality may play in the catalase activity
of manganese salophens, stopped-flow kinetic studies were used to provide spectroscopic
evidence of intermediates and their rates of their formation. The stopped-flow
spectroscopic experiments were conducted by postdoctoral associate Jake Soper on the
acid (1) and ester (2) functionalized manganese Hangman salophens, substituted with
methoxy in the 5 and 5' position as shown in Chart 2.2. The unfunctionalized manganese
salophen (3) was also investigated to provide a side by side comparison to the Hangman
compounds. The experiments were performed using m-CPBA as the oxygen atom source
instead of hydrogen peroxide, which would continue to react with the oxidizing
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Figure 2.2. (a) Stopped-flow UV-vis spectra obtained from reaction of m-CPBA (3.3
x 10-4) with 4.0 x 10-5 M 1 (red solid line) ca. 3 s post injection in 1:1 MeOH:MeCN
at -20 'C. (b) UV-vis spectrum obtained from a solution of 5.0 x 10-5 M 1 in
MeOH:MeCN at room temperature (red solid line). UV-vis spectrum obtained from a
solution of 5.0 x 10-5 M 1 in 1:1 MeOH:MeCN at room temperature in the presence of
benzoic acid (5.0 x 10 3 M) (black dotted line).
intermediate and complicate kinetic studies. The use of m-CPBA arrests the catalase
cycle after formation of the high valent manganese species, enabling detection of the first
two intermediates at the Hangman salophen platform.
The initial stage of the reaction upon addition of m-CPBA to 1 is characterized by small
changes in the stopped-flow UV-vis spectrum (Figure 2.2a), suggesting a simple ligand
substitution by the perbenzoate at the Mn(III) center. This substitution reaction was
modeled by the addition of benzoic acid to 1. The benzoate substrate circumvents the
possibility of 0-0 bond cleavage, therefore allowing the substitution reaction to be
isolated. The small spectral shifts observed for perbenzoate substitution are captured with
the benzoate model (Figure 2.2b). Global fitting of the transient spectra indicates that
ligand substitution is complete in 3 s at -20 'C.
The appearance of the Mn(III) perbenzoate complex (Figure 2.3a, black dotted line) is
immediately followed by a subsequent reaction that generates a species with the spectrum
shown by the green line in Figure 2.3a. The spectrum does not depend on the nature of
the oxidant; a similar spectrum is obtained with the same isosbestic points when m-CPBA
is replaced by the two-electron oxidant, iodosylbenzene. These results lead us to assign
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Figure 2.3. (a) Absorption spectra obtained from spectral global analysis of a stopped-
flow reaction of 4.0 x 10- 5 M 1 and 3.3 x 10- 4 M m-CPBA in 1:1 MeOH:MeCN at -20
'C. Formation of Mn(V) oxo (green solid line) is immediately followed by a bleach,
likely to a Mn"' decay product (red solid line) over 800 s. (b) Calculated
concentrations of the colored species with respect to time by spectral global analysis
by Jake Soper.
this intermediate to the Mn(V) oxo salophen. Several observations support this
assignment. First, the transient spectrum is reminiscent to that of structurally similar,
crystallographically characterized Mn(V) oxo complexes of bis-amido bis-alkoxo redox
platforms. 15 Moreover, the spectral features in Figure 2.3a (green line) concur with those
of other (non-oxo) multiply bonded Mn(V) ligand salophen species. The corresponding
nitrido complex, Mn[salophen(OMe)]N complex was also synthesized and isolated. The
crystal structure of the compound is similar to other Mn(V) nitrido complexes featuring a
formal Mn-N triple bond (d(Mn-N) = 1.523 (3) A). 6 The absorption spectrum of the
Mn(V) complex shows a pronounced absorption band at Xmax = 459 nm, similar to 420
nm feature that dominates the absorption spectrum of Figure 2.3a (green line). The
electron-donating methoxy group on the salophen platform of the Mn(V) oxo species
impart sufficient stability"7 that it is observed as a stopped-flow transient. The reactive
high-valent oxo intermediate eventually disappears 60-800 seconds after substrate
injection as evidenced by the decrease of the absorption profile across the entire spectral
range (360 - 700 nm). The final spectrum, shown by the red line in Figure 2.3a, strongly
resembles the Mn(III) starting material, though the product was not unequivocally
identified.
Table 2.2. Rates of the formation of Mn(V) oxo intermediates and their decay for a
series of Mn[salophen(X)] peroxyacid complexesa
O
II kl
Mn(III)-(H)OOCAr N Mn(V)- OX() "Mn(Ill)"
Entry Mn-Complex K, (s"') k2 (S-1)
1 Mn[HSX(OMe)-COOH] (1) 2.3 ± 0.6 x 102 3.6 ± 0.3 x 10-3
2 Mn[HSX(OMe)-COOMe] (2) 2.8 ± 0.8 x 10-2 2.5 ± 0.3 x 10-3
3 Mn[salophen(OMe)] (3) 2.1 ± 0.5 x 102  4.1 ± 0.3 x 10-3
4 Mn[HSX(OMe)-COOH] (1)b 2.9 ± 0.6 x 10-2 5.5 + 0.5 x 10 3
a Rate constants determined with global analysis using A to B to C kinetic model. All
reactions at -20 'C in 1:1 MeOH: MeCN with [Mn(III)] = 4.0 x 10-5 M and [m-CPBA]
= 3.3 x 10-4 M.
b [m-CPBA] = 13 x 104 M
The rate constants for the O-0O bond heterolysis to produce the Mn(V) oxo salophen and
its subsequent decay were obtained from global analysis of the full-spectral stopped-flow
data (360 - 700 nm). The data were modeled with a consecutive unimolecular kinetic
model in which the A - B phase represents the heterolytic O--0O bond cleavage to
furnish the Mn(V) oxo transient, and the B --* C phase corresponds to the decay of the
transient to the final Mn(III) species. Figure 2.3b illustrates the calculated concentrations
of each of the manganese species with respect to time according to this kinetic model,
and Table 2.2 provides the rate constants that yields the best fit for the kinetics model.
We note several features of the kinetics analysis: (1) Both the growth of the Mn(V)
transient spectrum and the decay of the Mn(III) reactant are simultaneously fit well by a
first-order exponential equation indicating heterolytic cleavage to generate Mn(V) oxo
occurs without intermediates. This result is consistent with the heterolysis of O-0O bonds
of peroxides at Fe(III) heme centers to form Compound 1.18 -20 (2) The production of the
Mn(V) oxo intermediate is independent of the presence of the hanging acid-base group
(entry 1 vs. 3 in Table 2.2) or intramolecular proton inventory (entry 1 vs. entry 2 in
Table 2.2). (3) The rate of the O--0O bond heterolysis appears to be independent of the
initial concentration of the m-CPBA oxidant (Table 2.2, entry 1 vs. entry 4) though an
increase in m-CPBA concentration results in a slightly enhanced decay of the Mn(V) oxo
intermediate (Table 2.2, k2 in entry 1 vs. entry 4).
2.3.3. Decomposition in the Presence of Hydrogen Peroxide
To address the role of the intramolecular acid on enhancing TON, 1 was monitored by
post-doctoral fellow Shih-Yuan Liu in the presence of H202 (30% aqueous solution in
MeOH) in homogeneous solution conditions. The UV-vis absorption spectrum shows that
the Mn(III) starting material gradually decomposes over time. Kinetics experiments show
that the decomposition of 1 is first order with respect to the Mn(III) complex and H20 2,
and zero order with respect to water. As shown by the rate constants in Table 2.3, the
Hangman architecture improves the kinetic stability of the salophen catalyst against
oxidative degradation by -1 order of magnitude. This increased stability is expected to
account for the higher TONs listed in Table 2.3 for the Hangman salophen system.
Table 2.3. Stability of Methoxy-Substituted Manganese Salophen Complexes
Mn-complex Yield of 02/ TONa kobs (s- )
Mn[HSX(OMe)-COOH]CI (1) 4500 2.9 x 104
Mn[HSX(OMe)-COOMe]Cl (2) 550 1.3 x 10-3
Mn[salophen(OMe)]Cl (3) 100 b  2.3 x 103
a Yield of 02 measured in TON after 1 hr of reaction time
b In the presence of I equivalent of benzoic acid
2.3.4. Mechanistic Implications
The results of the stopped-flow studies on the manganese Hangman salophen compounds
contrast with the results of the analogous studies on iron Hangman porphyrin compounds,
which also display high catalase activity. Despite what superficially appears to be the
same enhancement of catalytic activity by the same structural modification (addition of a
proximate carboxylic acid group by the rigid xanthene scaffold), it appears the reasons
behind the "Hangman effect" are different for the porphyrin and salophen ligand systems.
Addition of m-CPBA to the Fe(III) porphyrin hydroxide complex, tetramesityl porphyrin
Scheme 2.2. Proposed catalytic cycle for iron Hangman porphyrin and manganese
Hangman salophen compounds. The porphyrin compounds are indicated in green,
and the salophen in black. The catalase reaction is represented in blue. The stopped-
flow kinetic studies were performed using the red reagents, as well as the rates that
can be determined using the double-mixing setup.
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(TMP), and the two Fe(III) Hangman porphyrins functionalized with the acid and ester
group also undergo substitution to form the Fe(III) acylperoxo complex (shown as
reaction a in Scheme 2.2). 2 1 However, the substitution rate increases along the following
trend: TMP < HPX-CO 2Me < HPX-CO2H, which suggest the hydrogen-bonding
microenvironment for the Hangman porphyrin complexes assists in the ligand
substitution.2 1 This contrasts with the manganese salophen compounds, which undergo
ligand substitution at very close to the same rate for the Hangman compounds and the
unfunctionalized salophen (Table 2.2). The formation of the acyl peroxo porphyrin
complex is followed by cleavage of the O-0O to form a metal oxo, shown as reaction b in
Scheme 2.2. As discussed in Chapter 1, the two electron oxidation of Fe(III) heme in
hydroperoxidase enzymes to generate a ferryl Fe(IV) oxo with an associated radical that
resides on the ligand is commonly referred to as Compound I (reaction b1). 22-26 This is
coupled with the delivery of a proton from a precisely positioned acid/base residue in the
active-site cavity to the distal oxygen of a Fe(III) hydroperoxide complex, which
contributes a "pull' effect that facilitates two electron heterolytic bond cleavage.
22-25
'
27-32
Alternatively, homolytic cleavage of the O---O results in the one electron oxidation of the
metal to generate the less oxidizing Fe(IV) oxo, commonly called Compound II (reaction
b2).33'34 In the Hangman porphyrin compounds, the acid group impacts the ratio of
productive two electron heterolytic O-0O bond cleavage to form the high-valent
Compound I like oxidant, as opposed to homolytic cleavage to form a Fe(IV)=0, or by
favoring reaction b, over reaction b2 .2 1 However, the hanging group does not affect the
rate of formation of the Compound I like species.21 On the other hand, the acid group in
the Hangman salophen compounds does not appear to have the same effect; heterolytic
cleavage to form the Mn(V)=O occurs at close to the same rate and quantity for the
Hangman compounds as for the unfunctionalized salophens; the lower valent Mn(IV) oxo
is not observed (product from b2). It has been noted that Mn(III) Schiff-base compounds
are less prone to homolytic cleavage and one electron oxidation to form the less active
metal oxo species. 35' 36 Therefore these studies suggest that the "Hangman effect" that we
see for the manganese Hangman salophens does not affect the rate or reactivity in the
first two steps of the catalase cycle (substitution of the peroxo species, followed by 0-0
bond cleavage to form the high valent metal oxo species).
Using stopped-flow spectroscopic methods to investigate the kinetics of the next step
(reaction c, oxidation of hydrogen peroxide by the putative Mn(V) oxo to form oxygen
and water) is considerably more difficult. It would require a triple-mixing experiment in
order to add hydrogen peroxide to the premixed manganese salophen and m-CPBA
solution. Alternatively, monitoring the decay of the Mn(III) salophen in solution in the
presence of hydrogen peroxide indicates that the acid group may protect the compound
from oxidative damage. The greater stability of the manganese Hangman salophen
catalysts suggests that it is an important factor in the greater turnover numbers exhibited
in the dismutation of hydrogen peroxide.
2.3.5. Generation of Manganese Salophen Oxo with Hydrogen Peroxide
Chart 2.3
X
-X 3: X = OMe
Mr M-B 4: X = t-Bu
t-Bu
XB 6: X = Br
The generation of a Mn(V) oxo salen intermediate using H20 2 itself is highly desired
since this species is generally accepted to be the active oxidant for a variety of important
organic reactions,37-40 particularly in asymmetric epoxidation. Generation of the Mn(V)
oxo with H2 0 2 was not possible using the conditions employed with the m-CPBA system.
We discovered that Mn-oxo could be cleanly generated from H2 0 2 if the solution pH was
basic. Under these conditions, we observe spectral changes of 1 (Figure 2.4a) that have
the same isosbestic points as when the same complex is treated with m-CPBA (Figure 4b)
or with iodosylbenzene (Figure 2.4c).
The substituent effects of the salophen ligand on the absorption maxima of corresponding
Mn-oxo intermediates was determined by using redox-only Mn(salophen)Cl complexes
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Figure 2.4. Observation of a common oxidized Hangman salophen intermediate by
treating Mn[HSX(OMe)-COOH]CI (1) with three different oxidants: (a) hydrogen
peroxide, (b) m-CPBA, (c) iodosylbenzene.
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Figure 2.5. UV-vis of high-valent Mn-salophens: (a) comparison of the spectra of
Mn-oxo complexes derived from Mn[salophen(t-bu)] and Mn[salophen(OMe)],
respectively; (b) comparison of the spectra of Mn(V)-nitrido complexes derived from
Mn[salophen(t-bu)] and Mn[salophen(OMe)], respectively.
(Chart 2.3). These complexes were synthesized stepwise by condensing the appropriately
functionalized salicylaldehydes with 1,2-phenylenediamine followed by reflux with
manganese acetate in air. Workup with aqueous sodium chloride gives chloride as the
counteranion.
As can be seen from Figure 2.5a, the absorption maxima of the high-valent Mn-oxo
complexes exhibit a red shift along the series from X = t-Bu < X = OMe.4 1 Interestingly,
this spectral feature concurs with that of the corresponding high-valent Mn(V)-nitrido
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Mn(III)
salophen species (Figure 2.5b). Thus, for both high-valent Mn-salophen complexes (oxo
and nitrido) the observed spectral trends are consistent with a salophen ligand-to-metal
charge transfer parentage of the absorption band.
Upon standing, the high-valent Mn[salophen(X)]O intermediates decompose gradually.
On the other hand, treatment of Mn[salophen(t-Bu)]O with reducing substrates such as
Et 2S immediately produces a spectrum that strongly resembles the starting material
Mn(III)[salophen(t-Bu)]Cl (4) (Figure 2.6a). Similar spectral shifts are observed when
Et 2S is replaced with another reducing substrate, P(OEt)3 (Figure 2.6b). These results in
total support our assignment of the primary oxidation intermediate as a Mn(V) oxo
species.
Ivan V. Korendovych from Elena Rybak-Akimova's group at Tufts carried out stopped-
flow kinetic studies on the reactions of Mn[salophen(X)]Cl complexes with H20 2. The
formation of the Mn(V) oxo species was observed to be first order in the Mn-complex
and first order in H20 2 . Furthermore, the experiments established that the rate of Mn(V)
oxo formation at -50 'C is slightly enhanced when the redox platform contains 7-
donating, albeit G-withdrawing substituents (Table 2.4, entries 3-4 vs. entries 1-2). We
have also studied the kinetics of the Mn(V) oxo formation over a temperature range of
40K (233 - 273 K). As can be seen from Table 2.4, the resulting activation entropies are
consistent with a bimolecular transition state. Furthermore, the activation parameters for
the formation of the Mn(V) oxo are independent of substituent effects. These results are
consistent with a rate-limiting coordination of the H20 2 oxidant.
Table 2.4. Stopped-Flow Kinetic Studies on the Formation of Mn(V) oxo
Intermediatesa
ki (223 K)b AH 'b ASt 'b
Entry Compound k (nm) s1  kcal/mol e.u.
1 3 (X = H) 400 0.61 (3) 9.6(2) - 18(1)
2 4 (X = t-Bu) 420 0.75(8) 11 (1) - 10(5)
3 5 (X = OMe) 440 1.4 (2) 8.6 (7) -20 (3)
4 6 (X = Br) 410 2.14 (3) 8.8 (7) - 19 (3)
a Mn[salophen(X)]Cl = 2.5 x 10-5 M, [H20 2] =0.17 M, [NaOH] = 2.5 x 10-4 M
2.4. Concluding Remarks
We have successfully captured the active site of catalase enzymes by designing synthetic
Hangman constructs that precisely position an acid-base functionality from a xanthene
spacer over the face of salophen redox cofactors. In these systems, the distal function of
the enzymes is faithfully modeled by the acid-base hanging group5 allowing us to
compare the chemistry of model catalase systems to their biological counterparts. Using
stopped-flow methods and m-CPBA as opposed to H202 as the peroxide substrate allows
the reaction to be arrested after O-0O bond heterolysis, and allowing the Mn(V) oxo to
build-up and be detected with facility. This intermediate is often cited as the active
catalyst in model42 and enzymatic systems, but its characterization heretofore has
remained elusive. 43' 44 In accordance with theoretical predictions of the salen catalase
models,45'46 the stopped-flow results show that the rate for the production of the high-
valent oxo at the salen platform is independent of the distal acid-base functional group.
Instead, the role of the hanging group appears to stabilize the catalyst against oxidative
degradation.
Additionally, we have established reaction conditions to generate the Schiff base-derived
Mn(V) oxo that is capable of reacting with reducing substrates. Stopped-flow kinetic data
of an electronically diverse set of Mn-salophen complexes are consistent with a
mechanism involving a rate-limiting coordination of the oxidant to generate the Mn(V)
oxo intermediates.
2.5. Experimental
2.5.1. General Methods
Dichloromethane and diethyl ether were passed through a neutral alumina column under
argon before usage. NaOCI (13% in water) and hydrogen peroxide (30% solution) were
used as received from Alfa Aesar. The purchased hydrogen peroxide was volumetrically
determined to be 10.4 M (32%) via its decomposition to oxygen gas over manganese
dioxide. Methyl alcohol (anhydrous), ethyl alcohol (anhydrous), 1,2-phenylenediamine,
ammonium hydroxide (28% NH 3 in water), 3-tert-butyl-2-hydroxybenzaldehyde, diethyl
sulfide, and triethyl phosphate were used as received from Aldrich. Manganese(II)
acetate tetrahydrate (99+%) was used as received from Strem. 4-[2,7-Di-tert-butyl-5-
(4,5-diamino-cyclohexa-1,3-dienyl)-9,9-dimethyl-9H-xanthen-4-yl]-cyclohexa-1,3-
dienecarboxylic acid methyl ester (7)5 and 3-tert-butyl-2-hydroxy-5-methoxy-
benzaldehyde, 4 7 and Mn(salophen)Cl (X = OMe (3), t-Bu (4), Br (6)) 4 8 was prepared
according to literature procedures. The compound Mn[HSX(OMe)-COOH]Cl (1) was
synthesized and characterized according to published procedures and recrystallized from
CH2C12/Et20 before usage.
5
2.5.2. Physical Measurements
'H-NMR and 13C NMR spectra were recorded at the MIT Department of Chemistry
Instrumentation Facility (DCIF) on a Varian Inova 500 spectrometer. 'H NMR chemical
shifts are quoted in ppm relative to tetramethylsilane and spectra have been internally
calibrated to the monoprotio impurity of the deuterated solvent used. Spectra were
recorded at 20 'C unless otherwise stated.
UV-Visible absorption spectra were recorded on a Spectral Instruments 440
spectrophotometer. IR absorption spectra were recorded on a Perkin-Elmer 2000 FT-IR
spectrophotometer.
2.5.3. Synthesis
2.5.3.1. H2 [HSX(OMe)-COOMe] (8)
The synthesis was accomplished as described in Scheme 2. A vial containing a stirbar
was charged with 4-[2,7-di-tert-butyl-5-(4,5-diamino-cyclohexa- 1,3-dienyl)-9,9-
dimethyl-9H-xanthen-4-yl]-cyclohexa-1,3-dienecarboxylic acid methyl ester (7) (21.0
mg, 0.0373 mmol) and 3-tert-butyl-2-hydroxy-5-methoxy-benzaldehyde (16.0 mg, 0.078
mmol). Ethanol (0.5 mL) was added, and the vial was sealed with a Teflon cap, and the
reaction mixture was allowed to stir at 100 'C for 24 hours. The desired product
precipitated out of solution as a red-orange solid and was collected on a glass frit after
filtering and copious washing with EtOH. The resulting material was purified by column
chromatography (silica gel, pentane: dichloromethane 1: 1) to elute the desired product as
a yellow solid (24 mg, 69%). 'H NMR (500 MHz, CD 2Cl 2, 8): 13.50 (s, 1H), 13.41 (s,
1H), 8.75 (s, 1H), 7.97 (s, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.53 (d, J = 2.5 Hz, 1H), 7.52
(d, J = 2.5 Hz, IH), 7.38 (d, J= 8.0 Hz, 2H), 7.32 (dd, J - 8.5 Hz, J = 2.0 Hz, 1H), 7.31
(d, J = 2.5 Hz, 1H), 7.25 (d, J = 2.5 Hz, 1H), 7.22 (d, J = 2.0 Hz, 1H), 7.18 (d, J = 8.0
Hz, 1H), 7.06 (d, J= 3.0 Hz, 1H), 7.02 (d, J = 3.0 Hz, 1H), 6.97 (d,J = 3.0 Hz, 1H), 6.58
(d, J = 3.0 Hz, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 3.51 (s, 3H), 1.76 (s, 6H), 1.46 (s, 9H),
1.43 (s, 9H), 1.39 (s, 9H), 1.37 (s, 9H). 13C NMR (125 MHz, CD 2 C12, 8)-. 167.0, 164.8,
164.3, 155.9, 155.8, 152.1, 151.9, 146.5, 146.4, 146.3, 146.1, 143.4, 142.1, 142.0, 139.72,
139.70, 138.3, 131.2, 130.9, 130.1, 129.4, 129.3, 129.0, 128.9, 128.5, 126.4, 126.3, 123.1,
122.7, 121.6, 120.1, 120.0, 119.8, 119.3, 118.8, 112.7, 112.5, 56.24, 56.20, 52.3, 35.7,
35.51, 35.49, 35.08, 35.05, 32.1, 31.85, 31.80, 29.61, 29.60. FTIR (thin film) 2958, 2870,
1719, 1611, 1577, 1445, 1393, 1362, 1333, 1279, 1234, 1211, 1151, 1061. HRMS (ESI)
Calcd for C61H 70N207: ([M + H]) = 943.5256. Found 943.5237.
2.5.3.2. Mn[HSX(OMe)-COOMe)1CI (2)
The synthesis was accomplished as described in Scheme 2. A vial containing a stirbar
was charged with H2[HSX(OMe)-COOMe] (8) (21.0 mg, 0.0222 mmol) and
Mn(OAc) 2-4H20 (6.0 mg, 0.025 mmol). Ethanol (1.0 mL) was added, followed by
CH2C12 (0.2 mL) and the reaction mixture was stirred at room temperature for 24 h. The
dark brown reaction mixture was diluted with CH2C12. The organic extract was washed
with brine, dried over Na 2 SO 4 , and concentrated under vacuum. The crude material was
purified by column chromatography (CH 2C12/Et20 gradient), and the desired product was
obtained as a brown solid (22 mg, 96%). HRESI-MS ([M - C1] ÷) C61H68N 20 7MnC1 m/z,
Calcd. 995.4402, Found 995.4436.
2.5.3.3. H2[salophen(OMe)]
A vial containing a stirbar was charged with 1,2-phenylenediamine (0.108 g, 1.00 mmol)
and 3-tert-butyl-2-hydroxy-5-methoxybenzaldehyde (0.416 g, 2.00 mmol). Ethanol (4.0
mL) was added, the vial was sealed with a Teflon cap, and the reaction mixture was
stirred at 100 'C for 21 hours. The desired product precipitated out of solution as a red-
orange solid and was collected on a glass frit after filtering and copious washing with
ethanol (0.369 g, 76%). 'H NMR (500 MHz, CD 2C 2 , 8): 13.42 (s, 2H), 8.66 (s, 2H), 7.37
(dd, J = 5.5 Hz, 3.0 Hz, 2H), 7.29 (dd, J = 5.5 Hz, 3.0 Hz, 2H), 7.03 (d, J = 3.0 Hz, 2H),
6.77 (d, J = 3.0 Hz, 2H), 3.78 (s, 6H), 1.42 (s, 18H). "3C NMR (125 MHz, CD 2C12, 5):
164.8, 155.8, 152.1, 143.0, 139.8, 128.2, 120.1 (2x), 119.0, 112.5, 56.2, 35.5, 29.5. FTIR
(thin film) 1) = 2954, 1617, 1595, 1571, 1448, 1428, 1333, 1206, 1150, 1060 cm .
HRESI-MS ([M + Na]+) C30H36N 20 4 m/z, Cacld. 511.2567, Found 511.2584.
2.5.3.4. Mn[salophen(OMe)] Cl (3)
A vial containing a stirbar was charged with H2[salophen(OMe)] (0.070 g, 0.143 mmol)
and manganese (II) acetate tetrahydrate (0.039 g, 0.158 mmol). Ethanol (1.6 mL) was
added, and the reaction mixture was stirred at room temperature for 21 hours. The dark
brown reaction mixture was diluted with dichloromethane. The organic extract was
washed with brine. The desired product precipitated out of solution as a brown solid and
was collected on a glass frit after filtering and copious washings with diethyl ether (0.072
g, 87%). HRESI-MS ([M - C1]') C30H34N20 4MnCl m/z, Calcd. 541.1894, Found
541.1870.
2.5.3.5. H2[salophen], X = H
A vial containing a stirbar was charged with 1,2-phenylenediamine (108 mg, 1.00 mmol)
and 3-tert-butyl-2-hydroxy-benzaldehyde (356 mg, 2.00 mmol). Ethanol (4.0 mL) was
added, the vial was sealed with a Teflon cap, and the reaction mixture was stirred at 100
'C for 21 hours. The desired ligand precipitated from solution as a orange solid and was
collected on a glass frit after filtering and copious washings with EtOH (287 mg, 67%).
IH NMR (500 MHz, CD2C12):. 13.80 (s, 2H), 8.69 (s, 2H), 7.41-7.36 (m, 4H), 7.31-7.29
(m, 4H), 6.88 (t, J = 7.5 Hz, 2H), 1.42 (s, 18H). 13C NMR (125 MHz, CD 2CI2):. 165.0,
161.2, 143.1, 138.2, 131.3, 131.1, 128.2, 120.1, 119.7, 118.8, 35.3, 29.6. FTIR (thin film)
2959, 2943, 2908, 2867, 1610, 1571, 1427, 1391, 1363, 1311, 1275, 1194, 1146, 1107,
1087. HRMS (ESI) Calcd for C28H33N20 2: [M + H]+ = 429.25365. Found 429.25349.
2.5.3.6. Mn[salophen]Cl, X = H (5)
A vial containing a stirbar was charged with the ligand H2[salophen], X = H (60.0 mg,
0.131 mmol) and Mn(OAc) 2 *4H20 (36.0 mg, 0.144 mmol). Ethanol (1.6 mL) was added,
and the reaction mixture was stirred at room temperature for 21 hours. The dark brown
reaction mixture was diluted with CH 2C12. The organic extract was washed with brine,
dried over Na 2 SO 4 , and concentrated to dryness. The crude material was purified by
column chromatography (CH 2CI2/Et 20/MeOH gradient), and the desired final product
Mn[salophen]C1, X = H was obtained as a brown solid (60 mg, 84%). HRMS (ESI)
Calcd for C28H3oMnN20 2Mn: [M - Cl] = 481.16823. Found 481.16650.
2.5.3.7. Mn(V)[salophenlN, X = OMe
A vial containing a stirbar was charged with Mn(salophen)C1, X = OMe (3) (25 mg,
0.043 mmol) in 0.6 mL MeOH. Under vigorous stirring at room temperature, ammonium
hydroxide (41 gL, 0.65 mmol; 16M in water) was added dropwise followed by NaOCl
(130 [tL, 0.26 mmol; 2.0 M in water). CH 2C 2 was added, followed by water to form a
biphasic mixture. The brown organic phase was washed with water (x3), dried over
Na 2 SO 4, and concentrated to dryness. The crude material was purified by flash
chromatography (CH 2C12 as eluent) to furnish the desired product as a brown solid (16.1
mg, 67%). The UV-vis spectrum of Mn(V)[salophen]N, X = OMe is shown in red in
Figure 3b (5.0 x 10 M Mn(V)[salophen]N, X = OMe in 1: 1 MeOH: MeCN at room
temperature). 1H NMR (500 MHz, CD 2Cl2): 8.84 (s, 2H), 7.85 (dd, J = 6.0 Hz, 3.0 Hz,
2H), 7.40 (dd, J = 6.0 Hz, 3.0 Hz, 2H), 7.21 (d, J= 3.5 Hz, 2H), 6.71 (d, J = 3.5 Hz, 2H),
3.81 (s, 6H), 1.48 (s, 18H). 13C NMR (125 MHz, CD 2CI 2): 166.6, 158.4, 150.4, 145.7,
143.9, 128.0, 126.4, 119.3, 115.6, 110.6, 56.1, 36.3, 29.9. FTIR (thin film) 2944, 1602,
1582, 1534, 1458, 1427, 1411, 1387, 1359, 1312, 1212, 1191, 1059, 1040. HRMS (ESI)
Calcd for C30H34MnN 304: [M + H] = 555.1930. Found 555.1911.
2.5.3.8. Mn(V)[salophenjN, X = t-Bu
A vial containing a stirbar was charged with Mn[salophen]C1, X = t-bu (4) (25 mg, 0.040
mmol) in 0.6 mL MeOH. Under vigorous stirring at room temperature, ammonium
hydroxide (41 pL, 0.65 mmol; 16M in water) was added dropwise followed by NaOCl
(130 gL, 0.26 mmol; 2.0 M in water). CH 2C12 was added, followed by water to form a
biphasic mixture. The dark organic phase was washed with water (x3), dried over
Na 2 SO 4 and concentrated to dryness. The crude material was purified by flash
chromatography (pentane:CH 2CI2 = 2:1 as eluent) to furnish the desired product as a
greenish solid (19.5 mg, 81%). The UV-vis spectrum of Mn(V)[salophen]N, X = t-Bu, is
shown in blue in Figure 3b (5.0 x 10- 5 M Mn(V)[salophen]N, X = t-Bu in 1:1
MeOH:MeCN at room temperature). 'H NMR (500 MHz, CD 2C12): 8.89 (s, 2H), 7.86
(dd, J = 6.5 Hz, 3.5 Hz, 2H), 7.61 (d, J = 2.5 Hz, 2H), 7.40 (dd, J = 6.5 Hz, 3.5 Hz, 2H),
7.27 (d, J = 2.5 Hz, 2H), 1.51 (s, 18H), 1.35 (s, 18H). 13C NMR (125 MHz, CD2C 2):
168.6, 159.5, 145.8, 141.5, 139.0, 133.1, 128.8, 128.0, 119.8, 115.6, 36.4, 34.5, 31.5,
30.0. FTIR (thin film) 2954, 2909, 2867, 1605, 1579, 1527, 1488, 1463, 1422, 1387,
1359, 1258, 1197, 1179, 1046. HRMS (ESI) Calcd for C36H47MnN 30 2: [M + H]+ =
608.30433. Found 608.30316.
2.5.4. Stopped-flow Kinetic Studies
2.5.4.1. General Considerations
All solutions were prepared and handled in an inert atmosphere (argon-filled glove box),
unless otherwise noted. Kinetics measurements were made using a Hi-Tech Scientific
(Salisbury, Wiltshire, U.K.) SF-43 multi-mixing anaerobic cryogenic stopped-flow
instrument equipped with a Hi-Tech Scientific Kinetascan diode array rapid scanning
unit. Full-spectra kinetics data were fitted globally with the commercially available
software Specfit32 with IS-2 Rapid Scanning Kinetic Software (Hi-Tech Scientific).
2.5.4.2. Materials
MeOH (anhydrous) was used as received (Burdick & Jackson). All other solvents were
purchased from VWR Scientific Products, passed through an M. Braun, Inc. purification
system and sparged with N2 to remove trace 02 prior to use. 3-Chloroperoxybenzoic acid
(m-CPBA) was purchased from Aldrich (77%) and purified by washing with pH 7.40
phosphate buffer and recrystallized from pentane to remove 3-chlorobenzoic acid. Purity
(>95%) was determined by 'H NMR.
2.5.4.3. Stopped-Flow Experiments
In a representative procedure, a gas-tight syringe was charged with 8.0 x 10-5 M (1) in 1:
1 MeOH: MeCN (25 mL, 2.0 gmol). A second gas-tight syringe was charged with 6.6 x
10-4 M m-CPBA in a 1: 1 MeOH: MeCN (25 mL, 17 imol). The solutions were loaded
into the stopped-flow spectrophotometer and triggered by simultaneous injection of a 0.1
mL of each solution to make the reactant concentrations 4.0 x 10- M and 3.3 x 104 M in
manganese and m-CPBA, respectively. The solutions were cooled to -20 'C prior to
mixing and maintained at that temperature in a chilled heptane bath throughout the
reaction. The reaction was monitored by UV-vis spectroscopy. Spectra (350-700 nm)
were acquired for 100 s at 0.5 second intervals. Figure 2.2a shows the absorption
spectrum of the Mn(III) substitution of the axial chloride ligand of the reactant by the m-
CPBA substrate. The spectral changes associated with the addition of the non-reactive
benzoate, which serves as a model for the substitution reaction, are shown in Figure 2.2b.
Conditions to obtain spectra in Figure 2.2a.
Stopped-flow UV-vis spectra obtained from reactions of m-CPBA (3.3 x 10-4) with 4.0 x
10-5 M 1 (red solid line) ca. 3 s post injection in 1:1 MeOH: MeCN at 20 'C.
Conditions to obtain spectra in Figure 2.2b
UV-vis specrum obtained from a solution of 5.0 x 10-5 M 1 in 1: 1 MeOH: MeCN at
room temperature (red solid line). UV-vis spectrum obtained from a solution of 5.0 x 10-5
M 1 in 1:1 MeOH:MeCN at room temperature in the presence of benzoic acid (5.0 x 10-3
M) (black dotted line).
Conditions to obtain spectra in Figure 2.3a
Absorption spectra obtained from spectral global analysis of a stopped-flow reaction of
4.0 x 10 -5 M 1 and 3.3 x 10- M m-CPBA in 1:1 MeOH:MeCN at -20 'C over 800 s.
2.5.5. Hydrogen Peroxide Disproportionation Reactions
Dismutation reactions were performed at room temperature in a sealed (PTFE septum) 3
mL reaction vial equipped with a magnetic stirbar and a capillary gas delivery tube linked
to a graduated burette filled with water. The reaction vial was charged with a stock
solution of the corresponding catalyst in CH2C12 (1.0 mL). MeOH (0.5 mL) was added
followed by H20 2 (790 pL, 8.22 mmol; 10.4 M (30% aqueous solution), and the reaction
mixture was stirred vigorously. The time was set to zero immediately after the addition
of H20 2. The progress of the reaction was monitored volumetrically, and the amount of
produced 02 (n) was calculated through the gas equation pV=nRT, assuming that p = 1
atm.
The amount of catalyst used to obtain the results of Table 2.2: Mn[HSX(OMe)-COOH]Cl
(1.0 mg, 0.00098 mmol; from a 1.0 mg/mL CH 2Cl 2 stock solution) to give 106 cm 3 of 02
in 1 hr; Mn[HSX(OMe-COOMe]Cl (1.0 mg, 0.00097 mmol; from a 1.0 mg/mL CH 2Cl 2
stock solution) to give 13.0 cm 3 of 02 in I hr; and Mn[salophen(OMe)]Cl (0.56 mg,
0.00098 mmol) and benzoic acid (1.2 mg, 0.00098 mmol) in 10.0 mL CH 2Cl 2 ) to give 2.5
cm 3 of 0 2 in 1 hr.
2.5.6. UV-Vis Kinetics of Mn[HSX(OMe)]C1 (1) Decomposition in the Presence of
H20 2.
Kinetic studies were performed in a sealed quartz cuvette at room temperature. The
cuvette was charged with a stock solution of 1 (2.6 x 10-5 M) in MeOH (3.0 mL). H20 2
was added (50 gL; 32% aqueous solution; d = 1.1126 g/mL), thereby generating a 2.5 x
10-5 M, 0.17 M, and 0.69 M solution of 1, H20 2, and H20, respectively. The time was set
to zero immediately after addition of H20 2. The first spectrum was taken 30 seconds after
injection of H20 2. The progress of the reaction was monitored by UV-vis spectroscopy at
two minute intervals. The decrease in absorbance at 500 nm was fitted to an exponential
function, and kobs was determined to be 2.9 x 10-4 S-1
2.5.7. Independent Generation of High-Valent Mn(V) oxo
Conditions to obtain the spectra in Figure 3a
Absorption spectra from a stopped-flow reaction of 2.5 x 10-5 M Mn[HSX(OMe)-
COOH]Cl with 1.7 x 10- M H20 2 in 2.5 x 10 4 M NaOH solution in MeOH at -50 'C.
Formation of Mn-oxo (green) is observed at - 96 s post-injection.
Conditions to obtain the spectra in Figure 3b
Absorption spectra from spectral global analysis of a stopped-flow reaction of 4.0 x 10- 5
M Mn[HSX(OMe-COOH]Cl with 3.3 x 10 4 M m-CPBA in 1: 1 MeOH: MeCN at -20
'C. The calculated Mn-oxo intermediate at -60 s post-injection is shown in green.
Conditions to obtain the spectra in Figure 3c
Absorption spectra from a reaction of 5.0 x 10-s M Mn[HSX(OMe)-COOH]CI with
iodosylbenzene (50 equiv.) in 1: 1 MeOH: MeCN at room temperature. Formation of
Mn-oxo (green) is observed 28 min post-addition. Due to insolubility of iodosylbenzene,
the reaction solution was filtered through an acrodisc prior to measurement.
Conditions to obtain the spectra in Figure 4a
Absorption spectrum from a reaction of 2.5 x 10- 5 M Mn[salophen(X)]Cl with 3.5 x 10- 2
M H2 0 2 in 2.5 x l0 g M NaOH solution in MeOH at room temperature. Formation of
Mn[salophen(t-Bu)]O (blue) is observed 10 s post-injection. Formation of
Mn[salophen(OMe)]O (red) is observed 10 s post-injection.
Conditions to obtain the spectra in Figure 3, left
Absorption spectrum from a reaction of 2.5 x 10- 5 M Mn[salophen(t-Bu)]Cl with 3.5 x
102 M H20 2 in 2.5 x 10 4 M NaOH solution in MeOH (3.0 mL) at room temperature.
Formation of Mn[salophen(t-Bu)]O (green) is observed 10 s post-injection. Et 2S (100
mL, 0.937 mmol) is added at 50 s post-injection of H20 2. Formation of Mn[salophen(t-
Bu)]Cl starting material (red) is observed 20 s post-injection of Et2S.
Conditions to obtain the spectra in Figure 3, right
Absorption spectrum from a reaction of 2.5 x 10- 5 M Mn[salophen(t-Bu)]C1 with 3.5 x
10-2 M H20 2 in 2.5 x 10- M NaOH solution in MeOH (3.0 mL) at room temperature.
Formation of Mn[salophen(t-Bu)]O (green) is observed 10 s post-injection. P(OEt) 3 (100
mL, 0.584 mmol) is added at 50 s post-injection of H20 2 . Complete re-formation of
Mn[salophen(t-Bu)]Cl starting material (red) is observed 760 s post-injection of P(OEt)3.
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Chapter 3
Synthesis of Enantiopure Manganese
Hangman Salens and Their Epoxidation
Activity
Portions of the work presented in this chapter have been published:
Yang, J. Y.; Bachmann, J.; Nocera, D. G. J. Org. Chem. 2006, 71, 8706-8714.
3.1. Motivation and Specific Aims
The Hangman salophen system described in Chapter 2 permitted the study of redox
effects on the catalase activity, and the stopped-flow detection of intermediates in the first
two steps of the catalase cycle and the kinetics of their formation, including a putative
Mn(V) oxo species. We wished to extend the reactivity of the Hangman salen framework
to oxygen atom transfer (OAT) chemistry. In addition, we sought to modify the ligand
framework to incorporate a chiral functionality to see if we can add the feature of
enantioselectivity to OAT transformations. A synthetic strategy for the construction of
chiral salen ligands bearing two rigid xanthene spacers functionalized with carboxylic
acid groups is presented. Suzuki cross-coupling methodology is used to furnish the
appropriately functionalized xanthene spacers to a salicyaldehyde, which is subsequently
condensed with (1R,2R)-(-)- 1,2-diaminocyclohexane to produce salen ligands featuring
an expandable molecular cleft capable of multiple hydrogen bonding interactions, in
addition to metallosalen oxidation chemistry. Within this functionalized Hangman
framework, the stereochemistry of the cyclohexane backbone of the salen platform is
revealed in the epoxidation of 1,2-dihydronapthalene by the metal oxo.
3.2. Background
Catalytic oxygen atom transfer chemistry to olefins using first row metallosalen
compounds was first explored by Kochi1 -2 and Burrows 3 using achiral salen ligands.
Shortly thereafter, Katuski4 and Jacobsen 5 independently synthesized manganese salen
complexes incorporating chiral functionalities into the ligand that were capable of
epoxidizing a wide range of olefins with very high selectivity. Manganese salen catalysts
have been optimized to synthesize cis-disubstitued,6' 7  trans-disubstituted,8' 9
trisubstituted, 1o and even some monosubstituted'1 epoxides with high enantioselectivity.
Prior to this, the most selective epoxidation catalyst had been titanium tartrate, which is
limited in substrate scope to allylic alcohols.12 The broad substrate scope of manganese
• 5 13-19
salens and modular synthesis led to a rapid expansion to catalyst variants. 5,13-19
The most commonly used and commercially available catalyst is manganese [(1,2-
cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)] chloride (shown in Chart
Chart 3.1
t-Bu--<478 M t-Bu
t-Bu t-Bu
Jacobsen's catalyst
R2  R3  0
catalyst R R3R1 R4 R1 R4
80 - 95% ee
3.1), which combines the key electronic and steric features necessary for high selectivity
with synthetic accessibility and substrate generality.6" 3-20 It is frequently employed on
both a laboratory and industrial scale and its synthesis has been commercialized on a
multi-hundred kilogram scale.21'22 The widespread use of this catalyst has been fueled by
its ease of use and economical cost. This has mediated one of the catalyst's shortcomings;
decomposition under the oxidizing conditions typically limits the catalyst to double digit
turnover numbers (TON). Depending on the substrate, the TON can be as low ten.5 Given
the remarkable ability for the manganese Hangman porphyrins (HPX) to enhance the
epoxidation of olefins by an order of magnitude over the unmodified platform using the
mild oxidant hydrogen peroxide, we set out to unite the enantioselective OAT chemistry
of a salen framework with the PCET-mediated catalysis afforded by a Hangman
framework.
3.3. Results and Discussion
3.3.1. Ligand Design
We wished to incorporate the highly successful chiral 1,2-diaminocyclohexane bridge
into our Hangman architecture. This objective precluded the use of Hangman salophen
platforms of the type presented in Chapter 2, because the ligand bridge lacks the sp 3
carbons that can impart chirality. Simply replacing the 1,2-phenylenediamine backbone is
not prudent; attachment of the xanthene scaffold on a cyclohexane backbone would
dynamically shift the ligand geometry as it transitioned through chair and boat
conformers. Additionally, forming a bond between the aryl-carbon on the xanthene to the
aliphatic-carbon bond on the cyclohexanediamine is synthetically more challenging
relative to aryl-aryl bond coupling. Therefore, we sought to adjust the attachment point of
Chart 3.2
t-Bu t-Bu t-Bu t-Bu
/ 0 o0 \ 0 0
OH HO - -H HO
N -N\ - -N-/ \ -o 0 / \ / \ _ 0 0
t-Bu t-Bu t-Bu t-Bu
HSX* HphSX*
the functionalized xanthene to the 5 and 5' position on the phenolic arms of the
macrocycle.
The two imine bonds on a salen are prone to hydrolysis23-26 and exchange 27 which makes
it difficult to synthesize salens composed of two uniquely functionalized
salicylaldehydes, since they can easily disproportionate in the presence of trace water to
form a mixture of symmetric and asymmetric salens.2 29 (This issue is discussed further
in Chapter 5). To circumvent this problem, we construct the symmetric salen complex
using two equivalents of the functionalized salicylaldehyde per 1,2-cyclohexanediamine
bridge. The (1R,2R)-(-)-1,2-diaminocyclohexane enantiomer was targeted owing to its
lower cost. As the role of the acid-to-metal distance is unclear, we set out to synthesize
the two variants, named HSX* and HphSX*, shown in Chart 3.2. The synthesis and OAT
chemistry of these compounds is described below.
3.3.2. Synthesis of Hangman Salen Ligands (HSX*)
Scheme 3.1 illustrates our initial attempts to synthesize 5, the precursor to synthesis of
the HSX* ligand. We followed established methods to functionalize the xanthene bridge
selectively with a carboxylic acid (1) from the commercially available xanthene
dibromide.30,31 The methyl ester (2) derivative is obtained directly by protection of 1
upon refluxing methanol with a catalytic amount of sulfuric acid.31 We initially focused
on obtaining 5 by replacing the bromide in 1 with a boronic acid in order to establish a
site for subsequent cross-coupling with 5-bromosalicylaldehyde. This was achieved using
palladium catalyzed cross-coupling conditions with bis(pinacolato)diboron, 32 but the
reaction and the subsequent Suzuki coupling only proceeded when the acid is protected
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by an ester functionality. Methyl ester 2 was used to obtain the boronic ester which is
hydrolyzed to the boronic acid upon recrystallization to generate precursor 3 in 43%
yield. X-ray quality crystals confirmed the structure, shown in Figure 3.2 in the
Experimental Section. 3 is then coupled to 5-bromosalicylaldehyde to afford precursor 4
in 40% yield.33' 34 The two coupling steps provided product for a combined 17% yield.
However, it was found that the methyl ester proved difficult to deprotect to achieve the
desired precursor 5. Very little or no reaction was observed upon refluxing with a variety
of weak bases; the harsher reagent boron tribromide successfully gave the acid with a
modest 28% yield.
Alternatively, the benzyl ester protecting group on the acid was also used as shown in
Scheme 3.2. The benzyl ester 6 can be made in quantitative yield from the previously
described precursor 1 using benzyl alcohol and 3-dicyclohexylcarbodiimide with a
catalytic amount of 4-dimethylaminopyridine. 35 Following the otherwise analogous
synthetic route of replacing the bromide on the benzyl ester protected xanthene with a
boronic acid followed by Suzuki coupling to 5-bromosalicylaldehyde to give 8 also
Scheme 3.2
t-Bu t-Bu
\ýCO 2 H CO2Bn
a b
Br Br
t-Bu t-Bu
1 6
t-Bu t-Bu
CO2Bn CO2Bn
0 C00 c0
/ \ /a 0B(OH) 2  \ ' OH
t-Bu t-Bu
7 8
t-Bu
\ CO2Bn
/ N B(OH) 2
t-Bu
7
t-Bu
/ CO2H
d
0
/ -0
-OH
t-Bu
(a) benzyl alcohol, DCC, DMAP, CH 2Cl2, (b) bis(pinacolato)diboron, Pd(dppf)Cl 2,
KOAc, DMSO, (c) 5-bromosalicylaldehyde, Pd(dppf)C12, Na 2CO 3, DME: H20 (9:1),
(d) H2, Pd on charcoal, ethyl acetate
resulted in a modest combined yield of 19% in the successive palladium catalyzed cross-
coupling steps. Although the benzyl ester was easier to cleave using hydrogen gas over
activated palladium on charcoal, the overall yield along this synthetic pathway was not
favorable. We therefore sought an alternative synthetic pathway to the Hangman salen
ligand HSX*.
Scheme 3.3 outlines the synthetic strategy that successfully delivers the HSX* ligand in
good yield. With the appropriately functionalized xanthene precursor 1 in hand, the
construction of the salen macrocycle begins with the catenation of 3-formyl-4-
ethoxyphenyl boronic acid to the remaining bromide of 1. Effectively the site of boronic
acid and bromide functionalization on the xanthene and salicylaldehyde has been inverted
form that of Scheme 3.1 and Scheme 3.2. This important modification provides a better
nucleophilic site for the Suzuki cross-coupling step than the boronic acid functionalized
xanthene and consequently delivered 9 in good yield. Subsequent deprotection of the
methyl ether by treatment with boron tribromide 36' 37 yields the appropriate xanthene
functionalized salicylaldehyde derivatives 5. The construction of the salen ring is
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completed with the condensation, in high yield, of 5 with 0.5 equivalents of (lR,2R)-(-)-
1,2-diaminocyclohexane to produce the desired Hangman salen ligand 11. Mass spectral
evidence shows no evidence of any singly condensed diamine product and the 1H NMR
integrations are consistent with two functionalized xanthenes to one cyclohexanediamine
bridge. Analogous porphyrins ligands bearing two xanthene bridges possess two different
atropisomers (xanthenes facing each other across the macrocycle as opposed to the
xanthenes being one-up and one-down) that can be independently identified by 1H NMR
spectroscopy. For these porphyrin ligands, no exchange is observed between the two
atropisomers in solution at room temperature. 38'3 9 In contrast, the 'H NMR for the HSX*
and HphSX* ligands at room temperature show only one set of well-resolved ligand
peaks, suggesting there is either one atropisomer in solution, or exchange between the
two is extremely rapid. The metallated salen 12 is synthesized by refluxing the ligand
with manganese(II) acetate in air, followed by an aqueous sodium chloride solution
workup, which provides the chloride salt.
3.3.3. Synthesis of Benzoic Acid Functionalized Hangman Salen Ligands (HphSX*)
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In order to assemble the benzoic acid functionalized Hangman salen ligand (HphSX*), we
targeted the synthesis of precursor 25 (shown in Scheme 3.6). The selective
functionalization of the 4 and 5 positions of the xanthene spacer with a benzoic acid and a
salicylaldehyde functionality, respectively, was required. In order to attach these two
aryl groups, we once again looked to palladium-catalyzed cross-coupling methods.
The most straightforward attempt to achieve this selective functionalization is described
in Scheme 3.4. Xanthene dibromide was first allowed to react with one equivalent with
of 4-methoxycarbonylphenylboronic acid as shown in route A under Suzuki coupling
conditions. However, this did not result in the mono-functionalized xanthene spacer; the
product consisted only of the symmetric doubly functionalized benzoic acid (28). The
next attempt (route B) began with the boronic acid/ester group on the xanthenes,
effectively reversing the electrophile/nucleophile groups for the coupling reaction.
0
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Reaction with less than one equivalent of 5-bromosalicylaldehyde and methyl-4-
bromobenzoate resulted primarily in the bis-coupled products 14 and 28. The highest
yield for a monocatenated product was obtained by coupling the xanthene dibromide with
0.75 equivalents of 3-formyl-4-methoxyphenylboronic acid, which only provided 5%
yield of 15. Upon deprotection of the methyl ether via boron tribromide, we obtain 16,
which can be subsequently coupled under Suzuki conditions with
methoxycarbonylphenylboronic acid to give 17 for an overall yield of less than 3%. From
the resulting predominant biscoupled products in this series of reactions, it is apparent
that the initial coupling to the xanthene bromo or boronic acid group activates the other
aryl carbon site palladium-catalyzed Suzuki coupling that we employ, thus resulting in
impractical yields for the overall synthesis.
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We therefore sought to begin our synthesis with differentially functionalized xanthenes as
starting synthons, thereby introducing the selectivity before addition of the benzoic acid
and salicylaldehyde to the xanthene framework, as shown in Scheme 3.5. We xanthene
dibromide was treated with one equivalent of phenyllithium, followed by addition of
triisopropyl borate and hydrolysis. The resulting product (19) could be purified via
column chromatography. However, 19 was completely unreactive to the aryl boronic
acids and aryl bromides that we tested under a variety of Suzuki- coupling conditions.
Attempts were made to promote coupling using conditions described to couple the
generally more difficult aryl chlorides.4044 Notwithstanding, precursor 19 was found to
be completely inert to palladium-catalyzed cross-coupling conditions. In the same vein,
we isolated the alkyltin and bromo functionalized xanthene 18 was isolated by using
trimethyltin chloride following treatment with phenyllithium. Stille-coupling conditions45
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were attempted in an effort to attach a salicylaldehyde to the aryl tin site, but this strategy
also proved fruitless. It is not entirely clear why a xanthene functionalized with both
nucleophlilic and elctrophilic group would be unreactive to aryl-aryl bond coupling.
However, it appears from the attempts outlined in Scheme 3.4 that there are non-trivial
electronic effects between the two aryl carbons that are the site of functionalization. The
oxygen on the xanthene may effectively neutralize the nucelophilic or electrophilic nature
of the functionalized aryl carbons, limiting their ability to react with the palladium
catalyst.
Ultimately, the selective aryl coupling to the xanthene was achieved by an alternative
route, described in Scheme 3.6.46 The unreactive alkyltin and bromo functionalized
xanthene (20) was treated with elemental iodine to give 21. This allows the more
reactive aryl iodide to be selectively coupled to 4-bromobenzoic acid methyl ester using
the catalyst tetrakis(triphenylphosphine)palladium to give the benzoic acid methyl ester
functionalized xanthene 22, which can be deprotected to the acid by refluxing in base to
give 23. The bromo site on 23 can then be coupled to 3-formyl-4-methoxyphenyl boronic
acid to give 24, respectively. Deprotection of the methyl ether using boron tribromide
furnishes the salen precursors 25, which can be condensed with half an equivalent of
(1R,2R)-(-)-l,2-diaminocyclohexane to give the targeted benzoic acid and ester
functionalized Hangman ligand. Manganese ion is inserted into the salen core by
refluxing the ligand with an excess of manganese acetate in air, followed by workup with
a saturated aqueous sodium chloride solution to give 27 in 93% yield.
3.3.4. Epoxidation Activity of Manganese Hangman Salens
We tested the epoxidation of the prochiral olefin 1,2-dihydronapthalene by Mn(HSX*-
COOH)Cl (12) using sodium hypochlorite as the oxygen atom transfer source, and
conditions found to be optimal for previously studied manganese salen compounds. 47 We
were pleased to find that our modified chiral salen macrocycle transfers stereochemical
information in the oxygen atom transfer reaction to the prochiral substrate. The epoxide
product was resolved with 23% enantiomeric excess (ee) as determined by chiral GC, and
demonstrates communication with the chiral backbone and substrate despite the xanthene
functionalizations situated at the 5 and 5' position of the macrocycle. Whereas this ee
does not compete with the best salen epoxidation catalysts, it is on par with the
"introductory" ees observed for first generation catalysts, such as salen macrocycles
unfunctionalized in the 3 and 3' positions.' 5 However, we feel that we can improve on
this by making a minor modification on the ligand macrocycle.
3.3.5. Design of Sterically Protected Hangman Salens
Figure 3.1. Potential approaches of an olefin to Jacobsen's Catalyst. The high valent
oxo bound to the manganese (not shown) is perpendicular to and coming out of the
page. Figure is adapted from reference 19.
b
t-Bu'
The high selectivity that has been the centerpiece of Jacobsen's catalyst is believed to be
enforced by sterically encumbering functionalities incorporated in the macrocycle. Figure
3.1 shows the potential directions substrate can approach the high valent Mn(oxo), the
catalytic oxidant. T-Butyl group in the 5 and 5' position blocks approaches a and b, while
the tert-butyl groups in the 3 and 3' position deter approach c. This favors the
unencumbered approach a, which maximizes substrate communication with the chiral
diamine, orienting the substrate for high resulting enantioselectivity upon oxygen atom
transfer. 13- 15 ,19' 4 8'4 9 With this in mind, changes in the site of functionalization around the
macrocycle was considered with the goal of optimizing the enantiomeric selectivity
within this Hangman framework. Although determining the optimal routes in the initial
Hangman synthesis was not as straightforward as we had hoped, the modular nature of
salen ligands allowed us to more easily revise the ligand to add the bulky substituents at
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the desired 3 and 3' position. As described below, we were indeed able to quickly access
the HSX*tBu and HphSX* tBu ligands shown in Chart 3.3.
3.3.6. Synthesis of Mn[HSX* tBulCI and Mn[HphSX* tBu]CI
The synthesis of the Hangman family of salens substituted with tert-butyl groups in the 3
and 3' positions is presented in Scheme 3.7. The ligand construction again begins with
the commercially available 4,5-dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene to give
the functionalized precursors 1 and 22, as described earlier in this Chapter. Synthesis of
the precursor boronic ester 29, which installs the tert-butyl groups on the salicylaldehyde
prior to insertion into the ligand, required a two-step procedure. Firstly, the commercially
available 3-tert-butyl-2-hydroxybenzaldehyde was functionalized with a bromo group in
the 5 position (28) as described in the literature. 50 The bromo was then replaced with a
boronic ester functionality by palladium catalyzed cross coupling methods51 to give 29.
Synthon 29 serves as a good nucleophilic substrate for the conversion of xanthene
precursors 1 and 22 to 31 and 32, respectively. 34 Hangman ligands 33 and 34 are
provided by the condensation of 31 and 32 with 0.5 equivalent of (IR,2R)-(-)-1,2-
diaminocyclohexane. The amount of product depends critically on the stoichiometry of
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SR1 = H
a
29: R1 = Br
b 30: R, = B
t-Bu t-Bu t-Bu t-Bu
R2 R2 R2R
0d II.O.. O -O Q
St-Bu t-Bu t-Bu
t-B ""t-Bu t-Bu
t-Bu t-Bu t-Bu t-Bu
1: R2 = CO2H 31: R2= CO2H 33: R2= CO2H, M=2H e 35: R2= CO2H, M=MnCI
23: R2 = PhCO 2H 32 : R2= PhCO 2H 34: R2= PhCO 2H, M=2H 36: R2= PhCO 2H, M=MnCI
(a) Br 2, HOAc, (b) bis(pinacolato)diboron, KOAc, Pd(PCy 3)2, (c) 3-t-Butyl-2-
hydroxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzaldehyde, Na2CO3,
Pd(PPh 3)4, DMF/H20, (d) (I R,2R)-(-)-1,2-diaminocyclohexane, EtOH, (e) i)
Mn(OAc) 2(H20) 4, EtOH, ii) aq. NaCl
R,
(1R,2R)-(-)-1,2-diaminocyclohexane. If more than 0.5 equivalent is used, varying
amounts of product with an incompletely formed macrocycle is obtained; only one imine
forms to make an -- (ONN)- tridentate sparingly soluble ligand impurity. This
unintended product can be identified by 'H NMR and mass spectrometry. When 0.5
equivalent of (lR,2R)-(-)- 1,2-diaminocyclohexane is employed, 1H NMR integrations of
33 and 34 establish the presence of one cyclohexanediimine per two xanthene scaffolds.
Manganese acetate is again an efficient metalation agent for 33 and 34. The oxidized
Mn(III) products 35 and 36 are obtained when the metalation is performed in air followed
by a workup with aqueous sodium chloride.
3.3.7. Epoxidation Activity of Sterically Protected Manganese Hangman Salens
To investigate whether the presence of the acid Hangman moiety in conjunction with 3
and 3' substitution leads to better yields as well as enantioselectivity, a comparative study
was undertaken of the epoxidation of the prochiral olefin, 1,2-dihydronapthalene by 35
and 36 versus the unsubstituted Hangman salens, Mn(HSX* tBu-COOH)Cl and
Mn(HphSX* tBu-COOH)C1, and the non-Hangman catalyst (1R,2R)(-)[1,2-
cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)]manganese(III) chloride
(Jacobsen's catalyst). 47 Table 3.1 lists the TONs measured by GC/MS for the various
catalysts and oxidants. Unlike the Hangman porphyrin complexes, hydrogen peroxide is
limited in its utility as an oxidant owing to its proclivity to disproportionate. ' Hence
low TONs are observed for hydrogen peroxide as an oxidant even when diluted solutions
are added via a syringe pump to high concentrations of substrate to reduce the amount of
available hydrogen peroxide in solution. Conversely, the more commonly used oxidants,
sodium hypochlorite (NaOC1) under biphasic reaction conditions of dichloromethane and
water, and iodosobenzene (PhIO) in dichloromethane, results in higher TONs, but are
commensurate with the unmodified platform. The reactions using hydrogen peroxide and
iodosobenzene as the oxidant were also performed in the presence of one equivalent of
N-methylimidazole, as that has been shown to sometimes favorably affect overall activity
and catalyst stability. For the oxidants or conditions that we tried, we did not see any
significant improvement in TONs in the Hangman complexes, although both acid
functionalized Hangman complexes 35 and 36 give products with a considerably
Table 3.1. Turnover numbers (TON) for epoxidation of 1,2-dihydronapthalene in
dichloromethane
[O]
0
Oxidant t (hrs) Catalyst
Mn(salen)C1 a Mn(HSX*-tBu)C1 Mn(HphSX*-tBu)Cl
NaOC1 3 21 12 29
NaOCI 24 76 59 69
PhIO 3 22 28 25
PhlO 24 89 79 85
PhlO b 3 24 31 25
PhlO b 24 80 75 85
H202  4 3 2 2
H202b  4 6 9 4
a salen = (IR, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)].
b With 1 equivalent of N-methylimidazole.
improved 53% ee, demonstrating that the functionalities at the 3 and 3' positions on the
salicylaldehyde are a critical element for good enantioselectivity by maximizing
stereochemical communication between the manganyl oxo and substrate.13-15,19,49,54
3.3.8. Mechanistic Implications
Mn(V) oxo is believed to be the enantioselective oxidant in manganese salen epoxidation
reactions.' This manganyl oxo is formed by the activation of the O-X bond
(intermediate A in Scheme 3.8) of various oxidants."55 Computational56 studies performed
on the O-0O bond cleavage of acylperoxo manganese salen complexes in acidic and
neutral media identify the proton as a means to promote O-O bond heterolysis, and
prevent O--O bond homolysis to produce the less reactive Mn(IV) oxo. Such acid-base
induced bond activation chemistry, classically known as the "pull effect" in heme
oxidations, 57-6 1 is responsible for the enhanced olefin epoxidation observed in Hangman
porphyrin complexes.31,62 We did not see an increase in TON for our Hangman salenporphyrin complexes. We did not see an increase in TON for our Hangman salen
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compounds with iodosylbenzene and hypochlorite as the oxidant. We can therefore infer
that the acid group does not have any effect on cleaving the O-I or O-Cl bond,
respectively, to form B in Scheme 3.8. Using hydrogen peroxide as the oxidant, excess
equivalents successfully compete with substrate upon formation of B, and the catalase
activity mentioned in Chapter 2 (and Chapter 4, vide infra) predominates. Hence, olefins
are a poor probe for Mn(V) oxo formation with H20 2 as an oxidant. We also tried to
probe Mn(V) oxo formation with hydrogen peroxide using more electron rich substrates
such as sulfides or phosphates, but they are easily oxidized in the presence of oxidant
without any catalyst.
3.4. Concluding Remarks
We have developed a versatile methodology to install Hangman scaffolds on salen
macrocycles while maintaining the ligand's chiral framework. Two functionalized
xanthene scaffolds form a symmetric molecular cleft, which can be structurally tuned
with spacers appended to the xanthene scaffold. Epoxidation studies using prochrial
substrates such as 1,2-dihydronapthalene demonstrated asymmetric induction with an
introductory ee of 23%. Addition of tert-butyl groups on the macrocycle confers an
improved 53% enantioselectivity by promoting substrate interaction with the chiral
cyclohexanediamine backbone of the salen macrocycle. The turnover number (TON) for
•Y
epoxidation was also determined using hydrogen peroxide, sodium hypochlorite, and
iodosylbenzene as oxidants. We did not see any enhancement in TON for our Hangman
compounds, indicating either that the acid-hanging group does not facilitate formation of
the oxidizing intermediate (Mn(V) oxo) or that oxygen atom transfer to the olefin is the
rate-determining step in the epoxidation reaction.
3.5. Experimental Section
3.5.1. Materials
Silica gel 60 (70 - 230 and 230 - 400 mesh) was used for column chromatography.
Analytical thin layer chromatography was performed using F254 silica gel (pre-coated
sheets, 0.2 mm thick). Solvents for synthesis were reagent grade or better and used as
received from Aldrich or dried according to standard methods. 63 4,5-Dibromo-2,7-di-tert-
butyl-9,9-dimethylxanthene, boron tribromide (1.0 M in dichloromethane), (1R,2R)-(-)-
1,2-diaminocyclohexane, manganese(II) acetate tetrahydrate, 5-bromosalicylaldehyde, 4-
dimethylaminopyridine, 3-dicyclohexylcarbodiimide, 3-tert-butyl-2-
hydroxybenzaldehyde, 1,2-dihydronaphthalene, dodecane, and N-methylimidazole were
used as received from Aldrich. Iodosobenzene was used as received from TCI America.
Bis(pinacolato)diboron, 3-formyl-4-methoxyphenylboronic acid, and 4-
methoxycarbonylphenylboronic acid were used as received from Frontier Scientific.
Sodium carbonate, potassium acetate, dichloro[ 1,1 '-
bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct,
tetrakis(triphenylphosphine)palladium, bis(tricyclohexylphosphine)palladium(0),
trimethyltin chloride, tri(n-butyl)tin chloride, tri(i-propyl)borate, and (1R, 2R)-(-)-[1,2-
cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)]manganese(III) chloride
were used as received from Strem Chemicals. Phenyllithium (1.6- 1.7 M in cyclohexane)
and 30% aqueous solution of hydrogen peroxide were used as received from Alfa Aesar.
The following compounds were obtained using published protocols and their purity
confirmed by IH NMR: 4-hydroxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-
dimethylxanthene (1),31,39 4-methoxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-
dimethylxanthene (2), 31 4-bromo-2,7-di-tert-butyl-5-iodo-9,9-dimethyl-9H-xanthene 4-
(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-benzoic acid methyl ester
(22),46 and bromo-3-tert-butylsalicylaldehyde (1).64 An optimized synthesis for 4,5-di(5-
salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (14) will be presented in Chapter
5.
3.5.2. Physical Measurements
'H NMR, 13C NMR and "B NMR spectra were collected in CDCl3 or C 4DsO80 (Cambridge
Isotope Laboratories) at 25 'C unless otherwise noted. Spectra were taken on an Inova
500 or Mercury 300 Spectrometer housed in the MIT Department of Chemistry
Instrumentation Facility (DCIF). All chemical shifts are reported using the standard 6
notation in parts-per-million relative to tetramethylsilane. The 'H NMR and "3C NMR
spectra have been internally calibrated to the monoprotio impurity of the deuterated
solvent used. Boron trifluoride etherate was used as the standard for the "B NMR. High-
resolution mass spectral analyses were carried out by the MIT DCIF on a Bruker
APEXIV47e.FT-ICR-MS using an Apollo ESI source.
3.5.3. Synthesis
3.5.3.1. 5-(Boronic acid)-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthene-4-carboxylic
acid methyl ester (3)
Under nitrogen, 4-methoxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-dimethylxanthene (2)
(1.00 g, 2.18 mmol), bis(pinacolato)diboron (0.830 g, 3.27 mmol), potassium acetate
(0.747 g, 7.63 mmol), dichloro[1,1'-bis(diphenylphosphino)ferrocene]-palladium(II)
dichloromethane adduct (0.159 g, 0.218 mmol) was added to 10 mL of anhydrous
dimethylsulfoxide and heated to 90 'C for 36 hours. Upon cooling, 60 mL of benzene
was added and the solution was washed with 3 x 100 mL of deionized water. The organic
layer was dried over MgSO 4 and reduced by rotary evaporation to obtain a black crude
product which was taken up in 200 mL of hexane and filtered; this was repeated three
times. The combined filtrates were reduced by rotary evaporation and the resulting solid
was recrystallized in hot isopropyl alcohol to yield the product as a white crystalline solid
upon cooling (0.398 g, 43% yield). X-ray quality crystals were grown from isopropyl
alcohol; the structure is shown in Figure 3.2. 'H NMR (500 MHz, CDCl3, 6): 7.56 (d, J =
2.5 Hz, IH), 7.51 (d, J = 2.5 Hz, IH), 7.48 (m, 2H), 3.95 (s, 3H) 1.62 (s, 6H) 1.41 (bs,
2H), 1.34 (s, 9H), 1.33 (s, 9H). '3C NMR (500 MHz, CDC13, 6): 166.7, 152.6, 149.1,
145.8, 145.0, 135.5, 131.4, 128.6, 128.0, 127.4, 126.2, 125.5, 116.2, 64.3, 52.8, 34.5,
33.0, 32.9, 31.7, 31.5, 24.9. HRESI-MS ([M + H]+) C2 5H340 5 B m/z, Calcd. 425.2495,
Found 425.2494. Subsequent synthetic procedure to bring 3 to 4 and then 5 as shown in
Scheme 3.1 can be found in Appendix B.
Figure 3.2. Thermal ellipsoid plot of 5-(boronic acid)-2,7-di-tert-butyl-9,9-dimethyl-
9H-xanthene-4-carboxylic acid methyl ester (3). Thermal ellipsoids are drawn at the
50% probability level.
3.5.3.2. 5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthene-4-carboxylic
benzyl ester (6)
acid
4
-Hydroxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-dimethylxanthene (1) (0.500 g, 1.12
mmol), 4-dimethylaminopyridine (0.013 g, 0.107 mmol), and benzyl alcohol (0.12 mL,
1.12 mmol) was added to 50 mL of dry dichloromethane and the solution was cooled to 0
'C in an ice water bath. To this, 1.22 mL of a 1.0 M solution of 3-
dicyclohexylcarbodiimide in dichloromethane (1.22 mmol) was added and the reaction
stirred at 0 'C for 10 minutes than warmed to room temperature. Upon stirring for an
addition 6 hours at room temperature, the solution was again cooled to 0 'C, filtered, and
washed with a minimal amount of cold dichloromethane (about 6 mL). The filtrate was
reduced by rotary evaporation; the crude product was purified by column
chromatography (silica gel, 9:1 hexane: ethyl acetate) to elute the product as a pale
yellow oil that solidified under vacuum overnight. (0.599 g, 99% yield). IH NMR (500
MHz, CDCl3, 6): 7.71 (d, J = 2.5 Hz, 1H), 7.54 (m, 3H), 7.45 (d, J = 2.4 Hz, 1H), 7.38
(m, 2H), 7.33 (m, 2H) 5.50 (s, 2H), 1.65 (s, 6H), 1.34 (s, 9H), 1.33 (s, 9H). 13C NMR
(500 MHz, CDCI3, 6): 167.1, 147.4, 147.3, 145.7, 145.3, 136.5, 131.1, 130.7, 128.74,
128.72, 128.68, 128.3, 126.7, 126.6, 121.7, 119.7, 110.5, 67.3, 35.4, 34.79, 34.76, 32.2,
31.6, 20.8. HRESI-MS ([M + Na]÷) C3 1H350 3BrNa m/z, Calcd. 557.16406, Found
557.1641.
3.5.3.3. 2,7-Di-tert-butyl-9,9-dimethyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-
yl)-9H-xanthene-4-carboxylic acid benzyl ester (7)
Under nitrogen, 5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthene-4-carboxylic acid
benzyl ester (6) (0.500 g, 0.93 mmol), potassium acetate (0.321 g, 3.27 mmol),
bis(pinacolato)diboron (0.355 g, 1.40 mmol), and dichloro[l,1'-bis(diphenyl-
phosphino)ferrocene]palladium(II) dichloromethane adduct (0.068 g, 0.093 mmol) was
added to 5 mL of anhydrous dimethylsulfoxide and heated to 90 'C for 24 hours. Upon
cooling, 25 mL of benzene was added and the solution was washed with 3 x 50 mL of
water and dried with MgSO 4. The solvent was removed by rotary evaporation and the
resulting crude black oil was put under vacuum overnight to give a crude black solid. The
solid was stirred in 100 mL of hexane and filtered; this procedure was repeated three
times. The combined filtrate was rotary evaporated to reveal a semicrystalline colorless
solid, which was used in the next step without further purification.
3.5.3.4. 2,7-Di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid benzyl ester (8)
Under nitrogen, 2,7-di-tert-butyl-9,9-dimethyl-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-9H-xanthene-4-carboxylic acid benzyl ester (7) (0.307 g, 0.61
mmol) is added to 5-bromosalicylaldehyde (0.123 g, 0.61 mmol), sodium carbonate
(0.094 g, 0.91 mmol), dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II)
dichloromethane adduct (0.027 g, 0.034 mmol), 9 mL of 1,2-dimethoxyethane and 3 mL
of deionized water and heated to 90 'C for 48 hours. Upon cooling, 50 mL of
dichloromethane was added and the solution was washed with 2 x 50 mL of deionized
water. The combined aqueous layers were extracted with 20 mL of dichloromethane, and
the combined organic layers were dried with MgSO4. Upon solvent removal by rotary
evaporation the crude solid was purified by column chromatography (silica gel, 8:2
hexane: ethyl acetate) to elute the desired product as a colorless solid (0.102 g, 29%). 'H
NMR (500 MHz, CDCl3, 6): 11.03 (s, 1H), 9.96 (s, IH), 7.91 (d, J = 2.5 Hz, 1H), 7.72
(dd, J = 8.5 Hz, 2 Hz, 1H), 7.58 (m, 2H), 7.46 (d, J = 2 Hz, IH), 7.24 (m, 4H), 7.15 (m,
2H), 7.00 (2, J = 8.5 Hz, 1H), 5.06 (s, 2H), 1.71 (s, 6H), 1.37 (s, 9H), 1.33 (s, 9H).
HRESI-MS ([M + Na]÷) C38H40OsNa m/z, Calcd. 599.2768, Found 599.2781. Synthetic
procedure to deprotect 8 to give 5 can be found in Appendix B.
3.5.3.5. 2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-xanthene-
4-carboxylic acid (9)
Under nitrogen, a mixture of 4-hydroxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-
dimethylxanthene (1) (0.150 g, 0.338 mmol), 3-formyl-4-methoxyphenylboronic acid
(0.067 g, 0.371 mmol), sodium carbonate (0.052 g, 0.507 mmol),
tetrakis(triphenylphosphine)palladium (0.015 g, 0.020 mmol), DMF (9 mL), and
deionized water (I mL) was heated to 90 'C for 36 hours. Upon cooling, 10 mL of water
was added and the mixture was extracted with 3 x 25 mL of dichloromethane. The
organic portions were combined and dried over MgSO 4 and the solvent removed by
rotary evaporation. The crude solid was purified by column chromatography (silica gel,
8:2 pentane: ethyl acetate) to elute the colorless product (0.108 g, 64% yield). 'H NMR
(500 MHz, CDCI3, 6): 10.55 (s, 1H), 8.03 (d, J = 2.5 Hz, 1H), 7.98 (d, J = 2.5 Hz, 1H),
7.70 (dd, J = 8.5 Hz, 2 Hz, 1 H), 7.68 (d, J = 2.5 Hz, 1H), 7.49 (d, J = 2.5 Hz, 1H), 7.21
(d, J = 2 Hz, IH), 7.15 (d, J = 8.5 Hz, 1H), 4.02 (s, 3H), 1.73 (s, 6H), 1.37 (s, 9H), 1.34
(s, 9H). 13C NMR (500 MHz, CDCl 3, 6): 190.1, 167.8, 161.7, 148.3, 147.1, 146.3, 144.7,
137.6, 134.2, 131.3, 130.1, 130.0, 129.3, 128.21, 128.16, 126.4, 124.8, 122.1, 116.9,
112.2, 56.0, 35.1, 34.83, 34.80, 32.0, 31.7, 31.5. HRESI-MS ([M - H] ) C3 2H350 5 m/z,
Calcd. 499.2490, Found 499.2482.
Figure 3.3. Thermal ellipsoid plot of 2,7-di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-
9,9-dimethyl-9H-xanthene-4-carboxylic acid (5). Thermal ellipsoids are drawn at the
50% probability level.
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3.5.3.6. 2,7-Di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-xanthene-
4-carboxylic acid (5)
2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid (9) (0.545 g, 1.11 mmol) was added to 20 mL of dry dichloromethane and
cooled to 0 'C. A solution of boron tribromide (3 mL, 1.0 M in dichloromethane) was
added and upon stirring for 3 hours, 20 mL of water was added. The organic layer was
separated, washed with 10 mL of water, and dried over MgSO 4. The solvent was
evaporated and the residue was purified by column chromatography (silica gel, 98:2
dichloromethane: methanol) to elute the product (0.330 g, 62% yield). X-ray quality
crystals were grown by slow evaporation of a saturated dichloromethane solution. The
structure is shown in Figure 3.3. 1H NMR (500 MHz, CDCI3): 8 = 11.13 (s, IH), 9.97 (s,
1H), 8.02 (d, J = 2.5 Hz, 1H), 7.79 (d, J = 2.5 Hz, 1H), 7.71 (d, J = 2.5 Hz, 1H), 7.69 (d,
J= 2.5 Hz, 1H), 7.50 (d, J = 2.5 Hz, 1H), 7.23 (d, J = 2.5 Hz, 1H), 7.13 (d, J = 8.5, 1H),
1.74 (s, 6H), 1.39 (s, 9H), 1.38 (s, 9H). 13C NMR (500 MHz, CDC13, 6): 198.0, 169.8,
160.8, 147.0, 146.4, 145.7, 145.3, 138.7, 136.0, 130.6, 130.4, 130.1, 127.5, 126.4, 125.9,
125.8, 122.2, 121.5, 120.5, 117.5, 44.9, 35.1, 34.8, 34.7, 32.2, 31.7, 31.6. HRESI-MS ([M
- H] ) C31H330 5 m/z, Calcd. 485.2323, Found 485.2234.
3.5.3.7. H2(HSX*-COOH) (11)
A mixture of 2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid (5) (0.100 g, 0.206 mmol) was combined with (1R,2R)-(-)-
1,2-diaminocyclohexane (0.012 g, 0.103 mmol) in 4 mL of absolute ethanol and refluxed
for 12 hours. Upon cooling the solvent was removed by rotary evaporation and the
resulting yellow solid was washed with 1 mL of cold methanol and dried under vacuum
to yield 0.100 g of product (92% yield). 'H NMR (500 MHz, CDCI3, 8): 8.63 (s, 2H),
7.90 (d, J = 2 Hz, 2H), 7.76 (d, J = 2.5 Hz, 2H), 7.58 (d, J = 2.5 Hz, 2H), 7.38 (m, 4H),
7.23 (d, J = 2 Hz, 2H), 6.95 (d, J = 8.5 Hz, 2H), 3.60 (d, J = 9.5 Hz, 2H), 2.07 (d, J =
11.5 Hz, 2H), 1.95 (d, J = 9.5 Hz), 1.76 (s, 6H), 1.73 (m, 2H), 1.68 (s, 2H), 1.61 (s, 6H),
1.36 (s, 18H), 1.35 (s, 18H). HRESI-MS ([M - H]-) C68H77N2 0 8 m/z, Calcd. 1049.5676,
Found 1049.5676. Anal. Calcd for C68H7 8N20 8: C, 77.68; H, 7.48; N, 2.61. Found: C,
77.61; H, 756; N, 2.61.
3.5.3.8. Mn(HSX*-COOH)CI (12)
H2(HSX*-COOH) (11) (0.100 g, 0.095 mmol) and manganese(II) acetate tetrahydrate
(0.035 g, 0.143 mmol) was added to 8 mL of ethanol and refluxed for 3 hours in air.
Upon cooling 1 mL of an aqueous saturated sodium chloride solution was added and after
stirring for 5 minutes an additional 10 mL of water was added. The mixture was then
extracted with 2 x 6 mL of dichloromethane. The combined organic portions were then
washed with 5 mL of water and dried over MgSO 4. The solvent was removed by rotary
evaporation to yield the brown product (0.101 g, 93% yield). HRESI-MS ([M - Cl]-)
C68H76MnN 208 m/z, Calcd. 1103.4977, Found 1103.4931. Anal. Caled for
C68H76ClMnN2Os-2H 20: C, 69.46; H, 6.86; N, 2.38. Found: C, 69.65; H, 6.67; N, 2.21.
3.5.3.9. 2,7-Di-tert-butyl-9,9-dimethyl-4-dihydroxyborane-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-9H-xanthene (13)
Under nitrogen, a mixture of 4,5-dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (2.00 g,
4.17 mmol), bis(pinacolato)diboron (3.17 g, 12.5 mmol), potassium acetate (2.86 g, 29.2
mmol), dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane
adduct (0.305 g, 0.41 mmol), and anhydrous dimethyl sulfoxide (25 ml) was heated to 90
'C for 48 hours. Upon cooling, the mixture was extracted with 4 x 100 mL of
dichloromethane. The organic portions were combined and washed with 4 x 100 mL of
water and dried over MgSO4 and the solvent removed by rotary evaporation. 500 mL of
hexanes was stirred into the residue and filtered. The filtrate was reduced by rotary
evaporation to give a crude solid, which was recrystallized by hot isopropyl alcohol to
give the colorless product (0.622 g, 30 %). Upon recrystallization, the monoboronic acid
and mono-ester is typically the pure product. 'H NMR (300 MHz, CDC13, 6): 7.86 (d, J=
2.7 Hz, 1H), 7.72 (d, J = 2.4 Hz, 1H), 7.55 (d, J = 2.4 Hz, 1H), 7.47 (d, J = 2.7 Hz, 1H),
1.63 (s, 6H), 1.42 (s, 12H), 1.36 (s, 9H), 1.35 (s, 9H).
3.5.3.10. 5-(5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-2-methoxy-
benzaldehyde (15)
Under nitrogen, 3-formyl-4-methoxyphenylboronic acid (0.409 g, 1.56 mmol), 4,5-
dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (1.00 g, 2.08 mmol), sodium carbonate
(0.321 g, 0.321 mmol), and dichloro[1,1 '-bis(diphenylphosphino)ferrocene]palladium(II)
dichloromethane adduct (0.076 g, 0.104 mmol) was added to 18 mL of dimethoxyethane
and 6 mL of deionized water, degassed prior to use. This was heated to 90 'C for 12
hours. Upon cooling, the mixture was extracted with 4 x 75 mL of dichloromethane. The
organic portions were combined and washed with 2 x 25 mL of water and dried over
MgSO 4 . The solvent removed by rotary evaporation and the residue was purified by
column chromatography (silica gel, 7: 3 hexane: dichloromethane) to elute the product
(0.040 g, 5 % yield). 'H NMR (500 MHz, CDC13, 6): 10.56 (s, IH), 8.16 (d, J = 2.5 Hz,
1H), 8.04 (dd, J = 9 Hz, 2 Hz, 1H), 7.44 (d, J = 2 Hz, 1H), 7.43 (d, J = 2 Hz, 1H), 7.38
(d, J = 2 Hz, 1H), 7.30 (d, J = 2 Hz, 1H), 7.12 (d, J = 9 Hz, IH), 4.02 (s, 3H), 1.71 (s,
6H), 1.39 (s, 9H), 1.33 (s, 9H). 13C NMR (500 MHz, CDCl 3, 6): 190.0, 161.2, 146.9,
146.2, 145.4, 145.3, 138.4, 131.3, 130.7, 130.5, 129.9, 128.5, 127.7, 126.0, 124.5, 122.1,
121.9, 111.3, 110.2, 56.0, 35.5, 34.8, 34.7, 32.4, 31.7, 31.75, 31.72, 31.6. HRESI-MS ([M
+ Na]') NaC31H35BrO3 m/z, Calcd. 557.1662 Found 557.1662.
3.5.3.11. 5-(5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-2-hydroxy-
benzaldehyde (16)
Under nitrogen, 5-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-2-methoxy-
benzaldehyde (15) (0.040 g, 0.074 mmol) was added to dry dichloromethane (10 mL) and
the solution was cooled in an ice bath. Boron tribromide was added (1.4 mL, 1.0 M in
dichloromethane) and the solution was warmed to room temperature and for 12 hours.
The solution was washed with 3 x 6 mL of saturated sodium carbonate solution followed
by brine and dried using MgSO4. The solvent was removed by rotary evaporation to give
the product as a colorless oil (0.037 g, 97%). Synthetic procedure to take 16 to 17 can be
found in Appendix B.
3.5.3.12. (5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-trimethyl-
stannane (18)
4,5-Dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (1.00 g, 2.08 mmol) was added to 12
mL of dry tetrahydrofuran and cooled to -78' C in a dry ice/acetone bath. Phenyllithium
(1.7 mL, 1.8 M in cyclohexane) was added dropwise and the mixture was stirred for one
hour and then warmed to room temperature. Trimethyltin chloride was added and stirred
an additional hour. The solution was reduced by rotary evaporation to an oil, and purified
by column chromatography (silica gel, pentane) to elute the product (0.446g, 38% yield).
'H NMR (500 MHz, CDC13, 6): 7.46 (d, J = 2 Hz, IH), 7.36 (m, 3H), 1.66 (s, 6H), 1.37
(s, 9H), 1.34 (s, 9H).
3.5.3.13. 4-Bromo-2,7-di-tert-butyl-9,9-dimethyl-5-(4-hydroxyborane)-9H1-
xanthene (19)
4,5-Dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (2.00 g, 4.16 mmol) was added to
40 mL of dry tetrahydrofuran under nitrogen and cooled to -78' C in a dry ice/acetone
bath. Phenyllithium (2.4 mL, 1.8 M in cyclohexane) was added dropwise and the
reaction was stirred for one hour and then warmed to room temperature. Tri-i-
propylborate (0.95 mL 4.15 mmol) was added and the reaction stirred for an additional
hour. 20 mL of dilute HCL was then added slowly and the organic solvent was removed
by rotary evaporation. The remaining aqueous solution was filtered, and the colorless
precipitate was recrystallized from hot methanol, and further purified by column
chromatography (silica gel, 8: 2 hexane: ethyl acetate) to elute the product (1.440 g, 78 %
yield). iH NMR (300 MHz, CDCl 3, 6): 7.87 (d, J = 2.5 Hz, 1H), 7.55 (d, J = 2.5 Hz,
1H), 7.47 (d, J = 2.5 Hz, 1H), 7.39 (d, J = 2.5 Hz, 1H), 6.09 (bs, 2H), 1.66 (s, 6H), 1.37
(s, 9H), 1.34 (s, 9H). 13C NMR (500 MHz, CDCl3, 6): 153.19, 147.52, 146.31, 144.63,
132.51, 131.55, 128.61, 128.25, 126.42, 122.38, 109.73, 35.24, 35.82, 34.72, 32.56,
31.72, 31.58. "B NMR (500 MHz, CDCl3, 6): 28.42.
Figure 3.4. Thermal ellipsoid plot of 4-Bromo-2,7-di-tert-butyl-9,9-dimethyl-5-(4-
hydroxyborane)-9H-xanthene (19). Thermal ellipsoids are drawn at the 50%
probability level.
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3.5.3.14. (5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-tributyl-
stannane (20)
4,5-Dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (5.00 g, 10.42 mmol) was added to
80 mL of dry tetrahydrofuran and cooled to -78' C in a dry ice/acetone bath.
Phenyllithium (6.5 mL, 1.8 M in cyclohexane) was added dropwise and the mixture was
stirred for one and a half hours and then warmed to room temperature. Tri(n-butyl)tin
chloride was added and the reaction stirred an additional hour. The reaction was then
reduced by rotary evaporation to an oil, to which 10 mL of pentane was added and the
resulting solution filtered. The filtrate was reduced to oil and purified by column
chromatography (silica gel, pentane) to elute the product as colorless oil (3.12 g, 60%
yield). 'H NMR (500 MHz, CDCl3, 6): 7.46 (d, J = 2 Hz, 1H), 7.37 (m, 2H), 7.35 (d, J =
2 Hz, 1H), 1.66 (s, 6H), 1.61 (q, J = 8 Hz, 6H), 1.40 (m, 6H), 1.37 (s, 9H), 1.34 (s, 9H),
1.28 (t, J = 8 Hz, 6H), 0.91 (t, J = 8 Hz, 9H). "3C NMR (500 MHz, CDCl3, 6): 152.48,
146.36, 145.92, 145.78, 132.37, 131.48, 128.57, 128.45, 127.51, 123.31, 122.32, 109.80,
35.55, 34.71, 32.92, 31.82, 31.63, 29.54, 27.65, 13.98, 10.19. HRESI-MS ([M + Na]÷)
C35H55O 3BrOSn m/z, Calcd. 713.2355, Found 713.2352.
3.5.3.15. 4-(5-Bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-benzoic acid
(23)
A solution of 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-benzoic acid
methyl ester (22) (0.414 g, 0.773 mmol) in 10 mL of THF was refluxed with 5 mL of
saturated sodium hydroxide in water for 2 hours. The mixture was neutralized with
aqueous HCI and extracted with 3 x 25 mL of dichloromethane. The combined organic
layers were dried with MgSO 4 and the solvent removed by rotary evaporation to yield the
colorless product (0.334 g, 83.1% yield). 'H NMR (500 MHz, CDCI3, 6): 8.07 (d, J = 6.0
Hz, 2H), 7.65 (d, J = 6.0 Hz, 2H), 7.48 (s, 1H), 7.36 (s, 1H), 7.30 (s, IH), 7.22 (s, 1H),
1.63 (s, 6H), 1.28 (m, 18H). "3C NMR (500 MHz, CDCl3, 6): 172.6, 147.1, 146.3, 145.5,
145.4, 144.0, 131.4, 130.6, 130.2, 130.1, 128.6, 128.3, 128.0, 126.3, 122.9, 121.8, 110.4,
35.6, 34.83, 34.79, 35.4, 31.7, 31.6. HRESI-MS ([M + H]F) C30H330 3Br m/z, Calcd.
521.1686, Found 521.1679.
3.5.3.16. 4-[2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yi]-benzoic acid (24)
Under nitrogen, a mixture of 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-
yl)-benzoic acid (23) (0.300 g, 0.575 mmol), 3-formyl-4-methoxyphenylboronic acid
(0.114 g, 0.633 mmol), sodium carbonate (0.089 g, 0.864 mmol),
tetrakis(triphenylphosphine)palladium (0.025 g, 0.034 mmol), DMF (9 mL), and
deionized water (1 mL) was heated to 90 oC for 36 hours. Upon cooling, the mixture was
extracted with 3 x 100 mL of dichloromethane. The organic portions were combined and
dried over MgSO 4 and the solvent removed by rotary evaporation. The crude solid was
purified by column chromatography (silica gel, 98:2 dichloromethane: methanol) to elute
the colorless product (0.323 g, 97.3% yield). 1H NMR (500 MHz, CDCl3, 6): 10.41 (s,
1H), 7.87 (s, 1H), 7.82 (s, 1H), 7.74 (d, J = 1.25 Hz, 1H), 7.49 (d, J = 2.5 Hz, 1 H), 7.45
(d,J = 2.5 Hz, 1 H), 7.43 (dd, J= 6 Hz, 2.5 Hz, IH), 7.36 (d, J= 8 Hz, 2H), 7.18 (dd, J
- 8 Hz, 2 Hz, 2H), 6.68 (d, J = 8.5 Hz, 1H), 3.96 (s, 3H), 1.75 (s, 6H), 1.37 (s, 9H), 1.36
(s, 9H). 13C NMR (500 MHz, CDCI3, 6): 189.9, 171.9, 161.1, 146.0, 145.94, 145.88,
145.5, 137.4, 135.3, 130.9, 130.5, 130.0, 129.8, 129.7, 128.3, 128.2, 128.1, 127.0, 125.73,
125.70, 124.4, 122.7, 121.9, 111.0, 55.8, 35.4, 34.8, 31.83, 31.79, 31.77, 29.9, 27.5.
HRESI-MS ([M + Na]) C38H4005Na m/z, Calcd. 599.2768, Found 599.2757.
3.5.3.17. 4-[2,7-Di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yl]-benzoic acid (25)
4-[2,7-Di-tert-butyl-5-(3-fonrmyl-4-methoxy-phenyl)-9,9-dimethyl-9H-xanthen-4-yl]-
benzoic acid (24) (0.300 g, 0.520 mmol) was added to 10 mL of dichloromethane and
cooled to 0 'C. A solution of boron tribromide (1.6 mL, 1.0 M in dichloromethane) was
added and upon stirring for 2 hours, 6 mL of water was added. The organic layer was
separated, washed with 10 mL of water, and dried over MgSO 4. The solvent was
evaporated and the residue was purified by column chromatography (silica gel, 98:2
dichloromethane: methanol) to elute the product (0.181 g, 62% yield). 1H NMR (500
MHz, C4D80 5): 9.45 (s, IH), 7.74 (d,J = 8 Hz, 1H), 7.68 (d,J = 8 Hz, IH), 7.54 (d,J =
2 Hz, 2H), 7.45 (m, 4H), 7.31 (d, J = 8 Hz, 1H), 7.23 (dd, J = 10.5, 1.5 Hz, IH), 6.73 (d,
J = 8.5 Hz, 1H), 1.36 (s, 18H). 13C NMR (500 MHz, C4D80, 6): 196.9, 167.5, 161.7,
146.74, 146.66, 143.6, 138.6, 135.5, 133.0, 132.9, 132.5, 131.6, 131.5, 130.7, 130.6,
130.3, 130.1, 129.4, 129.3, 129.0, 126.7, 126.5, 123.3, 122.8, 121.8, 117.7, 36.1, 35.4,
32.0, 25.8, 25.6, 25.3, 25.2. HRESI-MS ([M - H] ) C3 7H3 70 5 m/z, Calcd. 561.2646,
Found 561.2646.
3.5.3.18. H2(HphSX*-COOH) (26)
A mixture of 4-[2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yl]-benzoic acid (25) (0.025 g, 0.044 mmol) was combined with (lR,2R)-(-)-
1,2-diaminocyclohexane (0.003 g, 0.022 mmol) in 5 mL of absolute ethanol and refluxed
for 15 hours. Upon cooling the solvent was removed by rotary evaporation and the
resulting yellow solid was washed with 0.5 mL of cold methanol and dried under vacuum
to yield the product as a dull yellow solid (0.026 g, 97 % yield). 'H NMR (500 MHz,
CDCI3, 25 'C, 6): 7.91 (m, 4H), 7.47 (d, J = 7 Hz, 2H), 7.68 (m, 4H), 7.55 (d, J = 7 Hz,
2H), 7.39 (m, 4H), 7.19 (m, 2H), 7.11 (s, 2H), 7.10 (s, 2H), 3.54 (bs, 2H), 2.33 (bs, 4H),
2.05 (bs, 4H), 1.72 (s, 12H), 1.35 (s, 18H), 1.30 (s, 18H). HRESI-MS ([M - H] )
C80H85N20 8 m/z, Caled. 1201.6311, Found 1201.6329.
3.5.3.19. Mn(HphSX*-COOH)Cl (27)
H2(HphSX*-COOH) (26) (0.010 g, 0.008 mmol) and manganese(II) acetate tetrahydrate
(0.003 g, 0.012 mmol) was added to 3 mL of ethanol and refluxed for 4 hours in air.
Upon cooling 0.5 mL of an aqueous saturated sodium chloride solution was added and
the mixture was extracted with 2 x 15 mL of dichloromethane. The combined organic
portions were then washed with 15 mL of water and dried over MgSO 4. The solvent was
removed by rotary evaporation to yield the brown product (0.010 g, 93% yield). HRESI-
MS ([M - Cl] ) CsoH 84MnN20 8 m/z, Calcd. 1255.5603, Found 1255.5605. Anal. Calcd
for C80H84 C1MnN 208: C, 74.37; H, 6.55; N, 2.17. Found: C, 74.21; H, 6.72; N, 2.10.
3.5.3.20. 2,7-Di-tert-butyl-9,9-dimethyl-4,5-di-(4-benzoic acid methyl ester)-9H-
xanthene (28)
28 was the major product of reaction A under several Suzuki coupling conditions shown
in Scheme 3.4. Characterization data: 1H NMR (500 MHz, CDCI3, 6): 7.72 (d, J = 8.5
Hz, 4H), 7.48 (d, J = 2 Hz, 2H), 7.28 (d, J = 8.5 Hz, 4H), 7.19 (d, J = 2 Hz, 2H), 3.96 (s,
6H), 1.75 (s, 6H), 1.36 (s, 18H). 13C NMR (500 MHz, CDCl3, 8): 167.1, 145.9, 143.0,
130.8, 129.7, 129.1, 128.6, 128.4, 125.7, 122.3, 52.2, 35.5, 34.8, 31.8, 31.6. HRESI-MS
([M + Na]÷) NaC39H4 20 5 m/z, Calcd. 613.2924, Found 521.1679.
3.5.3.21. 3-tert-Butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-
benzaldehyde (30)
Under nitrogen, a mixture of 5-bromo-3-tert-butylsalicylaldehyde (29) (1.00 g, 3.89
mmol), bis(pinacolato)diboron (1.087 g, 4.28 mmol), potassium acetate (0.572 g, 5.83
mmol), and bis(tricyclohexylphosphine)palladium(0) (0.130 g, 0.194 mmol) was
combined with 24 mL of dry dioxane and heated to 85 'C for 36 hours. Upon cooling, 20
mL of water was added and the mixture was extracted with 4 x 50 mL benzene. The
organic portions were combined and dried over MgSO 4. The solvent was removed by
rotary evaporation and the residue was purified by column chromatography (silica gel,
7:3 hexane: dichloromethane) to give the desired product (0.715 g, 60.4%). 'H NMR
(500 MHz, CDCl3, 25 'C): 6 = 12.00 (s, 1H), 9.90 (s, 1H), 7.93 (s, 1H), 7.91 (s, 1H), 1.43
(s, 9H), 1.35 (s, 12H). 13C NMR (500 MHz, CDC13, 65): 197.72, 163.81, 140.21, 140.18,
137.62, 120.61, 84.15, 35.04, 30.40, 29.44, 25.08. HRESI-MS ([M + H] +) calcd for
CI7H26BO4 m/z, 305.1933, found 305.1922.
3.5.3.22. 2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-dimethyl-
9H-xanthene-4-carboxylic acid (31)
Under nitrogen, 4-hydroxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-dimethylxanthene (1)
(0.400 g, 0.898 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (30) (0.300 g, 0.988 mmol), sodium carbonate
(0.139 g, 1.35 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.062 g, 0.053
mmol) were combined with 18 mL of DMF and 2 mL of deionized water and the mixture
was heated to 90 TC for 36 hours. Upon cooling 30 mL of dichloromethane was added
and the solution was washed with 10 mL of water. The aqueous layer was then extracted
with 2 x 10 mL dichloromethane and the combined organic portions were dried over
MgSO 4 . The solvent was removed by rotary evaporation and the residue was purified by
column chromatography (silica gel, 3:7 diethyl ether: pentane) to give the desired product
(0.265 g, 54%). 1H NMR (500 MHz, CDCI3, 25 'C): 6 = 11.92 (s, IH), 9.95 (s, 1H), 8.06
(d, J = 2 Hz, 1H), 7.71 (d, J = 2 Hz, 1H), 7.63 (d, J = 2 Hz, 1H), 7.57 (d, J = 2 Hz, 1H),
7.51 (d, J = 2 Hz, 1H), 7.24 (d, J = 2 Hz, IH), 1.76 (s, 6H), 1.48 (s, 9H), 1.40 (s, 9H),
1.37 (s, 9H). 13C NMR (500 MHz, CDCl3, 8): 197.29, 165.26, 161.25, 148.08, 147.57,
146.93, 144.52, 139.44, 135.25, 132.60, 131.19, 130.14, 129.00, 128.73, 128.54, 128.33,
126.68, 122.34, 120.88, 116.29, 35.32, 35.16, 34.91, 32.11, 31.72, 31.52, 29.32. HRESI-
MS ([M + H]") calcd for C 35H4 30 5 m/z, 543.3105, found 534.3109.
3.5.3.23. 4-[2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-
dimethyl-9H-xanthen-4-yl]-benzoic acid (32)
Under nitrogen, 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-benzoic
acid (22) (0.312 g, 0.598 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (30) (0.200 g, 0.657 mmol), sodium carbonate
(0.092 g, 0.897 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.041 g, 0.036
mmol) were added to 18 mL DMF and 2 mL deionized water. The mixture was heated to
90 'C for 36 hours. Upon cooling 30 mL of dichloromethane was added and the solution
was washed with 10 mL of water. The aqueous layer was then extracted with 2 x 15 mL
dichloromethane and the combined organic portions were dried over MgSO 4. The solvent
was removed by rotary evaporation and the residue was purified by column
chromatography (silica gel, 2:8 ethyl acetate: pentane) to give the desired product (0.273
g, 68% yield). 1H NMR (500 MHz, CDCI3, 25 °C): 8 = 11.72 (s, IH), 9.36 (s, IH), 7.80
(d, J = 8 Hz, 2H), 7.50 (m, 2H), 7.48 (d, J = 2 Hz, 1H), 7.32 (d, J = 8 Hz, 2H), 7.22 (J =
2 Hz, IH), 7.20 (m, 2H) 1.78 (s, 6H), 1.45 (s, 9H), 1.40 (s, 9H), 1.38 (s, 9H). 13C NMR
(500 MHz, CDC13, 6): 196.78, 170.83, 160.39, 145.95, 145.89, 145.78, 145.72, 143.74,
138.02, 135.02, 135.33, 133.63, 130.69, 130.38, 129.75, 129.62, 128.90, 128.69, 128.20,
127.69, 125.59, 122.75, 121.90, 120.39, 35.39, 35.08, 34.81, 31.14, 31.80, 31.77, 29.45.
HRESI-MS ([M + H] +) calcd for C4 1H470 5 m/z, 619.3418, found 619.3414.
3.5.3.24. H2[HSX*tBu-COOH] (33)
2
,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-xanthene-
4-carboxylic acid (31) (0.100 g, 0.184 mmol) was added to (IR,2R)-(-)-1,2-
diaminocyclohexane (0.010 g, 0.092 mmol) to 6 mL of absolute ethanol. The mixture
was heated to reflux for 12 hours. Upon cooling, the solvent was removed by rotary
evaporation and the residue was washed with 1 mL of cold methanol and then dried
under vacuum to give the bright yellow product (0.105 g, 98%). 'H NMR (500 MHz,
CDCl3, 250 C): 8 = 8.61 (s, 2H), 7.66 (s, 2H), 7.58 (bs, 2H), 7.51 (s, 2H), 7.46 (d, J = 2
Hz, 2H), 7.41 (d, J= 2 Hz, 2H), 7.31 (d, J= 2 Hz, 2H), 3.16 (bs, 2H), 2.97 (m, 2H), 2.31
(m, 2H), 1.83 (s, 12H), 1.52 (s, 18H), 1.50 (s, 4H), 1.39 (18H), 1.35 (18H). HRESI-MS
([M - H]-) calcd for C76H93N20 8 m/z, 1161.6926, found 1161.6884.
3.5.3.25. H2[HphSX*Bu-COOH] (34)
4-[2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yl]-benzoic acid (32) (0.050 g, 0.081 mmol) was added to (1R,2R)-(-)-1,2-
diaminocyclohexane (0.005 g, 0.040 mmol) to 5 mL of absolute ethanol. The mixture
was refluxed for 12 hours. Upon cooling, the solvent was removed by rotary evaporation
and the residue was washed with 1 mL of cold methanol and dried under vacuum to give
the yellow product (0.051 g, 96%). 'H NMR (500 MHz, CDC13, 25°C): 5 = 7.82 (m, 6H),
7.49 (d, J = 2 Hz, 2H), 7.43 (d, J = 2 Hz, 2H), 7.34 (m, 6H), 7.22 (m, 4H), 6.92 (s, 2H),
3.74 (m, 2H), 3.66 (bs, 2H), 3.51 (bs, 2H), 2.02 (bs, 4H), 1.76 (s, 12H), 1.56 (s, 18H),
1.39 (s, 18H), 1.38 (s, 18H). HRESI-MS ([M + H]') calcd for C88HI 03N20 8 m/z,
1315.7709, found 1315.7704.
3.5.3.26. Mn[HSX*lBu-COOHICl (35)
H2[HSX*-'Bu-COOH] (33) (0.105 g, 0.093 mmol) was added to manganese(II) acetate
tetrahydrate (0.033 g, 0.140 mmol) in 6 mL of absolute ethanol and the solution was
refluxed in air for 2 hours. Upon cooling, 1 mL of an aqueous saturated sodium chloride
solution was added and the mixture was stirred for 10 minutes and then extracted with 3
x 10 mL of dichloromethane. The organic layers were combined and washed with 10 mL
of water and then dried over MgSO 4. The solvent was removed by rotary evaporation to
leave the brown product (0.112 g, 99%). HRESI-MS ([M - Cl]+) calcd for
C76H92C1MnN 2 0 8 m/z, 1215.6229, found 1215.6241. Anal. Calcd for C76H92C1MnN 2Os:
C, 72.91; H, 7.41; N, 2.24. Found: C, 72.84; H, 7.46; N, 2.35.
3.5.3.27. Mn[HphSX*tBu-COOHICI (36)
H2[HphSX*-'Bu-COOH] (34) (0.025 g, 0.019 mmol) was combined with manganese(ll)
acetate tetrahydrate (0.007 g, 0.028 mmol) in 3 mL of absolute ethanol and refluxed in air
for 2 hours. Upon cooling, 0.5 mL of an aqueous saturated sodium chloride solution was
added and the mixture was stirred for 10 minutes and then extracted with 3 x 10 mL of
dichloromethane. The organic layers were combined and washed with 5 mL of water and
dried over MgSO4. The solvent was removed by rotary evaporation to give the brown
product (0.027 g, 100%). HRESI-MS ([M - C1] ) calcd for C88H100ooMnN 208 m/z,
1367.6860, found 1367.7056. Anal. Calcd for C88Ho100CIMnN208: C, 75.27; H, 7.18; N,
2.00. Found: C, 75.15; H, 7.38; N, 2.13.
3.5.4. Epoxidation of 1,2-Dihydronapthalene
For the determination of ee, the epoxidation method and conditions are modified from
previous epoxidation studies using manganese salen complexes. 47 5 mL of a 0.05 M
solution of Na2HPO4 was added to 12.5 mL of commercial bleach (Clorox). The pH of
this solution (-55 mM in NaOC1) was adjusted to pH 12 by the dropwise addition of 1.0
M NaOH solution and cooled to 0 'C. 4.5 mL of this prepared bleach solution was added
to a pre-cooled 0 'C solution of 1,2-dihydronapthalene (100 mg, 0.77 mmol) and
Mn[HSX*-COOH]Cl (12) (85 mg, 0.077 mmol, 10% catalyst loading) in 2 mL of
dichloromethane. 4.8 mL of the prepared bleach solution was added to a pre-cooled 0 'C
solution of 1,2-dihydronapthalene (104 mg, 0.800 mmol) and Mn[HSX*tBu-COOH]Cl
(35) (10 mg, 0.008 mmol, 1% catalyst loading) in 8 mL of dichloromethane. 3.6 mL of
the prepared bleach solution was added to a pre-cooled 0 'C solution of 1,2-
dihydronapthalene (78 mg, 0.600 mmol) and Mn[HphSX* tBu-COOH]Cl (36) (8.4 mg,
0.006 mmol, 1% catalyst loading) in 6 mL of dichloromethane. Upon stirring for 12
hours, the layers were separated and the aqueous layer was extracted with 2 x 6 mL of
dichloromethane. The combined organic layers were washed with 10 mL of water and 10
mL of a saturated sodium chloride solution and dried over MgSO 4. After solvent removal
by rotary evaporation the crude product was purified to by column chromatography
(silica gel, 98:2 pentane:ethyl acetate) to yield the epoxide product. The ee was
determined by use of a chiral GC calibrated using a pure racemic epoxide sample. The ee
measurements were performed using a chiral GC housed in Professor Timothy Jamison's
laboratory and the experiment was assisted by graduate students Chudi Ndubaku and
Ryan Moslin.
The data from Table 3.1 was determined as followed: 0.2 mM solutions of the catalyst
(1R, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)]
manganese(III) chloride (1.3 mg in 10 mL of dichloromethane), Mn[HSX*'Bu-COOH]Cl
(35) (2.5 mg in 10 mL of dichloromethane), and [HphSX*tBu-COOH]Cl (36) (2.8 mg in
10 mL of dichloromethane) were prepared. A 20 mM solution of 1,2-dihydronapthalene
and 10 mM dodecane (65 mg of 1,2-dihydronapthalene and 43 mg of dodecane in 25 mL)
was prepared. For NaOCI as the oxidant, the oxidant solution was prepared by mixing 2
mL of 0.05 M NaHPO4 and 5 mL of commercial bleach (Clorox) and 0.1 mL of 1 M
NaOH solution and then cooled to 0 'C. 1.5 mL of this solution was added to 0.5 mL of
each catalyst solution and 0.5 mL of the 1,2-dihydronapthalene/dodecane solution, pre-
cooled to 0 'C. For PhlO as the oxidant, 4.0 mg of PhIO was added to 0.5 mL of each
catalyst solution with 0.5 mL of the 1,2-dihydronapthalene/dodecane solution. For the
trial with an equivalent of N-methylimidazole, 10 [tL of a 0.0104 M solution (42.7 mg in
50 mL of dichloromethane) of N-methylimidazole was added to each reaction. For H20 2,
the oxidant solution was prepared by diluting 1 mL of 30% H2 0 2 solution with 9 mL of
H20. A 40 mM solution of 1,2-dihydronapthalene and 10 mM of dodecane was prepared
(130 mg 1,2-dihydronapthalene and 43 mg of dodecane in 25 mL of dichloromethane).
0.5 mL of this was added to 0.5 mL of each catalyst solution. The diluted solution of
H20 2 was added over 3 hours. Upon completion of the oxidant addition, the reaction was
stirred for an additional hour before being sampled. The concentration of the substrate
and epoxide product was determined by GC/MS with dodecane as the internal standard to
determine the turnover numbers (TON). The GC/MS spectra were taken on an Agilent
Technologies 6890N Network housed at the MIT DCIF.
3.5.5. X-Ray Crystal Data Collection and Refinement Parameters
Data collection and reduction
Crystals were coated with Paratone N oil and mounted on a glass fiber. X-ray diffraction
data were collected at -80 'C on a Siemens three-circle diffractometer equipped with a
CCD detector, using the Mo Ka radiation, selected by a graphite monochromator. The
data were integrated to hkf-intensity and the final unit cell calculated using the SAINT
v.4.050 program from Siemens. Solution and refinement were performed with the
SHELXTL v.5.03 suite of programs developed by G. M. Sheldrick and Siemens
Industrial Automation, 1995. No absorption correction was performed. The structure was
solved by direct methods; the least-squares refinement converged normally (with
hydrogen atoms placed at calculated positions using a standard riding model and refined
isotropically).
Table 3.2. Crystal data and structure refinement for 5-(boronic acid)-2,7-di-tert-butyl-
9,9-dimethyl-9H-xanthene-4-carboxylic acid methyl ester (3).
Identification code 030780a
Empirical formula C25 H33 BO5
Formula weight 424.32
Temperature 467(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group P 1
Unit cell dimensions a = 9.157(7) A -= 77.035(14)0
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
0 range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to 0 = 24.690
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I > 2c(I)]
R indices (all data)
Largest diff. peak and hole
b = 11.143(10) A
c = 12.500(11) A
1217.6(18) A3
/-= 83.053(17)0
y= 79.421(18)0
1.157 Mg/m 3
0.078 mm-1
456
0.20 x 0.17 x 0.04 mm 3
2.26 to 24.69'
-8<h<7, -11 <k< 12,-5< <14
2658
2654 [Rint = 0.0508]
63.9%
None
Full-matrix least-squares on F2
2654 / 0 / 291
1.083
R- =0.0970, wR2 =0.1710
R, = 0.1935, wR2 = 0.2057
0.201 and -0.212 e/A 3
Table 3.3. Crystal data and structure refinement 2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-
phenyl)-9,9-dimethyl-9H-xanthene-4-carboxylic acid (5).
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Density (calculated)
Absorption coefficient
F(000)
Crystal size
0 range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to 0 = 24.730
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>25(l)]
R indices (all data)
Largest diff. peak and hole
03084a
C31 H34 05
486.58
467(2) K
0.71073 A
Triclinic
P1
a = 9.7828(9) A
b = 9.8015(9) A
c = 15.2502(14) A
1336.8(2) A3
a = 78.978(2)0
6= 82.309(2)0
y=68.047(2)0
1.209 Mg/m 3
0.081 mm - 1
520
0.34 x 0.31 x 0.15 mm 3
2.27 to 24.730
-ll<h<7, -11 < k < 9, 18 < <18
6974
4471 [Rint = 0.0274]
97.6 %
None
Full-matrix least-squares on F2
4471 / 0 / 334
1.021
R, = 0.0720, wR2 = 0.1568
R1 =0.1084, wR 2 = 0.1738
0.476 and -0.284 e/A 3
100
Table 3.4. Crystal data and structure refinement 4-bromo-2,7-di-tert-butyl-9,9-dimethyl-
5-(4-hydroxyborane)-9H-xanthene (19)
Identification code 003321m
Empirical formula C23 .50 H31 B Br Cl 03
Formula weight 487.65
Temperature 193(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2 1/n
Unit cell dimensions a = 17.9609(11) A
b = 15.4003(9) A 8= 108.9950(10)0
c= 18.3354(11) A
Volume 4795.5(5) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 23.270
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
1.351 Mg/m3
1.847 mm-1
2024
0.42 x 0.40 x 0.38 mm3
1.77 to 23.270.
-10<=h<=19, -17<=k<=17, -
20<=1<= 18
21429
6890 [R(int) = 0.1133]
99.9%
None
Full-matrix least-squares on F2
6890 / 0 / 577
0.894
RI = 0.0568, wR2 = 0.1082
RI = 0.1263, wR2 = 0.1249
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Chapter 4
Catalase Activity and Epoxidation of
Functionalized Olefins by Manganese
Hangman Salens
Portions of the work presented in this chapter have been published:
Yang, J. Y.; Bachmann, J.; Nocera, D. G. J. Org. Chem. 2006, 71, 8706-8714.
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4.1. Motivation and Specific Aims
The ability of the Hangman salen platform to support multielectron chemistry mediated
by proton-coupled electron transfer (PCET) is established by their proclivity to promote
the catalytic disproportionation of hydrogen peroxide to oxygen and water (Chapter 2)
and OAT (Chapter 3) via a high-valent metal oxo. The stopped-flow spectroscopic
studies discussed in Chapter 2 afforded kinetic information on the reaction with the first
equivalent of hydrogen peroxide to produce the oxidizing species in the manganese
Hangman salophen complexes. Although the second step of the catalase reaction, the
oxidation of the second equivalent of hydrogen peroxide by the Mn(V) oxo, is difficult to
probe directly, it has been examined computationally. The modular nature of the salen
Hangman ligand permits these computational predictions to be examined experimentally
by correlating catalytic efficiency with structural features, such as the addition of steric
parameters around the ligand macrocycle and changes in the acid-to-metal distance
within the molecular cleft. The interplay of experiment with computation in further
elucidating the mechanism of catalase activity by salen active sites is examined in this
Chapter.
4.2. Background
The penchant to be highly effective mimics of the catalase enzyme (see equation 1) is a
characteristic shared by the manganese Hangman salophen complexes studied in Chapter
2,12 and the previously studied iron Hangman porphyrin complexes. 3'4 The hanging
group in the Hangman ligand construct mediates proton-coupled electron transfer (PCET)
activation that is at the core of bond-making and -breaking reactions in Nature. 5-8 In these
systems, the hanging acid-base functional group controls the secondary coordination
sphere for substrate assembly and activation, distilling the essential components of their
enzymatic counterparts. 9 We were compelled to expand our knowledge of the catalase
reaction,
catalase
2 H202 catalase 2H 20 + 02(1)
and specifically with salen as catalase mimics because of the efficacy of manganese salen
complexes as therapeutic agents of reactive oxygen species (ROS) in biological
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systems. lO Increased formation of ROS has been associated with a number of
pathological processes, including inflammatory, ischemic and neurodegenerative
diseases. I I Oxidative stress and tissue damage is thought to occur if the amount of ROS
generated exceeds the capabilities of existing natural antioxidants to neutralize them. 12
Preventing this damage has prompted the search for low molecular weight, non-toxic,
synthetic compounds that can catalytically reduce ROS to serve as antioxidant
theraputics. II ,13 The discovery of nonpeptidyl macrocyclic manganese compounds that
are competent superoxide dismutase (SOD) mimics l4,15 (dismutate superoxide to
hydrogen peroxide and oxygen) has resulted in the screening of many different
manganese compounds for SOD and/or catalase activity.16 (Not all SOD mimics are good
catalase mimics; the production of cytotoxic hydrogen peroxide from the dismutation of
superoxide makes both abilities equally important as a ROS scavenger).17 Currently, the
patented salen complexes manganese bis(salicylidene)-1 ,2-ethylenediamine chloride
(EUK-8), and manganese bis(3-methoxysalicylidene)-1 ,2-ethylenediamine chloride
(EUK-134)IS have displayed extremely high SOD and catalase activity, and has already
demonstrated success in removing cytotoxic amounts of hydrogen peroxide in animal I9-
23 and human tissue,24 preventing damage by endotoxic shock,20 stroke,22 and UV-light,24
as well as extending the life of a multicellular organism (the nematode Caenorhabditis
elegans).25 Both compounds are presently in clinical trials for their antioxidant
capabilities.26 The success of these compounds has prompted many structure-
reactivitylO,27 and computationafS,29 investigations aimed at elucidating key intermediates
and steps in the catalytic cycle and apply this knowledge to rationally design better
catalysts. To this end, the Hangman salen platform with its modular synthesis makes it an
ideal venue in which to define the structural and electronic properties of salen complexes
that are critical to enhanced ROS activity.
4.3. Results and Discussion
4.3.1. Synthesis
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Scheme 4.1
t-Bu t-Bu t-Bu t-Bu
/ \ R, R, R,
-0 -N .N/ ORR OM-O'_ O 2 /\ ,~2 -.- %
t-Bu t-Bu t-Bu t-Bu
3: R, = CO 2Me, R2 = Me 7 : R1 = CO2Me, M=2H
1 : R, = CO 2Me b 4 : R, = PhCO 2Me, R2 = Me d 8 : R, = PhCO 2Me, M=2Hb I d2: R1 = PhCO 2Me 5 : R1 = CO 2Me, R2 = H 9 : R, = CO 2Me, M=MnCI
6 : R, = PhCO 2Me, R2 = H 10: R, = PhCO 2Me, M=MnCI
(a) 3-formyl-4-methoxyphenylboronic acid, Na2CO 3, Pd(PPh 3)4, DMF: H20 (9:1), (b)
BBr3, CH 2C12, (c) (1R,2R)-(-)-1,2-diaminocyclohexane, EtOH, (d) i)
Mn(OAc) 2(H20) 4, ii) NaCl(aq)
The synthesis of acid functionalized compounds Mn[HSX*-COOH]Cl and Mn[HphSX*-
COOH]Cl is described in Chapter 3. To serve as control compounds, we also synthesized
the analogous methyl esters Mn[HSX*-COOMe]Cl and Mn[HphSX*-COOMe]C1, as
shown in Scheme 4.1. The methyl ester functionalized xanthene precursors 13,30 and 21
are Suzuki coupled 31 with 3-formyl-4-methoxyphenylboronic acid to give 3 and 4. The
methyl ethers on 3 and 4 are deprotected using boron tribromide. , 3 3 Boron tribromide is
also known to deprotect methyl esters, 34 however, 5 and 6 can be isolated by reducing the
reaction time to selectively cleave the methyl ether while leaving the ester intact in the
major product. Condensation of 5 and 6 with 0.5 equivalents of (1R,2R)-(-)-1,2-
diaminocyclohexane provides the ligands 7 and 8 respectively; they are metallated using
manganese acetate with an aqueous sodium chloride workup, as described for their acid
functionalized analogues in Chapter 3 to give 9 and 10.
Scheme 4.2
R - OH a 11 :BR=Ph / N
C
12 : M = 2H 13 : M = MnCI
(a) phenylboronic acid, Na2CO 3, Pd(dppf)C12, DME: H20 (3: 1), (b) (1R,2R)-(-)-1,2-
diaminocyclohexane, EtOH, (c) Mn(OAc) 2(H 20) 4, (ii) NaC1(aq)
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To generate a redox- only control compound that lacks the functionalized xanthenes, we
synthesized the salen ligand (R,R)-N,N'-Bis(5-phenylsalicylidene)-1,2-
cyclohexanediamine (12) (see Scheme 4.2), which is functionalized with phenyl groups
in the 5 and 5' positions. The functionalized salicylaldehyde 4-hydroxy-biphenyl-3-
carbaldehyde (11) can be synthesized by Suzuki coupling 3 1 5-bromosalicylaldehyde to
phenylboronic acid and the synthesis of the ligand (12) followed standard condensation
conditions. Manganese ion may be inserted into the salen core by refluxing the ligand
with an excess of manganese acetate in air, followed by workup with a saturated aqueous
sodium chloride solution to give Mn[5-phsalen]CI (13).
4.3.2. Catalase Activity of Manganese Hangman Salen Complexes
The acid-functionalized Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]Cl comprise a
structurally homologous series of doubly-bridged Hangman constructs in which the acid
Figure 4.1. Turnover number (TON) of hydrogen peroxide dismutation catalyzed by
manganese compounds [Mn(5-phsalen)Cl] (13) (13* in the presence of 2 equivalents
of benzoic acid), Mn[HSX*-COOH]C1, Mn[HSX*-COOMe]Cl (9), Mn[HphSX*-
COOH]Cl and Mn[HphSX*-COOMe]Cl (10) after 1 hour.
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group can be differentially extended over the face of the salen. We examined the activity
of Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]Cl and their corresponding methyl ester
analogues 9 and 10 towards the disproportionation of hydrogen peroxide in biphasic
dichloromethane/methanol, under similar conditions to those used in the prior catalase
studies. Figure 4.1 shows the turnover numbers (TON) for oxygen production by
Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]C1, and control systems in which (i) a
proton is absent from the hanging group (9 and 10) and (ii) the salen platform is
unmodified [Mn(5-phsalen)Cl] (13). The presence of the acid-base hanging group results
in a dramatic increase in catalase-type reactivity. Whereas high TON can be achieved
with Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]C1, relatively low TONs are
observed when the carboxylic acid functionality is replaced by an ester (9 and 10).
Similarly, control experiments with the redox-only manganese salen complex 13 shows
low activity for disproportionation. The addition of an external H+ source (benzoic acid)
enhances TON of the parent salen complex, but the activity remains far inferior to that of
Figure 4.2. Oxygen release from hydrogen peroxide dismutation catalyzed by
manganese compounds Mn(5-phsalen)Cl] (13) ( ), 13* (*in the presence of 2
equivalents of benzoic acid) (0), Mn[HSX*-COOH]Cl (*), Mn[HSX*-COOMe]Cl (9)
(x), Mn[HphSX*-COOH]Cl (+), and Mn[HphSX*-COOMe]Cl (10) (o) over 1 hour.
Inset shows reaction profile for the first five minutes excluding the methyl ester
compounds 9 and 10.
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Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]C1, which manages the proton by
intramolecular transfer from the hanging functional group. The superior activity of
Mn[HSX*-COOH]Cl and Mn[HphSX*-COOH]Cl is reflected in the activity profiles
shown in Figure 4.2. Both Mn[HSX*-COOH]C1 and Mn[HphSX*-COOH]Cl exhibit
similar reactivity profiles. Initial turnover frequencies are the similar for both catalysts
but Mn[HSX*-COOH]C1 appears to be more robust over time and hence exhibits higher
overall activity.
4.3.3. Mechanistic Insights
The dismutation of hydrogen peroxide by manganese salens 28' 2 9 is believed to proceed via
the same "ping-pong" mechanism that has been proposed for the catalase enzyme. 35 In
this mechanism (outlined in Scheme 4.3), the first molecule of hydrogen peroxide binds
to the Mn(III) metal site and oxidizes it to Mn(V) oxo, releasing a molecule of water. A
second molecule of hydrogen peroxide is then oxidized by the Mn(V) oxo forming
oxygen and water while the metal is reduced back to the Mn(IIl) resting state. Although
each step in this proposed catalytic cycle is not understood in detail, recent experimental
and theoretical investigations have provided valuable insight into the potential
intermediates and their kinetic and energetic parameters.
In Chapter 2, we replaced H20 2 by acyl peroxide to permit the catalase cycle at the
Hangman salophen platform to be arrested; upon proton transfer, the acyl peroxide
coordinated to the Mn(III) center furnishes a high-valent Mn(V) oxo intermediate,
isolating the first step of the cycle.2 The stopped-flow studies reveal that this step,
however, is not rate-determining and for this reason we believe the acid-to-metal distance
is less crucial for the first step in of the catalase cycle in the Hangman systems. A
theoretical study of manganese salen oxidation to from Mn(V) oxo by hydrogen peroxide
supports this observation. Abashkin and Burt found that 0-0 bond cleavage, oxidation
of the Mn, and water molecule formation is an efficient intramolecular one-step reaction
with the low calculated TS barrier of 3.6 kcal/mol. 28
Instead, subsequent oxidation of the second molecule of hydrogen peroxide by the Mn(V)
oxo appears to be rate-determining. 2 8,29 The hydrogen peroxide can approach the terminal
oxo in two different orientations, and it is this orientation that is critical to the second step
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in the catalytic cycle. A top-side approach forms the end-on assembly shown in the
transition state, and provides a low energy pathway towards oxidation of the hydrogen-
bonded peroxide. Following a singlet reaction channel with this assembly, (spin ground-
state of the resting catalyst), the activation barrier for protonation of the metal oxo by the
hydrogen peroxide (to form water and release oxygen) is a modest 11.7 kcal/mol.29 We
believe the hanging acid group in the molecular cleft is beneficial to promoting the
formation of the end-on intermediate via a hydrogen bonding network, shown as
intermediate A in Scheme 4.3.
If the hydrogen peroxide instead approaches the Mn(V) oxo in a side-on fashion, it can
form productive hydrogen-bonds with the phenolic oxygen as well as the metal oxo to
give intermediate B. Both protons on the hydrogen peroxide are necessary to protonate
the metal oxo and form water; therefore the hydrogen-bond with the phenolic oxygen
must be broken in order to return to the Mn(III) resting state and complete the catalytic
cycle. The effect of this high activation barrier is that B is a kinetically stable
intermediate which limits the overall catalytic activity by temporarily deactivating the
catalyst.29 It is proposed that addition of steric blocking groups in the 3 and 3' position,
ortho to the phenols, can prevent the side-on approach and formation of the hydrogen-
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bond to the phenolic oxygen to form intermediate B. This would provide our catalysts
with a further bias for intermediate A versus intermediate B, and should show enhanced
catalytic activity as a result. Engineering our catalyst to enforce the ideal intermediate
geometry is particularly important since in the absence of any of these features both
intermediates are almost energetically equal, with intermediate B only 1.8 kcal/mol lower
in energy than the end-on assembly. 29 As we have already synthesized the analogous
manganese Hangman salens that are functionalized with tert-butyl groups in the 3 and 3'
position, we are well situated to test this hypothesis.
4.3.4. Synthesis of Methyl Esters of Sterically Protected Manganese Hangman
Salens
The synthesis of acid functionalized compounds Mn[HSX* tBu-COOH]Cl and
Mn[HphSX* tBu-COOH]Cl is described in Chapter 3. The methyl ester analogues were
synthesized as described in Scheme 4.4 to serve as proton-absent control catalysts. The
two precursors 13,30 and 21 were synthesized stepwise as previously described. They were
Suzuki-coupled" with 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (synthesis described previously, compound 16 in
Chapter 3) to give 14 and 15, which is then condensed with 0.5 equivalents of (IR,2R)-
(-)-1,2-diaminocyclohexane. The manganese chloride ion was inserted similarly to the
procedure previously described in this Chapter, using manganese(II) acetate as the metal
Scheme 4.4
t-Bu t-Bu t-Bu t-Bu
\R R R RR
af... O b .. O o
Br OH 0 M /
t-Bu t-Bu t-Bu
t-Bu t-Bu t-Bu t-Bu
1 : R = CO 2Me 14: R = CO 2Me 16: R = CO 2Me, M=2H c 18: R = CO 2Me, M=MnCI
2 : R = PhCO 2Me 15: R = PhCO 2Me 17: R = PhCO 2Me, M=2H 19: R = PhCO2 Me, M=MnCI
(a) 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzalde-
hyde, Na 2CO 3 , Pd(PPh3)4, DMF: H2O (9:1), (b) (1R,2R)-(-)-1,2-diaminocyclohexane,
EtOH, (c) Mn(OAc) 2 (H20) 4 , (ii) NaCl(aq)
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precursor to give the methyl-ester-functionalized manganese Hangman 18 and 19.
4.3.5. Catalase Activity of Sterically Protected Manganese Salen Complexes
Hangman complexes Mn(HSX*tBu-COOH)Cl and Mn(HphSX* tBu-COOH)Cl were
examined for their catalytic activity. Figure 4.3 shows the turnover numbers (TON) for
hydrogen peroxide dismutation by the Hangman systems over the course of one hour.
These results are compared to two controls: a manganese salen lacking a xanthene
scaffold but with the tert-butyl groups in the 3 and 3' position and the analogous
Hangman platform functionalized with methyl esters. The unsubstituted control, [(1,2-
cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)] manganese chloride,
demonstrates negligible TONs, even with the addition of two equivalents of benzoic acid
to serve as an intermolecular proton source. Conversely, Hangman platforms show high
TONs, but only if a proton is present on the hanging group; Mn(HSX* tBu-COOH)Cl
exhibits TONs that are appreciably higher than Mn(HSX*tBu-COOMe)Cl (18), where the
Figure 4.3 Turnover number (TON) of hydrogen peroxide dismutation catalyzed by
manganese compounds Mn(salen)C1, Mn(salen)CI in the presence of 2 equivalents of
benzoic acid), Mn[HSX* tBu-COOH]CI, Mn[HSX* tBu-COOMe]Cl (18), Mn[HphSX*
tBu -COOH]Cl and Mn[HphSX* tBu-COOMe]Cl (19) after 1 hour.
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acid functionality has been replaced by an ester. The activity of Mn(HphSX*t Bu -
COOH)C1, with the acid extended from the xanthene with a phenylene group, also
demonstrates increased activity with respect to its methyl ester analogue Mn(HphSX* t Bu -
COOMe)Cl (19), albeit to a lesser extent. We note that the activity of 19 is complicated
by ester hydrolysis. Oxygen evolution is initially slow and ceases within 15 minutes of
hydrogen peroxide addition. At this point, a marked increase in activity is observed and
TONs are obtained that are higher than expected from the initial rate. Mass spectrometry
of Mn-containing species obtained from quenched reaction mixtures (-20 min) reveals
the presence of manganese salen complexes with the methyl ester deprotected.
Deprotection of methyl esters to give the acid derivative with hydrogen peroxide is
possible owing to the high pKa of the conjugate acid. Moreover it has been shown that
HOO- can nucleophilically cleave the methyl ester in some cases. 36 The oxygen evolution
profiles for the catalysts tested are shown in Figure 4.4.
4.3.6. Mechanistic Insights into Steric Protection
The effect of substitution at the 3 and 3' positions is revealed by comparison of the
activity of Mn(HSX*-COOH)Cl and Mn(HphSX*-COOH)Cl to Mn(HSX*tBu-COOH)Cl
and Mn(HphSX*'Bu-COOH)C1, respectively. An approximately three-fold increase in the
catalase activity is observed upon substitution of the tert-butyl groups. The overall TONs
are closely tied with the reaction rates in the first two minutes of the reaction. The initial
rate constants (kinit) for H 20 2 consumption by the four acid functionalized manganese
Hangman complexes are listed in Table 1. Mn(HSX*t Bu-COOH)Cl and Mn(HphSX*tBu -
Table 4.1. Observed turnover number (TON) and initial rate constant (k,) for Catalase-
like H202 disproportionation catalyzed by manganese catalysts in 2: 1
dichloromethane/methanol at 250 C.
Catalyst ki (M-1 s- )
Mn(HSX*-COOH)C1 6
Mn(HSX*tBu-COOH)Cla 14
Mn(HphSX-COOH*)Cl 5
Mn(HphSX* tBu-COOH)Cl 10
a Similar numbers were obtained using 2: 1 THF/methanol as the solvent.
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COOH)Cl display kinit that are roughly double that of their respective unsubstituted
congeners. Though the reactions are run under biphasic conditions with methanol serving
as a phase transfer reagent between dichloromethane/catalyst solution and the aqueous
hydrogen peroxide phase, reaction rates and TON are not limited by the biphasic nature
of the reaction. Dissolution of the more soluble Mn(HSX*tBu-COOH)Cl in
tetrahydrofuran and methanol yields a homogenous reaction mixture. Addition of the
aqueous hydrogen peroxide to this solution results in TONs that are commensurate with
those obtained under the biphasic conditions
We believe that it is the confluence of the hydrogen-bonding scaffold of the Hangman
platform and the steric blocking groups in the 3 and 3' position of Mn(HSX*t Bu -
COOH)Cl and Mn(HphSX*tBu-COOH)Cl that keeps the system on cycle and leads to the
enhanced rates and TONs for catalase activity.
4.3.7. Density Functional Theory on Manganese Hydroperoxide Hangman Salen
Complexes
Scheme 4.3 presents the possibility that the acid group of the Hangman scaffold enhances
catalase activity by pre-assembling intermediate A, which rapidly disproportionates to
bring the catalyst back to its resting state. The {Mn(V) oxo-H20 2} assembly is expected
to be sensitive to the positioning of the acid-base group over the face of the salen
platform. Energy minimized geometry optimizations were performed on our two acid
Figure 4.4. Energy minimized structure obtained from DFT of the hydroperoxide
complexes of Mn(HSX*-COOH), showing one of the carboxylic acids is hydrogen
bonded to the oxygen on the xanthene scaffold, while the other is hydrogen bonded to
the hydroperoxide.
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functionalized manganese Hangman salen ligands using the Amsterdam Density
Functional (ADF) program. In order to simplify the calculations, the methyl and tert-
butyl groups on the xanthene were excluded, and the cyclohexanediamine bridge was
replaced with ethylenediamine. The complexes were modeled with a hydroperoxide
bound axial to the manganese. The geometric parameters are listed in Table 4.3 later in
this Chapter, and the input file and optimized coordinates in the converged calculations
are listed in Appendix C.
For Mn[HSX*-COOH]OOH, the geometry optimized structure is shown in Figure 4.6.
Whereas one carboxylic acid can hydrogen-bond with the unbound oxygen on the
hydroperoxide at an acid-to-metal distance of -5 A, the other forms an unconstructive
intramolecular hydrogen-bond with the oxygen on the xanthene. To form this
intramolecular hydrogen bond, the xanthene tilts appreciably toward the plane of the
macrocycle ring presumably driven by the stabilization incurred from the formation of
the six-membered ring. This intramolecular bond has been observed in porphyrin
xanthene complexes in the absence of substrate.37 Hence, only one hanging group need
be involved for substrate assembly, even when two are available.
Figure 4.5. Energy minimized structure obtained from DFT of the hydroperoxide
complexes of Mn(HphSX*-COOH) showing the two carboxylic acids span the face of
the salen macrocycle to make a -(COOH) 2- dimer that interacts with the
hydroperoxide via a hydrogen bond.
The hydrogen bond network is structurally different for the phenyl-spaced system. Two
analogous energy-minimized calculation of the hydroperoxide bound Mn(HphSX*-
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Figure 4.6. Energy minimized structure obtained from DFT of the hydroperoxide
complexes of Mn(HphSX*-COOH) with the xanthenes splayed away from each other,
precluding formation of the -(COOH) 2- dimer. Each of the carboxylic acids has a
hydrogen- bonding interaction with the hydroperoxide.
COOH) were performed. The first revealed that the addition of the phenylene spacer
permits the two acids to comfortably span the distance above the salen platform to form
an intramolecular carboxylic acid dimer (Figure 4.7). An alternative structure was
explored by tilting the xanthene scaffolds away from each other so that while both
carboxylic acids can still form productive hydrogen bonds with the bound hydroperoxide,
they are not facing each other and thus cannot form a -(COOH) 2- dimer (Figure 4.8).
The structure is destabilized by 44 kJ/mol relative to that of the -(COOH) 2- dimer (Table
4.2) showing that formation of the dimer confers significant stabilization to Mn(HphSX*-
COOH). The formation of this stabilizing intramolecular hydrogen bond is likely
accompanied by a decrease in the acidity of the proton over the reactive cleft.
Accordingly, substrate assembly will be diminished due to the reduced ability to form
additional hydrogen bonds, thus accounting for the lower catalase activity of the benzoic
Table 4.2 Total bond energies of calculated manganese Hangman salen compounds.
Compound Total Energy (kJ/mol)
Mn(HSX*)-OOH -56695.92
Mn(HphSX*)-OOH (carboxylic acid dimer) -69749.31
Mn(HphSX*)-OOH (no carboxylic acid dimer) -69704.88
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acid functionalized complexes compared to when the acids are directly attached to the
xanthene bridge (vide supra), where the two acids are too far apart to form an
intramolecular dimer.
4.3.8. Acid-to-Metal Distance Effects
Chart 4.1
,-CO2H HO2C -
u tBu
-N I N
t-Bu t-Bu
Mn[HSD*tbu]CI Mn[HphSD* tBu]CI
Although the HSX* framework displayed greater catalase activity than HphSX*, the
correlation between reactivity and functional group distance can not be directly compared
because of the carboxylic acid dimer formed in the latter. Therefore, we are unable to
discern the effect of the acid distance from changes in the acid pKa upon formation of the
dimer. Because of the importance of the acid hanging groups in assembly of the
hydrogen peroxide in the molecular cleft, we wanted to investigate this effect. To this
end, we synthesized two additional Hangman ligands by replacing the xanthene scaffolds
with dibenzofuran. The geometry of the dibenzofuran scaffold positions the functionality
away from the metal center. By synthesizing the dibenzofuran manganese Hangman
salen compounds functionalized with carboxylic acid Mn[HSD* tBu-COOH]C1 and
benzoic acid Mn[HphSD* tBu-COOH]Cl (shown in Chart 4.1), we gain two additional
complexes to study the effect of the acid distance on catalase activity.
4.3.9. Synthesis of Dibenzofuran Analogues of Manganese Hangman Salens
The Hangman salen compounds using the dibenzofuran scaffold were assembled
according to the sequence described in Scheme 4.5. 4,6-Dibromodibenzofuran (20) was
synthesized by dilithiation of the commercially available dibenzofuran using sec-
butylithium followed by bromination by elemental bromide.38 To generate the
carboxylic-acid-functionalized Hangman, 4,6-dibromodibenzofuran was monolithiated
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Scheme 4.5
\-, Ri CO2 H
a 20: R, = Br b c
O 21 : R, = CO2H 0
Br 0 O
'OH
t-Bu d
22 23: M= 2H -24:M= MnCI
Ri e 20:RR=Br \ PhCO2 R2  Me
S25: R, = SnBu3  h [2: R2 = H
O g 26 :Ri = I b O0
27: R1 = PhCO 2 Me
Br Z 0
OH
t-Bu
\ PhCO 2H . PhCO 2H HO2CPh
Sc - /O .
OH t-Bu t-Bu
t-Bu d
29 30: M = 2H 31: M = MnCI
(a) (i) Phenyllithium, cyclohexane/THF, (ii) CO 2 gas (b) 3-tert-butyl-2-hydroxy-5-
(4,4,5,5-tetramethyl-[l,3,2]dioxaborolan-2-yl)-benzaldehyde, Na 2CO 3 , Pd(PPh 3)4,
DMF/H 20, (c) (1R,2R)-(-)-1,2-diaminocyclohexane, EtOH, (d) (i) Mn(OAc) 2(H20)4 ,
EtOH, (ii) aq. NaCI, (e) (i) Phenyllithium, cyclohexane/THF, (ii) SnBu 3Cl, (f) 12,
CH 2C02, (g) 4-methoxycarbonylphenyboronic acid, CsF, Pd(PPh3)4, dioxane, (h)
BBr 3, CH 2C12
using phenyllithium and carbon dioxide was bubbled through the solution to form 4-
bromo-6-hydroxycarbonyldibenzofuran (21). 38 Palladium-catalyzed Suzuki coupling
conditions with 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-
benzaldehyde31 furnished the salen precursor 22. Synthesis of the benzoic acid
functionalized dibenzofuran required additional steps, similar to the multi-step procedure
used to obtain the analogous xanthene derivative.' 4,6-Dibromo-dibenzofuran (20) was
monolithiated using phenyllithium, followed by addition of tributyltin chloride to give
25. Addition of elemental iodine to 25 gave 4-bromo-6-iododibenzofuran (26). The aryl-
iodo position could be allowed to selectively react using palladium-catalyzed Suzuki
cross-coupling conditions with 4-methoxycarbonylphenylboronic acid to give 27. The
deprotected benzoic acid derivative of 27 could not be isolated cleanly due to its
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insolubility, but 27 can be coupled directly with 3-tert-butyl-2-hydroxy-5-(4,4,5,5-
tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzaldehyde to give the more soluble 28. The
methyl ester can then be easily deprotected using boron tribromide to give 29. Ligand
precursors 22 and 29 can be condensed with half an equivalent of (1R,2R)-(-)-1,2-
diaminocyclohexane to give the ligands 23 and 30 in good yields. Manganese(III)
chloride can be inserted by refluxing with manganese(II) acetate, followed by workup
with an aqueous sodium chloride solution to give Mn[HSD*tBu-COOH]Cl (24) and
Mn[HphSD* tBu-COOH]Cl (31).
4.3.10. Density Functional Theory of Dibenzofuran Analogues of Manganese
Hangman Salens
Figure 4.7. Energy-minimized structures obtained from DFT of the hydroperoxide
complex Mn[HSD* tBu]OOH.
We examined the geometric parameters of the two manganese Hangman compounds
Mn[HSD* tBu-COOH]Cl (24) and Mn[HphSD* tBu-COOH]Cl (31), using the same
geometry optimized energy-minimization calculations on the hydroperoxide bound
species (replacing the chloride). Again, in order to simplify the calculations, we replaced
the cyclohexanediamine bridge with ethylenediamine and did not include the tert-butyl
and methyl groups. Selected bond and distance measurements for those two compounds
as well as the xanthene analogues are shown in Table 4.4 (located at the end of the
Chapter). For Mn[HSD* tBu-COOH]Cl (24), we find that the dibenzofuran tilts the
carboxylic acid functionalities appreciably away both vertically and laterally from the
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Figure 4.8. Energy-minimized structures obtained from DFT of the hydroperoxide
complex Mn[HphSD* tBu]OOH.
bound hydroperoxide, giving an average acid-to-metal distance of about 7.4 A (see
Figure 4.7). We expect this distance can increase slightly with some rotation about the
dibenzofuran-salen bond. As shown in Figure 4.8 (bottom), when the scaffold is
functionalized by a benzoic acid in Hangman complex 31, the acid is moved closer to the
metal along the salen macrocycle plane, but the tilt upwards forced by the dibenzofuran
geometry also moves the acid further away vertically from the metal center, giving acid-
to-metal distances of about 7.0 A and 7.6 A. In this structure, unlike the xanthene
analogue, the carboxylic acids are not close enough to form an intermolecular carboxylic
acid dimer.
4.3.11. Catalase Activity: Acid-to-Metal Distance Effects
The Hangman complexes Mn[HSD* tBu-COOH]Cl (24) and Mn[HphSD*tBu-COOH]Cl
(31) were evaluated for their reactivity in catalyzing the disproportionation of hydrogen
peroxide. The amount of 02 evolved in turnover numbers (TON) for each catalyst is
shown in Table 1. Of the two Hangman complexes with dibenzofuran scaffolds, the
benzoic acid functionalized catalyst [HphSD* tBu-COOH]C1 (31) demonstrated greater
activity, averaging 2537 TON after one hour. The acid-functionalized Mn[HSD* tBu -
COOH]CI (24), however, displays much lower activity, averaging only 767 TON an hour
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Table 4.2. Observed Turnover Number (TON) for H20 2 Disproportionation by
Manganese Hangman Catalysts over One Hour. a
Catalyst TON
Mn[HphSX*tBu]Clb 2495
Mn[HSX*tBu]Clb  5328
Mn[HphSD* tBu]C1 2537
Mn[HSD*tBu]CI 838
Mn[salen]ClbPc 164
Mn[salen]Clbd 182
a In 2:1 dichloromethane: methanol at 25 'C.
b Data taken from ref. 10.
c salen = (LR,2R)-(-)-[(1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)].
d Two equivalents of benzoic acid.
under the same conditions. For comparison, we have also included the average TON
from our two previously studied xanthene based Hangman salen compounds. The acid
functionalized xanthene Hangman Mn[HSX*tBu]Cl demonstrates the best catalase
activity, while the benzoic acid functionalized version Mn[HphSX* tBu]Cl is slightly less
active but similar to the dibenzofuran analogue [HphSD* tBu-COOH]Cl (31).
Although the distances are similar, the ideal assembly of the second equivalent of
hydrogen peroxide is thought to be roughly linear. This may explain why compound
[HphSD* tBu-COOH]Cl (31), where the increase in acid distance is primarily
perpendicular from the metallosalen macrocycle, is a superior catalysts to Mn[HSD*tBu -
COOH]C1 (24), which moves shifts the acids both vertically and horizontally. While
Mn[HSD* tBu-COOH]Cl (24) is the poorest-performing Hangman salen compound
studied thus far (shown in Table 4.2), it still outperforms the redox only manganese salen
platform with the addition of two equivalents of benzoic acid. So while it provides less
than ideal carboxylic acid distance for hydrogen peroxide, the structural Hangman
framework that provides the hydrogen bonding environment over the metal center is
better than the only having the proton source.
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4.3.12. Epoxidation of Functionalized Olefins
In Chapter 3, we examined the manganese Hangman salens with xanthene scaffolds for
their epoxidation activity. While they retained the ability to catalyze enantioselective
oxygen atom transfer, analogous to their manganese salen counterparts lacking the
Hangman framework, there was no appreciable enhancement in turnover number (TON).
From these results and our stopped-flow studies using Hangman salophens (discussed in
Chapter 2), the hanging group does not appear to facilitate the formation of the high
valent Mn(V) oxo species using peroxide, hypochlorite, or iodosobenzene as the oxidant.
However, we saw in this Chapter that the hanging group can assist hydrogen peroxide
oxidation by pre-assembly in the molecular cleft, resulting in turnover numbers orders of
magnitude over their unfunctionalized analogues. We sought to apply this principle to the
epoxidation of olefins appended with a functional group capable of hydrogen-bonding,
Scheme 4.6
thereby positioning the substrate for oxidation over the Mn(V) oxo, as shown in Scheme
4.6.
4-Acetoxystyrene was our initial substrate as it is well behaved in the GC-MS conditions
we employed to determine turnover numbers. As the different acid-to-metal distances in
our Hangman salens form molecular clefts of varying size, we examined the epoxidation
activity for the all of our acid fmunctionalized complexes, Mn[HphSX* tBu]C1,
Mn[HSX*tBu]C1, Mn[HphSD* tBu]C1, and Mn[HSD* tBu]Cl (listed from shortest to
longest acid-to-metal distance). As a control, we also examined the TON for an
unmodified manganese salen platform. Sodium hypochlorite was used as the oxidant. The
results we obtained are shown in Table 4.3. Although there was improvement in the TON
for some of the Hangman complexes, particularly Mn[HphSX* tBu]C1, the observed yield
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Scheme 4.7
Br .OH a
Br
b
(a) pivaloyl chloride, pyridine, CH 2C 2, (b) tributyl(vinyl)tin, Pd(PPh3)4, toluene
for the epoxidation product for this substrate was not very high. Instead, we saw a
significant amount of a-mono- and di-chlorinated product, which was present in greater
amounts for the Hangman catalysts.
To prevent the formation of this side product, we initially thought to use the trifluorinated
analogue, but found during its synthesis that the trifluoroacetate appendage was
extremely prone to hydrolysis, particularly in the presence of base. 39 Instead, we used the
pivalic acid analogue, which was synthesized in two steps, shown in Scheme 4.7. 4-
Bromophenol was treated with pivaloyl chloride in the presence of pyridine to give 32,40
which was coupled under Stille coupling conditions 41 with tributyl(vinyl)tin to give the
functionalized olefin product 33.
This modified substrate prevents formation of the a-mono- and di-chlorinated side
products discussed above; the epoxidized substrate is instead the major product. As
shown in Table 4.3, the manganese Hangman salens with the functionalized xanthene
scaffolds demonstrate better epoxidation activity than the unmodified salen platform. The
dibenzofuran Hangman salen analogues show approximately the same activity as the
control. Although thus far we have only examined the two substrates described above, we
believe the enhanced TON we see with some of the Hangman complexes could be due to
a modest substrate pre-assembly via the carboxylic acid functionalities. Epoxidation of
functionalized olefins typically brings Sharpless' titanium tartrate catalyst to mind, which
enforces allylic alcohol assembly through a covalent bond between the metal and alcohol
group.42-44 In this case, we are using hydrogen-bonding interactions instead of covalent
interactions to direct reactivity. Hydrogen-bond interactions, along with n-stacking, are
thought to be important for the high regio- and stereoselective oxidation chemistry
performed by monoxoygenases, 4 5 48 heme peroxidases, 49 and fatty acid desaturases. 50-55
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Table 4.3. Analysis of products and turnover numbers (TON) for epoxidation
reactions as determined using GC/MS with 4-acetoxystyrene (R = H) and 2,2-
dimethyl-propionic acid 4-vinyl-phenyl ester (R = t-Bu) over 1 and 3 hours, using
sodium hypochlorite as the oxidant.
0 R
"N~ ~0
NaOCI
0 R
0
Mn(salen)Cla
Mn(HphSX* tBu)CI
Mn(HSX* tBu)Cl
Mn(HphSD* tBu)CI
Mn(HSD* tBu)C1
a salen = (1R,2R)-(
butylsalicylidene)]
R = H, (TON)
products
epoxid
1 hrs 3 hrs
1 3
11 13
5 10
9 7
4 8
monochl. dichl.
3 hrs 3 hrs
8 5
24 22
25 23
26 20
26 21
R -= t-Bu, (TON)
products
epoxide (34)
I hrs 3 hrs
3 8
3 26
7 16
7 8
4 4
)-[(1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
The use of more labile non-covalent interactions plays an important role in facilitating
substrate turnover and catalyst activity. Secondary environments that take advantage of
this have already been successfully incorporated into synthetic catalysts to enforce
substrate selectivity.5 6-6 1 Although we have yet to demonstrate regioselectivity in our
epoxidation reactions, the hydrogen-bonding interactions we are accessing in our
Hangman framework are reminiscent of those found in enzymatic systems.
4.4. Concluding Remarks and Future Work
Comparison of the reactivity profiles and overall TON for H20 2 dismutation between
Hangman salens with pendant acid and methyl ester groups establishes the importance of
a hydrogen bonding group is in facilitating catalysis. Computational studies suggest that
only one carboxylic acid is needed to promote the favored end-on hydrogen peroxide
assembly with the metal oxo catalytic intermediate. When the functional group is
extended with a phenylene spacer, the two carboxylic acids are sufficiently close to form
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a -(COOH) 2- dimer, which reduces the propensity of the hanging group to promote
substrate assembly; accordingly, lower catalytic activity is observed.
The activity of the oxo catalyst of Mn salens is enhanced by the positioning of an acid-
base group over the salen that is modified with steric blocking groups at the 3 and 3'
position of the macrocycle, as predicted by theoretical investigations into the mechanism.
The hydrogen bonding network established by the Hangman scaffold and the steric
blocking groups work in concert to promote the end-on assembly of the second
equivalent of the hydrogen peroxide in conformation that productive for its subsequent
oxidation by the manganyl oxo. These design principles should find utility for the
construction of general Mn salen catalysts displaying enhanced ROS activity.
As the hydrogen-bonding functionalities on our Hangman ligands serve as a platform for
facilitating hydrogen peroxide disproportionation, we would like to investigate their
effect on the related ROS, the superoxide radical. This is a particularly important activity
in the context of developing therapeutic agents against oxidative stress.62-69 As mentioned
in the introduction, most manganese salens behave as superoxide dismutate (SOD)
mimics as well as demonstrating high catalase activity. 70,'7 1 The two most effective are
currently being tested in human studies. 17' 26 However, unlike catalase activity, the only
methods for detecting SOD activity are indirect. 72 Typically, superoxide is generated in
low levels using xanthine/xanthine oxidase. The concentration of superoxide can be
quantitatively tested spectroscopically using a reporter molecule, commonly
ferricytochrome c, which is reduced by superoxide and produces a spectral shift.73' 74
More accurate measurements of superoxide concentration can be made via
spectroscopically observing the superoxide itself using stopped-flow 72 or using pulse
radiolysis. 75 Regardless of the method used to measure SOD activity, they all require the
assay to be performed in aqueous solutions.
Synthesizing water-soluble versions of our Hangman complexes should be fairly
straightforward; the assembly of appropriately functionalized precursors should follow a
similar synthetic path we have already developed. Disulfonated xanthene derivatives are
already commonly used in the synthesis of water-soluble ligand for hydroformulation
catalysts76 and photoinitiaters. 77 The installation of sulfonate groups using fuming
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sulfuric acid should be feasible for a xanthene dibromide precursor. Additionally, our
chiral cyclohexane bridge is not necessary for this activity; therefore we can replace our
diamine bridge with one that possesses water solubilizing functional groups.
Of all of the complexes studied using the Hangman framework (porphyrin, salophen, and
salen), the Hangman salens are best suited to assay for SOD activity and potential use in
biological systems. In the Hangman porphyrin system, it was the iron complex that
displayed high catalase activity. Most of the interest in synthesizing a therapeutic drug
has focused on manganese. The likely product of catalyst decomposition is the hydrated
metal ion, and of the three metal ions used in the pursuit of SOD mimics, iron, copper
and manganese, the latter is the least toxic.62' 78 (Iron can also perform Fenton chemistry
with hydrogen peroxide to form hydroxyl radicals). The Hangman salophens will likely
be limited in their ability to serve as a therapeutic drug as well. Manganese salophens are
active SOD mimics under laboratory conditions, but showed loss of activity when
incubated in a cell culture, indicating instability under biological conditions. 79
Conversely, manganese salen compounds have demonstrated cytoprotective activity in
vivo. 19-25 They are stable in bovine serum albumin (BSA) and in acidic conditions.o, 80
This is particularly important as tissue in ischemic stress (lack of oxygen) can approach
pH 5. '•"2 All of these factors make the manganese Hangman salen system an ideal
candidate for extending our studies of ROS neutralization activity.
4.5. Experimental Section
4.5.1. Materials
Silica gel 60 (70-230 and 230-400 mesh) was used for column chromatography.
Analytical thin layer chromatography was performed using F254 silica gel (pre-coated
sheets, 0.2 mm thick). Solvents for synthesis were for reagent grade or better and used as
received or dried according to standard methods. 83 Boron tribromide (1M in
dichloromethane), iodine, 5-bromosalicylaldehyde, phenylboronic acid, 4-bromophenol,
pivaloyl chloride, pyridine, 4-acetoxystyrene, and (1R,2R)-(-)-1,2-diaminocyclohexane
were used as received from Aldrich. Bis(pinacolato)diboron and 3-formyl-4-
methoxyphenyl-boronic acid was used as received from Frontier Scientific.
Tetrakis(triphenylphosphine)palladium, tri(n-butyl)tin chloride, dichloro[ 1,1-
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bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct,
tributyl(vinyl)tin, sodium carbonate, cesium fluoride, and manganese(II) acetate
tetrahydrate were used as received from Strem Chemicals. Phenyllithium (1.6-1.7 M in
cyclohexane) and 30% aqueous solution of hydrogen peroxide were used as received
from Alfa Aesar. The following compounds were obtained using published protocols and
their purity confirmed by 'H NMR: 4-methoxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-
dimethylxanthene (1),3 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-
benzoic acid methyl ester (2), 3  4,6-dibromo-dibenzofuran (20),38 4-bromo-6-
hydroxycarbonyldibenzofuran (21).38 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde was synthesized as described in Chapter 3.
4.5.2. Physical measurements
IH NMR and 13C NMR spectra were collected in CDCl3 or C4 D80 (Cambridge Isotope
Laboratories) at the MIT Department of Chemistry Instrumentation Facility (DCIF) using
an Inova 500 or Mercury 300 Spectrometer at 25 'C. All chemical shifts are reported
using the standard 8 notation in parts-per-million relative to tetramethylsilane and spectra
have been internally calibrated to the monoprotio impurity of the deuterated solvent used.
High-resolution mass spectral analyses were carried out by the MIT Department of
Chemistry Instrumentation Facility on a Bruker APEXIV47e.FT-ICR-MS using an
Apollo ESI source.
4.5.3. Synthesis
4.5.3.1. 2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid methyl ester (3)
Under nitrogen, a mixture of 4-methoxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-
dimethylxanthene (1) (0.300 g, 0.653 mmol), 3-formyl-4-methoxyphenylboronic acid
(0.130 g, 0.722 mmol), sodium carbonate (0.101 g, 0.981 mmol), tetrakis(triphenyl-
phosphine)palladium (0.029 g, 0.040 mmol), DMF (9 mL), and deionized water (1 mL)
was heated to 90 'C for 36 hours. Upon cooling, the mixture was extracted with 3 x 75
mL of dichloromethane. The organic portions were combined and dried over MgSO 4 and
the solvent removed by rotary evaporation. The crude solid was purified by column
chromatography (silica gel, 3:7 hexane: dichloromethane) to elute the colorless product
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(0.333 g, 99% yield). 1H NMR (500 MHz, CDCl 3, 8): 10.54 (s, 1H), 8.01 (d, J = 2.5 Hz,
1H), 7.85 (dd, J = 8.5 Hz, 2.5 Hz, 1H), 7.57 (s, 2H), 7.43 (d, J = 2.5 Hz, 1H), 7.21 (d, J
= 2.5 Hz, IH), 7.10 (d, J= 8.5 Hz, 1H), 4.01 (s, 3H), 3.50 (s, 3H), 1.70 (s, 6H), 1.36 (s,
9H), 1.33 (s, 9H). '3 C NMR (500 MHz, CDC13, 6): 190.0, 167.7, 160.9, 147.4, 146.1,
145.3, 145.2, 138.2, 131.4, 131.1, 130.2, 130.0, 127.9, 126.3, 126.2, 125.9, 124.5, 121.9,
119.7, 111.2, 56.0, 52.0, 35.0, 34.7, 34.6, 32.1, 31.7, 31.5. HRESI-MS ([M + Na]+)
NaC 33H3 80 5 m/z, Calcd. 537.2611, Found 537.2601.
4.5.3.2. 4-[2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yll-benzoic acid methyl ester (4)
Under nitrogen, a mixture of 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-
yl)-benzoic acid methyl ester (2) (0.200 g, 0.374 mmol), 3-formyl-4-
methoxyphenylboronic acid (0.074 g, 0.411 mmol), sodium carbonate (0.058 g, 0.563
mmol), tetrakis(triphenylphosphine)palladium (0.016 g, 0.022 mmol), DMF (9 mL), and
deionized water (1 mL) was heated to 90 'C for 36 hours. Upon cooling, the mixture was
extracted with 3 x 100 mL of dichloromethane. The organic portions were combined and
dried over MgSO4 and the solvent removed by rotary evaporation. The crude solid was
purified by column chromatography (silica gel, dichloromethane) to elute the colorless
product (0.219 g, 99% yield). 1H NMR (500 MHz, CDC13, 8): 10.39 (s, IH), 7.77 (d, J =
8.5 Hz, 2H), 7.74 (d, J = 2.5 Hz, 1H), 7.47 (d, J = 2.5 Hz, 1H), 7.44 (d, J = 2.5 Hz, 1H),
7.38 (dd, J = 8.5 Hz, 2.5 Hz, IH), 7.31 (d, J = 8.5 Hz, 2H), 7.16 (m, 2H), 6.57 (2, J = 8.5
Hz, 1H), 3.97 (s, 3H), 3.89 (s, 3H), 1.74 (s, 6H), 1.36 (s, 9H), 1.35 (s, 9H). 13C NMR
(500 MHz, CDCl3, 8): 190.3, 167.8, 161.5, 146.5, 146.42, 146.40, 146.3, 144.0, 138.1,
131.4, 131.3, 131.1, 130.4, 130.0, 129.7, 128.9, 128.5, 128.4, 126.23, 126.17, 124.9,
123.0, 122.4, 111.5, 56.2, 52.7, 35.9, 35.3, 32.3, 32.2. HRESI-MS ([M + Na] )
C 39H4 2OsNa m/z, Calcd. 613.2924, Found 613.2920.
4.5.3.3. 2,7-Di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid methyl ester (5)
2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid methyl ester (3) (0.200 g, 0.389 mmol) was added to 8 mL of
dichloromethane and cooled to 0 'C. A solution of boron tribromide (1.2 mL, 1.0 M in
dichloromethane) was added and upon stirring for 1 hour, 4 mL of water was added. The
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organic layer was separated, washed with 10 mL of water, and dried over MgSO 4. The
solvent was evaporated and the residue was purified by column chromatography (silica
gel, 99:1 dichloromethane: methanol) to elute the product (0.054 g, 28% yield). 1H NMR
(500 MHz, CDCl3, 6): 11.12 (s, 1H), 10.07 (s, 1H), 7.96 (d, J = 2 Hz, 1H), 7.76 (dd, J =
8.5 Hz, 2 Hz, 1H), 7.58 (d, J = 2.5 Hz, 1H), 7.56 (d, J = 2 Hz, IH), 7.45 (d, J = 2.5 Hz,
1H), 7.25 (d, J = 2 Hz, 1H), 7.09 (d, J = 8.5 Hz, 1H), 3.55 (s, 3H), 1.71 (s, 6H), 1.38 (s,
9H), 1.34 (s, 9H). 13C NMR (500 MHz, CDCl3, 6): 197.8, 167.5, 160.8, 147.3, 146.3,
145.4, 145.3, 138.9, 135.9, 131.0, 130.3, 130.2, 127.6, 126.4, 126.0, 125.8, 122.2, 120.3,
119.8, 117.2, 52.3, 35.1, 34.8, 34.7, 32.3, 31.8, 31.6. HRESI-MS ([M + H] ) C 3 2H 3 70 5
m/z, Calcd. 501.2636 Found 501.2625.
4.5.3.4. 4-[2,7-Di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yll-benzoic acid methyl ester (6)
4-[2,7-Di-tert-butyl-5-(3-formyl-4-methoxy-phenyl)-9,9-dimethyl-9H-xanthen-4-yl]-
benzoic acid methyl ester (4) (0.100 g, 0.169 mmol) was added to 8 mL of
dichloromethane and cooled to 0 'C. A solution of boron tribromide (0.51 mL, 1.0 M in
dichloromethane) was added and stirred for I hour. 4 mL of water of was then added. The
organic layer was separated, washed with 10 mL of water, and dried over MgSO 4. The
solvent was evaporated and the residue was purified by column chromatography (silica
gel, dichloromethane) to elute the product (0.076 g, 78% yield). 'H NMR (500 MHz,
CDCl3, 6): 10.87 (s, 1H), 9.29 (s, 1H), 7.26 (d,J= 8.5 Hz, 2H), 7.49 (d,J= 2.5 Hz, 1H),
7.46 (m, 2H), 7.33 (m, 2H), 7.31 (s, 1H), 7.20 (d, J = 2 Hz, 1H), 7.17 (d, J = 2 Hz, 1H),
6.85 (d, J = 8.5 Hz, 1H), 4.00 (s, 3H), 1.76 (s, 6H), 1.37 (s, 18H). 13C NMR (500 MHz,
CDCl 3, 8): 197.0, 167.4, 161.1, 146.5, 146.4, 146.1, 146.0, 143.6, 138.6, 135.8, 130.93,
130.91, 130.4, 130.3, 129.6, 129.1, 128.9, 128.1, 126.3, 126.0, 123.2, 122.7, 120.8, 117.8,
52.8, 35.8, 35.3, 32.7, 32.3. HRESI-MS ([M + Na]+) C38H4Os5Na m/z, Calcd. 599.2768,
Found 599.2756.
4.5.3.5. H2(HSX*-COOMe) (7)
A mixture of 2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid methyl ester (5) (0.050 g, 0.100 mmol) was combined with
(1R,2R)-(-)-1,2-diaminocyclohexane (0.006 mg, 0.050 mmol) in 5 mL of absolute
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ethanol and refluxed for 8 hours. Upon cooling the solvent was removed by rotary
evaporation and the resulting solid was washed with 1 mL of cold methanol and dried
under vacuum to yield the product as a yellow solid (0.053 g, 98%). 'H NMR (500 MHz,
CDCl 3, 8): 13.42 (bs, 2H), 8.46 (s, 2H), 7.55 (d, J = 2.5 Hz, 2H), 7.52 (d, J = 2.5 Hz,
2H), 7.56 (s, 2H), 7.45 (d, J = 2.5 Hz, 2H), 7.38 (d, J = 2.5 Hz, 2H), 7.16 (d, J = 2.5 Hz,
2H), 6.96 (d, J = 9 Hz, 2H), 3.45 (d, J = 9 Hz, 2H), 3.32 (s, 6H), 1.99 (d, J = 9 Hz, 2H),
1.92 (d, J = 9 Hz, 2H), 1.78 (d, J = 9 Hz, 2H), 1.69 (s, 6H), 1.67 (s, 6H), 1.53 (t, J = 9
Hz, 2H), 1.43 (s, 9H), 1.33 (s, 9H). 13C NMR (500 MHz, CDC13, 8): 168.2, 165.3, 160.3,
147.4, 146.0, 145.4, 145.2, 134.0, 133.2, 131.2, 130.1, 129.1, 128.6, 126.2, 126.1, 125.7,
121.4, 120.1, 118.3, 116.5, 72.9, 52.1, 35.1, 34.73, 34.70, 33.5, 32.1, 31.9, 31.7, 31.6,
24.4. HRESI-MS ([M + H] ) C70H83N20 8 m/z, Calcd. 1079.6144, Found 1079.6167.
4.5.3.6. H 2(HphSX*-COOMe) (8)
A mixture of 4-[2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthen-4-yl]-benzoic acid methyl ester (6) (0.018 g, 0.031 mmol) was combined with
(lR,2R)-(-)-1,2-diaminocyclohexane (0.002 g, 0.016 mmol) in 5 mL of absolute ethanol
and refluxed for 8 hours. Upon cooling the solvent was removed by rotary evaporation
and the resulting yellow solid was washed with 0.5 mL of cold methanol and dried under
vacuum (0.019 mg, 98% yield). 'H NMR (500 MHz, CDCl3, 6): 13.09 (bs, 2H), 8.05 (s,
2H), 7.65 (d, J = 8 Hz, 2H), 7.61 (d, J = 8 Hz, 2H), 7.43 (d, J = 1.5 Hz, 2H), 7.35 (d, J =
2 Hz, 2H), 7.20 (m, 4H), 7.13 (d, J = 2 Hz, 2H), 7.09 (d, J =1.5 Hz, 2H), 7.02 (m, 4H),
6.50 (d, J = 8 Hz, 2H), 4.37 (t, J = 11.5 Hz, 2H), 3.25 (bs, 2H), 2.97 (m, 4H), 1.72 (s,
6H), 1.67 (s, 6H), 1.53 (bs, 2H), 1.34 (s, 18H), 1.38 (s, 18H). "3C NMR (500 MHz,
CDC13, 5): 167.1, 164.8, 160.3, 146.1, 145.9, 145.6, 142.9, 138.1, 135.3, 133.5, 132.8,
130.9, 130.43, 130.37, 129.6, 129.0, 128.8, 128.5, 128.1, 125.8, 125.6, 122.2, 121.2,
118.2, 116.3, 72.8, 52.1, 35.4, 34.8, 34.74, 34.68, 33.0, 32.14, 32.11, 31.7, 31.2, 29.91,
29.87, 29.6, 24.4. HRESI-MS ([M + H]+) C82H9 1N20 8 m/z, Calcd. 1231.6770, Found
1231.6799.
4.5.3.7. Mn(HSX*-COOMe)CI (9)
H2(HSX*-COOMe) (7) (0.020 g, 0.019 mmol) and manganese(II) acetate tetrahydrate
(0.007 g, 0.029 mmol) was added to 4 mL of ethanol and refluxed for 2 hours in air.
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Upon cooling 0.5 mL of an aqueous saturated sodium chloride solution was added and
the mixture was extracted with 2 x 15 mL of dichloromethane. The combined organic
portions were then washed with 15 mL of water and dried over MgSO 4. The solvent was
removed by rotary evaporation to yield the brown product (0.021 g, 98% yield). HRESI-
MS ([M - Cl]) C70H80MnN20 8 m/z, Calcd. 1131.5290, Found 1131.5318. Anal. Calcd
for C7oH80oC1MnN 2 08: C, 72.00; H, 6.90; N, 2.40. Found: C, 71.82; H, 6.72 N, 2.48.
4.5.3.8. Mn(HphSX*-COOMe)CI (10)
H2(HphSX*-COOMe) (8) (0.010 g, 0.008 mmol) and manganese(II) acetate tetrahydrate
(0.003 g, 0.012 mmol) was added to 3 mL of ethanol and refluxed for 4 hours in air.
Upon cooling 0.5 mL of an aqueous saturated sodium chloride solution was added and
the mixture was extracted with 2 x 15 mL of dichloromethane. The combined organic
portions were then washed with 15 mL of water and dried over MgSO 4. The solvent was
removed by rotary evaporation to yield the brown product (0.010 g, 93% yield). HRESI-
MS ([M - Cl] ) C82 Hs88MnN 208 m/z, Calcd. 1283.5926, Found 1283.5857. Anal. Calcd
for C82H88CIMnN208: C, 74.61; H, 6.72; N, 2.12. Found: C, 74.53; H, 6.60; N, 2.10.
4.5.3.9. 4-Hydroxy-biphenyl-3-carbaldehyde (11)
Under nitrogen, 5-bromosalicylaldehyde (1.00 g, 4.98 mmol), phenylboronic acid (0.910
g, 7.46 mmol), sodium carbonate (0.800 g, 7.46 mmol), dichloro[1,1'-bis(diphenyl-
phosphino)ferrocene]palladium(II) dichloromethane adduct (0.109 g, 0.15 mmol) was
added to degassed 1,2-dimethoxyethane (36 mL) and deionized water (12 mL) and heated
to 80 'C for 24 hours. Upon cooling, 20 mL of deionized water was added, and the
solution was extracted with 3 x 100 mL dichloromethane. The organic layers were
combined and dried using MgSO 4 and the solvent was removed by rotary evaporation.
The residue was purified by column chromatography (silica gel, 7: 3 pentane:
dichloromethane) to elute the product (0.355 g, 36%). 'H NMR (500 MHz, CDCl3, 8):
11.02 (s, 1H), 10.00 (s, 1H), 7.28 (m, 2H), 7.56 (m, 2H), 7.47 (t, J = 7 Hz, 2H), 7.37 (t, J
= 7 Hz, 1H), 7.10 (d, J = 8 Hz, IH). 13C NMR (500 MHz, CDCl3, 6): 196.89, 161.13,
135.93, 132.05, 129.175, 129.08, 128.66, 127.58, 126.80, 126.77, 118.31. HRESI-MS
([M + Na]') NaCl 3HI 00 2 m/z, Calcd. 221.0573, Found 221.0562.
4.5.3.9. (R,R)-N,N'-Bis(5-phenylsalicylidene)-1,2-cyclohexanediamine (12)
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A mixture of 4-hydroxybiphenyl-3-carbaldehyde (11) (0.300 g, 1.51 mmol) was refluxed
with (1R,2R)-(-)-1,2-diaminocyclohexane (0.086 g, 0.757 mmol) in 5 mL of absolute
ethanol for 12 hours and then cooled to 0 'C and filtered. The precipitate was collected by
vacuum filtration and washed with 2 x 5 mL of cold ethanol and dried in vacuo to yield
0.241g of the bright yellow product in 67% yield. 'H NMR (500 MHz, CDCl3, 6): 13.39
(bs, 2H), 8.35 (s, 2H), 7.50 (d, J = 2 Hz, 2H), 7.47 (m, 2H), 7.46 (s, 2H), 7.40 (s, 2H),
7.38 (m, 4H), 7.30 (s, 2H), 7.29 (s, 2H), 6.97 (d, J = 9 Hz, 2H), 3.38 (d, J = 9 Hz, 2H),
1.99 (m, 2H), 1.92 (d, J = 9 Hz, 2H), 1.78 (d, J = 9 Hz, 2H), 1.51 (t, J = 9 Hz, 2H). 13C
NMR (500 MHz, CDC13, 6): 165.0, 160.7, 140.4, 132.1, 131.2, 130.1, 128.9, 126.9,
126.7, 118.9, 117.5, 72.9, 33.3, 24.3. HRESI-MS ([M + H]+) C32H3 1N20 2 m/z, Calcd.
475.2380, Found 475.2371.
4.5.3.10. Mn[(R,R)-N,N'-Bis(5-phenylsalicylidene)-l,2-cyclohexanediaminatoj Cl
(13)
(R,R)-N,N'-Bis(5-phenylsalicylidene)-1,2-cyclohexanediamine (12) (0.050 g, 0.105
mmol) and manganese(II) acetate tetrahydrate (0.039 g, 0.158 mmol) was added to 4 mL
of ethanol and refluxed for 4 hours in air. Upon cooling 1 mL of an aqueous saturated
sodium chloride solution was added and the mixture was extracted with 2 x 15 mL of
dichloromethane. The combined organic portions were then washed with 15 of mL of
water and dried over MgSO4. The solvent was removed by rotary evaporation to yield a
brown product (0.050 g, 84% yield). HRESI-MS ([M - Cl] ) C32H2- 8MnN20 2 m/z, Calcd.
527.1526, Found 527.1518. Anal. Calcd for C32H28CIMnN2 O2 : C, 68.27; H, 5.01; N,
4.98. Found: C, 68.20; H, 5.21.; N, 5.08.
4.5.3.11. 2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-dimethyl-
9H-xanthene-4-carboxylic acid methyl ester (14)
Under nitrogen, 4-methoxycarbonyl-5-bromo-2,7-di-tert-butyl-9,9-dimethylxanthene (1)
(0.100 g, 0.218 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (0.073 g, 0.239 mmol), sodium carbonate (0.034
g, 0.327 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.015 g, 0.013mmol)
were added to 9 mL DMF and I mL deionized water. The mixture was heated to 90 'C
for 24 hours. Upon cooling 10 mL of deionized water was added and the solution was
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extracted with 3 x 20 mL of dichloromethane. The combined organic portions were
washed with 10 mL of deionized water and dried over MgSO 4. The solvent was removed
by rotary evaporation and the residue was purified by column chromatography (silica gel,
1:9 diethyl ether: pentane) to give the desired product (0.084 g, 69% yield). iH NMR
(500 MHz, CDCl3, 25 °C): 6 = 11.87 (s, 1H), 10.03 (s, 1H), 7.78 (d, J = 2.5 Hz, 1H), 7.68
(d, J = 2.5 Hz, 1H), 7.57 (d, J = 2.5 Hz, 1H), 7.56 (d, J = 2.5 Hz, 1H), 7.44 (d, J = 2.5
Hz, 1H), 7.22 (d, J= 2.5 Hz, 1H), 3.46 (s, 3H), 1.71 (s, 9H), 1.49 (s, 9H), 1.38 (s, 9H),
1.33 (s, 9H). 13C NMR (500 MHz, CDCl 3, 6): 198.41, 198.12, 167.24, 160.40, 147.40,
146.11, 145.31, 145.28, 137.72, 136.22, 134.02, 130.92, 129.98, 129.46, 128.44, 126.50,
126.16, 125.81, 121.99, 120.30, 120.28, 119.65, 52.04, 35.14, 35.08, 34.78, 34.72, 32.47,
31.75, 31.58, 29.45. HRESI-MS ([M + Na]+) caled for C36H 44NaO5 m/z, 579.2903, found
579.2911.
4.5.3.12. 4-[2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-9,9-
dimethyl-9H-xanthen-4-yl]-benzoic acid methyl ester (15)
The addition of 4-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4yl)-benzoic acid
methyl ester (2) (0.100 g, 0.187 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (0.063 g, 0.205 mmol), sodium carbonate (0.029
g, 0.280 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.013 g, 0.011 mmol) to 9
mL DMF and 1 mL deionized water was performed under N2 . The mixture was heated to
90 'C for 24 hours. Upon cooling 10 mL of deionized water was added and the solution
was extracted with 3 x 20 mL of dichloromethane. The combined organic portions were
washed with 10 mL of deionized water and dried over MgSO 4. The solvent was removed
by rotary evaporation and the residue was purified by column chromatography (silica gel,
1:9 diethyl ether: pentane) to give the desired product (0.106 g, 90% yield). 'H NMR
(500 MHz, CDCl 3, 25'C): 6 = 11.66 (s, 1H), 9.29 (s, 1H), 7.67 (s, 1H), 7.65 (s, 1H), 7.49
(d, J = 2.5 Hz, 1H), 7.47 (dd, J = 2.5 Hz, 7 Hz, 2H), 7.27 (d, J = 2.5 Hz, 1H) 7.25 (s,
1H), 7.18 (m, 2H), 7.16 (d,J = 2.5 Hz, 1H), 3.98 (s, 3H), 1.76 (s, 6H), 1.42 (s, 9H), 1.39
(s, 9H). 13C NMR (500 MHz, CDCl 3, 6): 197.00, 196.93, 166.84, 160.27, 145.93, 145.87,
145.70, 142.88, 137.86, 135.39, 133.71, 130.64, 130.39, 129.63, 129.06, 128.92, 128.57,
128.40, 128.26, 125.76, 125.54, 122.64, 121.93, 120.35, 52.20, 35.38, 35.03, 34.79,
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32.13, 31.78, 31.75, 29.43. HRESI-MS ([M + Na]) calcd for C42H48OsNa m/z, 655.3185,
found 655.3196.
4.5.3.13. H2IHSX*-Bu-COOMe] (16)
2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-
4-carboxylic acid methyl ester (14). (0.040 g, 0.072 mmol) was added to (1R,2R)-(-)-1,2-
diaminocyclohexane (0.004 g, 0.036 mmol) in 4 mL of absolute ethanol and heated to
reflux for 12 hours. Upon cooling, the solvent was removed by rotary evaporation and the
residue was washed with 1 mL of cold deionized water and then dried under vacuum to
give the bright yellow product (0.042 g, 98%). 'H NMR (500 MHz, CDCl3, 25 0 C): 6 =
13.92 (bs, 2H), 8.46 (s, 2H), 7.55 (d, J = 2.5 Hz, 2H) 7.51 (d, J = 2.5 Hz, 2H), 7.37 (m,
4H), 7.29 (d, J = 2 Hz, 2H), 7.15 (d, J = 2 Hz, 2H), 3.46 (d, J = 10 Hz, 2H), 3.18 (s, 6H),
2.02 (d, J = 7 Hz, 2H), 1.92 (d, J = 10 Hz, 2H), 1.80 (d, J = 7 Hz, 2H), 1.69 (s, 6H), 1.68
(s, 6H), 1.53 (m, 2H), 1.40 (s, 18H), 1.34 (s, 18H), 1.33 (s, 18H). HRESI-MS ([M + H])
calcd for C78H99N20 8 m/z, 1191.7396, found 1191.7342.
4.5.3.14. H2 [HphSX*-tBu-COOMe] (17)
4-[2,7-Di-tert-butyl-5-(3-tert-butyl-5-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-
xanthen-4-yl]-benzoic acid methyl ester (15) (0.050 g, 0.080 mmol) was added to
(lR,2R)-(-)-1,2-diaminocyclohexane (0.004 g, 0.040 mmol) to 6 mL of absolute ethanol
and the mixture was refluxed for 12 hours. Upon cooling, the solvent was removed by
rotary evaporation and the residue was washed with 1 mL of cold deionized water and
dried under vacuum to give the yellow product (0.053 g, 100%). IH NMR (500 MHz,
CDCI3, 25 oC): 6 = 13.71 (bs, 2H), 7.48 (d, J = 8 Hz, 4H), 7.42 (d, J = 2.5 Hz, 2H), 7.39
(d, J = 2.5 Hz, 2H), 7.09 (m, 6H), 7.02 (d, J = 2 Hz, 2H), 6.97 (d, J = 2 Hz, 2H), 6.87 (d,
J = 2 Hz, 2H), 2.91 (s, 6H), 3.32 (J = 10 Hz, 2H), 2.07 (bs, 2H), 2.04( bs, 2H), 1.97 (d, J
= 10 Hz, 2H), 1.72 (s, 6H), 1.70 (s, 6H), 1.55 (m, 2H), 1.34 (s, 18H), 1.31 (s, 18H), 1.14
(s, 18H). HRESI-MS ([M + H]+) calcd for C90H107N20 8 m/z, 1343.8022, found
1343.8016.
4.5.3.15. Mn[HSX*-'Bu-COOMe]Cl (18)
H2[HSX*-tBu-COOMe] (16) (0.020 g, 0.017 mmol) was added to manganese(II) acetate
tetrahydrate (0.006 g, 0.025 mmol) in 4 mL of absolute ethanol and the solution was
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refluxed in air for 2 hours. Upon cooling, 0.5 mL of an aqueous saturated sodium
chloride solution was added and the mixture was stirred for 10 minutes and then extracted
with 3 x 10 mL of dichloromethane. The organic layers were combined and washed with
10 mL of water and then dried over MgSO 4. The solvent was removed by rotary
evaporation to leave the brown product (0.021 g, 98%). HRESI-MS ([M - Cl] ) calcd for
C78H96MnN20 8 m/z, 1243.6542, found 1243.6582. Anal. Calcd for C78H96C1MnN 2Os: C,
73.19; H, 7.56; N, 2.19. Found: C, 73.01; H, 7.76; N, 2.30.
4.5.3.16. Mn [HphSX*- tBu-COOMe]Cl (19)
H2[HphSX*- tBu-COOMe] (17) (25 mg, 0.019 mmol) was combined with manganese(II)
acetate tetrahydrate (6.8 mg, 0.028 mmol) in 4 mL of absolute ethanol and refluxed in air
for 2 hours. Upon cooling, 0.5 mL of an aqueous saturated sodium chloride solution was
added and the mixture was stirred for 10 minutes and then extracted with 3 x 10 mL of
dichloromethane. The organic layers were combined and washed with 5 mL of water and
dried over MgSO 4. The solvent was removed by rotary evaporation to give the brown
product (0.026 g, 98%). HRESI-MS ([M - Cl] ÷) calcd for C9oHI 04MnN 2Os m/z,
1395.7168, found 1395.7136. Anal. Calcd for C9o0HI0 4C1MnN 2Os: C, 75.48; H, 7.32; N,
1.96. Found: C, 75.34; H, 7.45; N, 2.03
4.5.3.17. 6-(3-tert-Butyl-5-formyl-4-hydroxyphenyl)-dibenzofuran-4-carboxylic
acid (22).
Under nitrogen, a mixture of 4-bromo-6-hydroxycarbonyldibenzofuran (21) (0.200 g,
0.687 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-
benzaldehyde (0.230 g, 0.756 mmol), sodium carbonate (0.106 g, 1.03 mmol), and
tetrakis(triphenylphosphine)palladium (0.048 g, 0.041 mmol) was added to 14.5 mL of
DMF and 1.5 mL of deionized water and heated to 90 'C for 36 hours. Upon cooling, the
reaction mixture was extracted with 3 x 20 mL of dichloromethane. The combined
organic layers were then washed with 2 x 20 mL of water and dried over MgSO 4, and the
solvent was removed by rotary evaporation. The residue was purified by column
chromatography (8: 2 pentane: ethyl acetate) to give the colorless product (0.125 g, 47 %
yield). 1H NMR (500 MHz, C 4D 80, 25'C): 6 = 12.08 (s, 1H), 10.06 (s, 1H), 8.40 (d, J =
2 Hz, 1H), 8.37 (d, J = 2 Hz, 1H), 8.29 (dd, J = 7.5 Hz, 1 Hz, 1H), 8.13 (dd, J= 7.5 Hz,
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1 Hz, IH), 8.03 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.80 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.47 (inm,
2H), 1.56 (s, 9H). 13C NMR (500 MHz, C4H 80, 8): 198.13, 164.97, 160.67, 154.99,
153.44, 137.98, 134.22, 132.49, 129.79, 127.10, 125.94, 125.76, 125.18, 124.38, 124.26,
123.79, 122.59, 121.28, 119.49, 116.25, 35.04, 28.93. HRESI-MS ([M + Na] ÷) cacld for
C24H20OsNa m/z, 411.1208, found 411.1202.
4.5.3.18. H2 [HSD*tBu-COOH] (23)
A mixture of 4-[6-(3-tert-butyl-5-formyl-4-hydroxy-phenyl)-dibenzofuran-4-yl]-benzoic
acid methyl ester (22) (30.0 mg, .077 mmol) and (lR,2R)-(-)-1,2-diaminocyclohexane
(4.4 mg, 0.039 mmol) was added to 6 mL of absolute ethanol. The solution was heated to
reflux for 2 hours and upon cooling the solvent was removed by rotary evaporation. The
yellow residue was washed with 0.3 mL cold methanol and dried under vacuum to give
the product (30 mg, 91% yield). HRESI-MS ([M + H] +) cacld for C54Hs5 1N20 8 m/z,
855.3640, found 855.3631. Anal. Calcd for C54H5soN 20 8: C, 75.86; H, 5.89; N, 3.28.
Found: C, 75.73; H, 6.01; N, 2.45.
4.5.3.19. Mn[HSD* tBu-COOHI CI (24)
A mixture of 23 (30.0 mg, 0.035 mmol) and manganese(II) acetate tetrahydrate (13.0 mg,
0.053 mmol) was added to 4 mL of absolute ethanol and heated to reflux for 2 hours.
Upon cooling, 4 mL of saturated aqueous sodium chloride was added and the solution
was stirred for 20 minutes and the solid was collected by filtration and washed with
water. Upon drying, the brown solid was taken up in dichloromethane and filtered. The
filtrate was reduced to give the brown product (14 mg, 42% yield). HRESI-MS ([M -
Cl]) cacld for C5 4 H4 8MnN 208 m/z, 907.2792, found 907.2821. Anal. Caled for
C54H4 8CIMnN 208: C, 68.75; H, 5.13; N, 2.97. Found: C, 68.66; H, 5.23 N, 2.85.
4.5.3.20. (6-Bromo-dibenzofuran-4-yl)-tributyl-stannane (25)
Under nitrogen, a solution of 4,6-dibromodibenzofuran (20) (0.500 g, 1.53 mmol) in 40
mL of dry THF was cooled in an acetone/dry ice bath. Phenyllithium (1.1 mL, 1.7 M
solution in cyclohexane) was added and the resulting solution was stirred for 30 minutes
and then warmed to room temperature and stirred for an additional 30 minutes before the
addition of tri(n-butyl)tin chloride (0.549 g, 1.69 mmol). After 15 minutes, the solvent
was removed by rotary evaporation to give an oily residue. 15 mL of pentane was added
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and the solution was filtered. The filtrate was reduced back to an oil by rotary
evaporation and purified by column chromatography (silica gel, pentane) to give the
desired product as an oil at room temperature (0.592 g, 72% yield). 'H NMR (500 MHz,
CDC13, 25 0 C): 8 = 7.94 (d, J= 8 Hz, 1H), 7.90 (d, J= 7.5 Hz, 1H), 7.66 (m, 2H), 7.43 (t,
J = 8 Hz, 1H), 7.23 (t, J = 8 Hz, 1H), 1.76 (min, 6H), 1.48 (sextet, J = 7.5 Hz, 6H), 1.39 (t,
J= 8 Hz, 6H), 1.00 (t, J = 7.5 Hz, 9H). 13C NMR (500 MHz, CDCl 3, 6): 162.21, 153.29,
135.69, 129.70, 126.35, 124.23, 123.66, 123.41, 122.16, 121.08, 119.73, 104.72, 29.41,
27.65, 13.98, 10.29.
4.5.3.21. 4-Bromo-6-iodo-dibenzofuran (26)
Iodine (0.280 g, 1.75 mmol) was slowly added to a rapidly stirring solution of (6-bromo-
dibenzofuran-4-yl)-tributylstannane (25) (0.592 g, 1.10 mmol) dissolved in 10 mL of
dichloromethane. After stirring for one hour, the solution was washed with a saturated
aqueous sodium carbonate solution (2 x 10 mL) followed by 10 mL of deionized water.
The organic portion was dried over MgSO4 and the solvent was removed by rotary
evaporation to give an oily solid which was purified by loading onto a short silica plug,
flushing with pentane, followed by dichloromethane to elute the product as colorless
solid (0.386 g, 94%). 'H NMR (500 MHz, CDCl 3, 25 0 C): 6 = 7.90 (d, J = 8 Hz, I H),
7.87 (m, 2H), 7.66 (d, J = 8 Hz, 1H), 7.26 (dt, J = 8 Hz, 2.5 Hz, 1H), 7.15 (dt, J -= 5.5
Hz, 2.5 Hz, IH). 13C NMR (500 MHz, CDC13, 6): 153.06, 136.89, 130.88, 126.16,
125.08, 124.70, 124.57, 121.14, 120.32, 105.05, 75.82. HRESI-MS ([M + Na]f) cacld for
C1 2H6BrIONa m/z, 394.8539, found 394.8542.
4.5.3.22. 4-(6-Bromo-dibenzofuran-4-yl)-benzoic acid methyl ester (27)
Under nitrogen, a mixture of 4-bromo-6-iodo-dibenzofuran (26) (0.250 g, 0.670 mmol),
4-methoxycarbonylphenylboronic acid (0.133 g, 0.737 mmol), cesium fluoride (0.336 g,
2.21 mmol) and tetrakis(triphenylphosphine)palladium (0.077 g, 0.067 mmol) was added
to 8 mL of 1,2-dimethoxyethane and heated to 90 'C for 24 hours. Upon cooling to room
temperature, the solvent was removed under vacuum and the residue was taken up in 50
mL of dichloromethane and washed with 2 x 10 mL of deionized water. The organic
portion was dried with MgSO 4 and the solvent was removed by rotary evaporation. The
residue was purified by column chromatography (silica gel, 7: 3 dichloromethane:
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pentane) to give the colorless product (0.235 g, 92%). 1H NMR (500 MHz, CDCl3,
250 C): 6 = 8.21 (d, J = 8.5 Hz, 2H), 8.04 (d, J = 8.5 Hz, 2H), 7.90 (dd, J = 7.5 Hz, 1 Hz,
1H), 7.87 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.66 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.61 (dd, J = 7.5
Hz, 1 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.22 (t, J = 7.5 Hz, 1H), 3.98 (s, 3H). '3C NMR
(500 MHz, CDCl3, 6): 166.99, 153.29, 153.09, 140.40, 130.30, 130.01, 129.34, 128.59,
127.33, 125.38, 125.14, 124.80, 124.19, 123.84, 120.94, 119.72, 104.68, 52.23. HRESI-
MS ([M + H]+) calcd. for C20HI4BrO 2 m/z, 381.0121, found 381.0130.
4.5.3.23. 4-[6-(3-tert-Butyl-5-formyl-4-hydroxyphenyl)dibenzofuran-4-yll-benzoic
acid methyl ester (28)
Under nitrogen, a mixture of 4-(6-bromo-dibenzofuran-4-yl)-benzoic acid methyl ester
(27) (0.250 g, 0.656 mmol), 3-tert-butyl-2-hydroxy-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-benzaldehyde (0.219 g, 0.72 1mmol), sodium carbonate (0.101
g, 0.984 mmol), and tetrakis(triphenylphosphine)palladium (0.045 g, 0.039 mmol) was
added to 9 mL of DMF and 1 mL of deionized water and heated to 90 'C for 24 hours.
Upon cooling, the reaction mixture was extracted with 3 x 20 mL of dichloromethane.
The combined organic layers were then washed with 2 x 20 mL of water and dried over
MgSO4, and the solvent was removed by rotary evaporation. The residue was purified by
column chromatography (7:3 dichloromethane: pentane) to give the colorless product
(0.238 g, 76% yield). 'H NMR (500 MHz, CDC13, 25 0 C): 6 = 11.91 (s, 1H), 9.97 (s, 1H),
8.16 (d, J = 9 Hz, 2H), 8.10 (d, J = 2 Hz, 1H), 8.03 (dd, J = 9 Hz, 1 Hz, 1H), 7.97 (m,
4H), 7.68 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.63 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.49 (quartet, J =
7.5 Hz, 2H), 3.98 (s, 3H), 1.44 (s, 9H). 13C NMR (500 MHz, CDC13 , 8): 197.47, 167.01,
161.10, 153.42, 141.03, 138.84, 134.81, 132.07, 130.08, 129.52, 128.86, 128.74, 127.52,
127.15, 126.47, 125.21, 125.02, 124.95, 124.88, 123.84, 123.75, 121.06, 121.02, 120.87,
119.97, 119.84, 52.44, 35.25, 29.32. HRESI-MS ([M + Na]+) calcd for C3 1H26 OsNa m/z,
501.1672, found 501.1678.
4.5.3.24. 4-[6-(3-tert-Butyl-5-formyl-4-hydroxyphenyl)dibenzofuran-4-yl]-benzoic
acid (29)
Under nitrogen, 4-[6-(3-tert-butyl-5-formyl-4-hydroxyphenyl)dibenzofuran-4-yl]-benzoic
acid methyl ester (28) (0.080 g, 0.167 mmol) was dissolved in 6 mL of dry
dichloromethane and cooled to 0 'C in an ice bath. A solution of 1.0 M boron tribromide
138
(0.50 mL, 0.502 mmol) was added via syringe and the temperature of the reaction
mixture was raised to room temperature. This was then stirred for 2 hours, upon which 10
mL of deionized water was added. The subsequent mixture was extracted with 3 x 20
mL of dichloromethane, and the combined organic layers was washed with 10 mL of
fresh deionized water, and than dried over MgSO 4 and the solvent was removed by rotary
evaporation. The residue was purified by column chromatography (99:1
dichloromethane: methanol) to give the colorless product (0.046 g, 59% yield). IH NMR
(500 MHz, C4D80, 25QC): 6 = 12.10 (s, 1H), 11.48 (bs, 1H), 10.04 (s, 1H), 8.16 (m, 4H),
8.11 (dd, J = 7.5 Hz, 1 Hz, 1H), 8.06 (m, 3H), 7.77 (dd, J = 7.5 Hz, 1 Hz, 1H), 7.71 (dd,
J = 7.5 Hz, 1 Hz, IH), 7.50 (min, 2H), 1.44 (s, 9H). 13C NMR (500 MHz, C4D80, 6):
198.96, 167.64, 161.68, 154.31, 154.18, 141.43, 139.10, 135.22, 133.14, 131.50, 131.04,
129.45, 128.53, 128.00, 127.40, 126.12, 125.90, 125.82, 124.73, 124.68, 122.31, 121.68,
120.70, 35.89, 29.75. HRESI-MS ([M + H] +) calcd for C30H250 5 m/z, 465.1696, found
465.1691.
4.5.3.25. H2[HphSD*tBu-COOH] (30)
A mixture of 4-[6-(3-tert-butyl-5-formyl-4-hydroxyphenyl)dibenzofuran-4-yl]-benzoic
acid (29) (42.0 mg, 0.090 mmol) and (IR,2R)-(-)-1,2-diaminocyclohexane (5.2 mg,
0.045 mmol) was added to 6 mL of absolute ethanol. The solution was heated to reflux
for 2 hours and upon cooling the solvent was removed by rotary evaporation. The bright
yellow residue was washed with 0.5 mL cold methanol and dried under vacuum to give
the product (36 mg, 80% yield). HRESI-MS ([M + H]-) cacld for C66H 59N20 8 m/z,
1007.4266, found 1007.6217. Anal. Calcd for C 66H 58N 20 8: C, 78.71; H, 5.80; N, 2.78.
Found: C, 78.52; H, 6.00 N, 2.85.
4.5.3.26. Mn[HphSD* tBu-COOH]CI (31)
A mixture of 30 (30.0 mg, 0.030 mmol) and manganese(II) acetate tetrahydrate (11.0 mg,
.045 mmol) was added to 6 mL of absolute ethanol and heated to reflux for 2 hours.
Upon cooling, 4 mL of saturated aqueous sodium chloride was added and the solution
was stirred for 20 minutes and the solid was collected by filtration and washed with
water. Upon drying, the brown solid was taken up in tetrahydrofuran and filtered. The
filtrate was reduced to give the brown product (30 mg, 91% yield). HRESI-MS ([M -
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Cl] ÷) cacld for C66H56MnN208 m/z, 1059.3423, found 1059.3457. Anal. Calcd for
C66H56 CIMnN2 08: C, 72.36; H, 5.15; N, 2.56. Found: C, 72.16; H, 5.26 N, 2.43.
4.5.3.27. 2,2-Dimethylpropionic acid 4-bromophenyl ester (32)
4-Bromophenol (1.00 g, 5.78 mmol) was dissolved in 20 mL of dry dichloromethane.
Pyridine (0.93 mL, 11.56 mmol) was added via syringe, followed by pivaloyl chloride
(1.42 mL, 11.56 mmol) and the reaction was stirred for 24 hours. 20 mL of deionized
water was added to quench the reaction, and the separated aqueous layer was extracted
with 2 x 20 mL of dichloromethane. The combined organic layers were dried using
MgSO 4 , and the solvent removed by rotary evaporation. The residue was purified by
column chromatography (silica gel, 2: 8 pentane: dichloromethane to dichloromethane) to
elude the product (1.40 g, 94% yield). 'H NMR (500 MHz, CDCl3 , 8): 7.49 (dd, J = 9
Hz, 5Hz, 2H), 6.96 (dd, J = 9H, 1.5 Hz, 2H), 1.35 (s, 9H). HRESI-MS ([M + Na] -) calcd
for NaC, 3H160 2 m/z, 227.1043, found 227.1043.
4.5.3.28. 2,2-Dimethylpropionic acid 4-vinylphenyl ester (33)
Under nitrogen, 2,2-dimethylpropionic acid 4-bromophenyl ester (32) (0.500 g, 1.94
mmol), tri(butyl)vinyltin (0.762 g, 2.05 mmol), and
tetrakis(triphenylphosphine)palladium (0.450 g, 0.39 mmol) was added to toluene (8 mL)
and heated to 1100 C in a sealed bomb for 12 hours. Upon cooling, 50 mL of
dichloromethane was added, and the solution was washed with 2 x 10 mL of deionized
water and dried using MgSO4 . The solvent was removed by rotary evaporation and the
residue purified by column chromatography (silica gel, 9: 1 pentane: dichloromethane) to
yield the colorless product (0.351 g, 88% yield). IH NMR (300 MHz, CDCl3 , 6): 7.45 (d,
J = 8.4 Hz, 2 H), 7.07 (dd, J = 6.9 Hz, 1.8 Hz, 2H), 6.74 (dd, J = 17.8 Hz, 10.8 Hz, 1H),
5.75 (dd, J = 17.8 Hz, 0.6 Hz, 1H), 5.28 (dd, J = 17.8 Hz, 0.6 Hz, 1H), 1.42 (s, 9H). 13C
NMR (500 MHz, CDCl3, 6): 177.12, 150.78, 136.05, 135.22, 127.22, 121.92, 121.67,
113.96, 39.18, 27.25.
4.5.3.29. 2,2-Dimethylpropionic acid 4-oxiranylphenyl ester (34)
5 mL of a 0.05 M solution of Na2HPO4 was added to 12.5 mL of commercial bleach
(Clorox). This was added to 2,2-dimethylpropionic acid 4-vinylphenyl ester (33) (0.150
g, 0.68 mmol) and manganese(salophen)chloride (25 mg, 0.04 mmol) in 10 mL of
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dichloromethane and stirred for 3 hours. The solution was extracted with 3 x 10 mL of
dichloromethane and the organic layers were combined and dried using MgSO 4 and the
solvent removed by rotary evaporation and resulting residue purified by column
chromatography (silica gel 3: 7 pentane: dichloromethane) to elude the product (0.45 g,
31% yield). 'H NMR (500 MHz, CDCl 3, 6): 7.29 (d, J = 8.5 Hz, 2H), 7.04 (d, J = 8.5,
2H), 3.87 (t, J = 2 Hz, 1H), 3.15 (dd, J = 5 Hz, 4 Hz, 1H), 2.78 (dd, J = 5 Hz, 2 Hz, 1H),
1.36 (s, 9H). '13C NMR (500 MHz, CDCl 3, 6): 177.26, 156.10, 135.11, 126.67, 121.85,
52.17, 52.49, 27.31. HRESI-MS ([M + Na] +) calcd for NaC13H160 3 m/z, 243.0992, found
243.0998.
4.5.4. Hydrogen Peroxide Disproportionation Reactions
Dismutation reactions were performed at room temperature in a sealed (PTFE septum) 20
mL reaction vial equipped with a magnetic stirbar and a capillary gas delivery tube linked
to an inverted graduated burette filled with water. The reaction vial was charged with a
stock solution of the corresponding catalyst in CH2Cl 2 (1.0 mL). MeOH (0.5 mL) was
added followed by H20 2 (790 [tL, 8.22 mmol; 10.4 M (30%) aq. solution), and the
reaction mixture was stirred vigorously. The time was set to zero immediately after
addition of H20 2. The conversion was monitored volumetrically, and the amount of 02
(n) produced was calculated through the perfect gas equation pV = nRT, assuming that p
= 1 atm. As a check on our experimental set-up, MnO 2 was employed to dismutate the
hydrogen peroxide completely. Calibration runs show that the amount of oxygen
collected matches the amount expected, given the concentration of the hydrogen peroxide
solution.
The amount of catalyst used to obtain the turnover numbers for the catalase experiments:
Mn(5-phsailen)Cl (13) (1.0 mL from a 5.3 mg into 10 mL CH2Cl2 solution or 0.00095
mmol) to give an average of 1.01 mL 02 in 1 hour. Mn(5-phsalen)Cl (13) with I
equivalent of benzoic acid (1.0 mL from a 2.7 mg Mn(5-phsalen)Cl and 0.6 mg benzoic
acid into 5 mL CH2Cl solution or 0.00095 mmol of each) to give 3.21 mL 02 in 1 hour.
Mn(HSX*-COOH)Cl (1.0 mL from a 5.6 mg into 5 mL CH 2 C12 solution or 0.00095
mmol) to give 35.91 mL 02 in 1 hour. Mn(HSX*-COOMe)Cl (9) (1.0 mL from a 5.54
mg into 5 mL CH2Cl2 solution or 0.00095 mmol) to give 1.61 mL 02 in 1 hour.
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Mn(HphSX*-COOH)Cl (1.0 mL from a 2.5 mg into 2 mL CH 2CI2 solution or 0.00095
mmol) to give 18.01 mL 02 in 1 hour. Mn(HphSX*-COOMe)CI (10) (1.0 mL from a 2.5
mg into 2 mL CH2CI2 solution or 0.00095 mmol) to give 2.01 mL 02 in 1 hour. (1R, 2R)-
(-)-[ 1,2-Cyclohexanediamino-NNN'-bis(3,5-di-tert-butylsalicylidene)]manganese(III)
chloride (1.0 mL from a 6.0 mg into 10 mL CH 2CI 2 solution or 0.00095 mmol) to give an
average of 3.7 mL 02 in 1 hour. (1R, 2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-
tert-butylsalicylidene)] manganese (III) chloride with 2 equivalent of benzoic acid (1.0
mL from a 6.0 mg (IR, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)]manganese(III) chloride and 1.2 mg benzoic acid into 10 mL CH 2C12
solution or 0.00095 mmol and 0.0019 mmol respectively) to give on average 4.2 mL 02
in 1 hour. Mn(HSX*-'Bu-COOH)Cl (1.0 mL from a 3.0 mg into 5 mL CH 2C12 solution or
0.000475 mmol) to give 60.7 mL 02 in I hour. Mn(HSX*- tBu-COOMe)Cl (18) (1.0 mL
from a 2.4 mg into 2 mL CH2C 2 solution or 0.00095 mmol) to give 1.4 mL 02 in 1 hour.
Mn(HphSX*-COOH)Cl (1.0 mL from a 1.3 mg into 2 mL CH 2 CI2 solution or 0.00095
mmol) to give 56.9 mL 02 in 1 hour. Mn(HphSX*-COOMe)Cl (19) (1.0 mL from a 2.7
mg into 2 mL CH 2C12 solution or 0.00095 mmol) to give 27.5 mL 02 in 1 hour. The
standard deviations on the turnover number (TON) measurements over one hour are
derived from at least three data points.
4.5.5. Epoxidation of Functionalized Olefins
The TON for epoxidation of 4-acetoxystyrene was determined as follows: 0.47 mM
solutions of the catalyst (1R, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)]manganese(III) chloride (7.5 mg in 25 mL of dichloromethane),
Mn[HSX* tBu-COOH]C1 (5.9 mg in 10 mL of dichloromethane), [HphSX*tBu-COOH]Cl
(6.7 mg in 10 mL of dichloromethane), Mn[HSD*'Bu-COOH]Cl (2.2 mg in 10 mL of
dichloromethane), [HphSD* tBu-COOH]Cl (5.2 mg in 10 mL of dichloromethane) were
prepared. A 47.5 mM solution of 4-acetoxystyrene and 23.75 mM dodecane (192.6 mg of
4-acetoxystyrene and 101.1 mg of dodecane in 25.00 mL) was prepared. For NaOCI as
the oxidant, the oxidant solution was prepared by mixing 10 mL of 0.05 M NaHPO4 and
25 mL of commercial bleach (Clorox) and 1.0 mL of I M NaOH solution and then cooled
to 0 'C. 1.0 mL of this solution was added to 0.5 mL of each catalyst solution and 0.5 mL
142
of the 4-acetoxystyrene/dodecane solution, pre-cooled to 0 'C and stirred at room
temperature.
The TON for epoxidation of 2,2-dimethylpropionic acid 4-bromophenyl ester was
determined as follows: A 47.5 mM solution of 2,2-dimethylpropionic acid 4-bromo-
phenyl ester and 23.75 mM dodecane (242.6 mg of 2,2-dimethylpropionic acid 4-bromo-
phenyl ester and 101.1 mg of dodecane in 25 mL) was prepared. For each reaction, 0.5
mL of the catalyst solution (as prepared above) were added to 0.5 mL of the of 2,2-
dimethylpropionic acid 4-bromophenyl ester/dodecane solution and cooled to 0 'C. 1.0
mL of the oxidant solution pre-cooled to 0 'C (as prepared above) was added to each
reaction and stirred at room temperature.
The reactions were calibrated at time zero, and examined by GC/MS at t = 1 hour and 3
hours. The response factor of the substrate and epoxidation product relative to the internal
standard of dodecane was determined and fitted with at least three points using a linear
calibration curve. The calibration curve was used to determine the concentration of the
substrate and epoxide product, and calculate the corresponding turnover numbers (TON)
based on the concentration of the latter. The GC/MS spectra were taken on an Agilent
Technologies 6890N Network housed at the MIT DCIF.
4.5.6. Density Functional Theory Calculations
Gas-phase density functional theoretical (DFT) calculations of the hydroperoxide
complexes of Mn(HSX*-COOH), Mn(HphSX*-COOH), Mn(HSD*-COOH),
Mn(HphSD*-COOH) were performed using the Amsterdam Density Functional
(ADF2002.02) 84,85 package on a home-built Linux cluster of sixty Intel processors
running in parallel groups of twelve. To simplify the calculation, the t-butyl and methyl
groups were removed from the xanthenes, as well as replacing the cyclohexyl backbone
to ethylenediamine. The generalized gradient approximation (GGA) was implemented by
use of Becke's 1988 exchange functional 86 and Perdew and Wang's 1991 correlation
functional.87 The basis set was of triple-zeta quality for manganese, oxygen, and nitrogen,
with a double set of polarization functions for Mn and a single polarization set for O and
N, and of double-zeta quality with single polarization set for carbon and hydrogen; the
frozen core approximation was used for the 1s shell of C, N, and O and for the ls, 2s, and
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2p shells of Mn. Full geometry optimizations of the entire complexes were run at O0 K.
All computations were carried out in the quintet spin state and the spin restriction was
lifted. The molecular geometries and the spatial components of the resulting Kohn-Sham
single-electron wavefunctions were visualized and analyzed using the software
Molekel.88 '8 9 The input (run) file and final geometry optimized output coordinates are
located in Appendix C.
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Chapter 5
Synthesis of Amido-Imine Macrocyclic
Ligands
153
5.1. Motivation and Specific Aims
Several key catalyst design elements have been identified for managing oxidation and
catalase chemistry promoted by Hangman salophen and Hangman salen architectures,
such as redox properties and the presence of proximate acid-base functionalities.
Incorporation of these features into one Hangman Schiff-base ligand is difficult owing to
imine hydrolysis. This complication provided the impetus for the design of the amido-
imine bisphenolic macrocycle described in this Chapter. The resulting Hangman ligand
framework incorporates: (1) the chiral trans-cyclohexyldiamine bridge; (2) an open site
for facile integration of electron-withdrawing/donating functionalities along the
macrocycle; and, (3) the acid-base group over the reactive metal site. The resulting
manganese complex is examined for its oxygen atom chemistry to ascertain whether the
crucial catalyst profiles are maintained in a non-salen redox platform.
5.2. Background
The epoxidation studies described in Chapter 3 reveal that manganese salens bearing two
functionalized xanthene scaffolds are capable of catalytically epoxidizing olefins
enantioselectively.1, 2 Chiral information is relayed to the substrate by the enantiopure
cyclohexanediamine bridge and the redox properties of the salophen ring can be tuned
with substituent modification. 3 We were interested in retaining these properties upon
removal of one of the Hangman scaffolds. The xanthene scaffold Hangman ligand
architecture shown in Chart 5.1 is present to position an acid-base functionality in the
secondary coordination sphere, and the cyclohexanediamine bridge incorporates the
Chart 5.1
t-Bu
I control of acid-base properties
incorporation of chirality
I control of redox propertie
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desired chiral function. The lack of a second xanthene pillar allows for greater flexibility
in design by opening a site for the installation of various functional groups to tune the
redox properties of the metal center, as demonstrated by the Hangman salophen ligand of
Chapter 2. With this ligand, we hope to integrate all of the productive elements of the
previously described Hangman Schiff-base ligand constructs.
5.3. Results and Discussion
5.3.1. Synthetic Attempts towards a Hangman Salen Bearing a Single
Functionalized Xanthene Scaffold
Isolated salen ligands that are asymmetric across their diamine bridge are rare, 4-7 and in
these cases, small amounts of symmetrical impurities are typically observed 4' 5 owing to
facile hydrolysis of the imine bond (represented in Figure 5.1).8 The hydrolysis occurs
even under very mild conditions. 9 One of the more successful approaches for
synthesizing a salen composed of two unique salicylaldehyde units involves a precursor
with one amine protected by forming the hydrochloric acid salt (2),6 as shown in Scheme
5.1. This half-salen (2) can be synthesized in two steps. First, hydrochloric acid in diethyl
ether is added dropwise to a solution of the diamine to give 1, which is subsequently
condensed with 3,5-di-tert-butyl salicylaldehyde to give 2.6 The HCI can then be removed
using triethylamine to expose the amine for condensation with the xanthene-
functionalized-salicylaldehyde (3). However, the resulting product is a mixture of
symmetric and asymmetric salens. An effort was made to separate the mixture, but
attempts to isolate the desired ligand were frustrated by the reappearance of the
symmetric ligand in solution. In an effort to avert hydrolysis of the imines, the
condensation was performed under rigorously dry conditions over activated molecular
Figure 5.1. Equilibrium representing the exchange reaction that produces symmetric
impurities when salens containing two unique phenolate arms undergo hydrolysis. The
two unique salicylaldehyde components are represented in blue (dashed) and red
(solid).
(CHa)n (CH 2)n (CH2)nI N . , H=N N%=
, N-• N• N ,,--,=" ",--,- ,
', "-"OH H7H H. -- OH HO---" ")
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Scheme 5.1
NNH3C,
t-Bu - OH
t-Bu
t-Bu
HO 2C
3 t-Bu
(a) 3,5-di-tert-butyl salicylaldehyde, MeOH/EtOH, 4A mol. sieves
sieves. Notwithstanding, the reaction produces water and thus we were unable to prevent
the disproportionation of the ligand. A re-design of the ligand was needed to circumvent
the hyrdrolysis re-distribution.
5.3.2. Design and Synthesis of Amido-Imine Macrocycles and Manganese Complexes
To evade the problem presented by Figure 5.1 in the synthesis of an asymmetric salen,
we decided to replace one of the imine bonds with an amido bond, which are less prone
to hydrolysis. We targeted the synthesis of macrocyclic "half-units", where a
cyclohexanediamine could be singly condensed to form an amido bond, leaving the other
amine available to form an imine bond.
The step-wise synthesis of the necessary precursors is described in Scheme 5.2. We
Scheme 5.2
H
0
a
X OH -a
t-Bu
X = t-Bu
X=H
4 : X = OMe
5:X= Br
6 : X = NO2
X = t-Bu
7:X=H
8 : X = OMe
9:X= Br
10 : X = NO2
NH NH2
b
-b X OH
R2
11 : X = t-Bu, R2 = t-Bu
12:X=H, R2 H
13: X = H, R2 = t-Bu
14: X = OMe, R2 = t-Bu
15 : X = Br, R2 = t-Bu
16 : X = NO2, R2 = t-Bu
(a) Ag 20, 3M NaOHaq, (b) (I1R,2R)-(-)-1,2-diaminocyclohexane, N-
methylmorpholine, 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimine-HC1, CH 2Cl2, or
i) SOC12 , ii) (1R,2R)-(-)-1,2-diaminocyclohexane, Et 3N, CH 2Cl 2
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H2N NH3CI
assembled a series of salicylaldehydes with various functionalities in the 5 position. 3,5-
di-tert-butyl salicylaldehyde and 3-tert-butyl salicylaldehyde were obtained
commercially. The methoxy,10 bromo,11 and nitro12 functionalized salicylaldehydes (4 -
6) could all be prepared in one step as described in the literature. The aldehydes were
oxidized to the carboxylic acid by heating with silver(I) oxide in basic solution. Coupling
proceeded with one equivalent of (1R,2R)-(-)-l,2-diaminocyclohexane using two
methods to form the amide bond. 11 and 12 were synthesized in higher yields by
allowing the acid and diamine to react with 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimine-HC1 and N-methylmorpholine. 13 - 16 were synthesized by allowing
the acid to react with thionyl chloride to form the acetyl chloride in situ, followed by
addition of the diamine. Both methods gave varying amounts of the symmetric diamide
ligand impurity despite dilute reaction conditions. The symmetric ligand was separated
from the desired products 11 - 16 by column chromatography. Macrocycle formation is
completed by condensation of the amine to the imine, furnishing the amido-imine
macrocycles shown in Scheme 5.3.
Scheme 5.3
0 17: M = 2H
a tN% M N 
B c 18:M= Mn
O t-Bu t-Bu
NH NH2  t-Bu
0
t-Bu OH
HO - 19: M =2H
t-Bu 
"
11 C 1N .N- 20: M = Mn
t-Bu O
t-Bu
t-Bu
(a) 3,5-di-tert-butyl-2-hydroxybenzaldehyde, EtOH, (b) 2,7-di-tert-butyl-5-(3-formyl-
4-hydroxy-phenyl)-9,9-dimethyl-9H-xanthene-4-carboxylic acid, EtOH, (c)
Mn(OAc) 2(H20) 4, EtOH
11 was refluxed in ethanol with 3,5-di-tert-butyl salicylaldehyde to give the bright yellow
macrocycle 17. The Hangman-type ligand 19 was also synthesized by condensation of 11
with a salicylaldehyde attached to the carboxylic acid functionalized xanthene scaffold.
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With 19, we saw no evidence of any functional group exchange in solution. The distinct
phenolic groups were maintained in the NMR spectrum. The manganese(III) ion can be
inserted into the ligands 17 and 19 by refluxing with manganese(II) acetate tetrahydrate
in ethanol in air to give 18 and 21, respectively. The amido nitrogen is deprotenated
during metallation to afford the neutral complex. 13 The molecular weights of the ions
(sodium adduct) obtained by high resolution mass spectrometry are consistent with this
formulation for the complex. Unique amide (C=0) and imine (C=N) stretches are present
in the infrared spectra. The C=O stretch is observed at 1628 cm - ' in 17 and 1638 cm - ' in
19. In the manganese complexes, the stretching frequency shifts to 1624 cm -1 in 18 and
1626 cm -- in 20. The shift upon metallation is more dramatic for the imine bond; the
stretching frequency at 1587 cm -1 in 17 and 1588 cm - 1 in 19 shifts to 1535 cm _1 and 1531
cm 1 in their respective manganese complexes.
5.3.3. Epoxidation Activity of Manganese Complexes
We were interested in ascertaining how our substitution of an amido group for an imine
in our ligand would affect the reactivity compared to its double-scaffold salen congeners.
Particularly, we were interested in learning whether this ligand framework could support
the type of oxidation chemistry observed in salens, and if the chirality of the ligand would
be transferred effectively to substrate. To this end, we examined the manganese complex
20 towards the epoxidation of 1,2-dihydronapthalene. Sodium hypochlorite was used as
the external oxidant, under the same conditions previously used to study their salen
counterparts.1, 2 The complexes did catalytically perform the desired epoxidation
chemistry with good yields, but the epoxide product was racemic. The lack of
asymmetric induction by these ligands may be due to their geometry. In salens, the
geometry of the macrocycle in the Mn(V) oxo species is believed to be roughly planar.14
However, the analogous diamido macrocycles are known to be more structurally flexible
and they can deviate from a non-planar coordination. 5-18 If such conformational changes
perturb substrate approaches towards the oxidizing intermediate, then communication
with the chiral cyclohexane bridge may be prevented.
5.4. Concluding Remarks
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Although there was no chiral induction by the amido-imine ligands, they represent an
interesting family of trianionic ligands. The oxygen atom transfer chemistry performed
by the manganese complexes suggest they are capable of supporting high-valent metal
oxidation states. This result is not too surprising as similar diamido diphenolic ligands
have long been used to stabilize metals in high oxidation states. 19 -24 Additionally, the
synthetic method is extremely modular. Several variations of the "half-units" were
rapidly synthesized with varying functionalities, permitting facile synthetic tuning of
electronic and steric ligand properties.
5.5. Experimental Section
5.5.1. Materials
Silica gel 60 (70 - 230 and 230 - 400 mesh) was used for column chromatography.
Analytical thin layer chromatography was performed using F254 silica gel (pre-coated
sheets, 0.2 mm thick). Solvents for synthesis were reagent grade or better and used as
received from Aldrich or dried according to standard methods.25 3,5-Di-tert-butyl-2-
hydroxybenzaldehyde, 3-tert-butyl-2-hydroxybenzaldehyde, 3,5-di-tert-butylsalicylic
acid, salicylic acid, 1-[3-dimethylamino)propyl)-3-ethylcarbodiimide hydrochloric acid,
N-methylmorpholine, (1R,2R)-(-)-1,2-diaminocyclohexane, thionyl chloride, manganese
(II) acetate tetrahydrate and 1,2-dihydronapthalene were used as received from Aldrich.
Silver(I) oxide was used as received from Strem Chemicals.
The following compounds were obtained using published protocols and their purity
confirmed by 1H NMR: (lR,2R)-(-)-l,2-diaminocyclohexane-HCI adduct (1),' 2-[(2-
aminocyclohexaneimino)-methyl]-4,6-di-tert-butyl-phenol.HCI adduct (2), 7 2,7-di-tert-
butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-carboxylic acid (3),' 3-
tert-butyl-2-hydroxy-5methoxybenzaldehyde (4), l°  5-bromo-3-tert-butyl-2-
hydroxybenzaldehyde (5),11 3-tert-butyl-2-hydroxy-5-nitrobenzaldehyde (6). 12
5.5.2. Physical Measurements
1H NMR and '"C NMR spectra were performed in CDC13 (Cambridge Isotope
Laboratories) at 25 'C unless otherwise noted. Spectra were taken on an Inova 500 or
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Mercury 300 Spectrometer housed in the MIT Department of Chemistry Instrumentation
Facility (DCIF). All chemical shifts are reported using the standard 8 notation in parts-
per-million relative to tetramethylsilane. The 1H NMR and 1 3C NMR spectra were
internally calibrated to the monoprotio impurity of the deuterated solvent used. High-
resolution mass spectral analyses were carried out by the MIT DCIF on a Bruker
APEXIV47e.FT-ICR-MS using an Apollo ESI source.
5.5.3. Synthesis
5.5.3.1. 3-tert-Butyl-2-hydroxybenzoic acid (7)
3-tert-Butyl-2-hydroxybenzaldehyde (0.300 g, 1.68 mmol) and silver(I) oxide (0.234 g,
1.01 mmol) were added to 8 mL of 3 M aqueous NaOH solution and heated to 80 'C for 4
hours, followed by stirring at room temperature for an additional 12 hours. The solution
was then neutralized using HCl and filtered. The white precipitate was washed with
diethyl ether (20 mL) to leave the product (0.180 g, 46% yield). 1H NMR (500 MHz,
CDCb3, 6): 11.21 (s, 1H), 7.82 (dd, J = 8 Hz, 2 Hz, 1H), 7.54 (dd, J = 8 Hz, 2 Hz, 1H),
6.87 (t, J = 8 Hz, lH), 1.44 (s, 9H).
5.5.3.2. 3-tert-Butyl-2-hydroxy-5-methoxy-benzoic acid (8)
3-tert-Butyl-2-hydroxy-5-methoxybenzaldehyde (4) (0.500 g, 2.40 mmol) and silver(I)
oxide (0.557 g, 2.40 mmol) was added to 8 mL of 3 M aqueous NaOH solution and
heated to 80 TC for 4 hours, followed by stirring at room temperature for 8 hours. The
solution was then neutralized using HCi and filtered. The precipitate was washed with
diethyl ether (10 mL) to leave the red product (0.131 g, 24% yield). 'H NMR (500 MHz,
CDCl 3, 8): 10.90 (s, 1H), 7.23 (d, J = 3 Hz, 1H), 7.19 (d, J = 3 Hz, 1H), 3.81 (s, 3H),
1.43 (s, 9H). 13C NMR (500 MHz, CDCI3, 8): 175.45, 157.08, 151.37, 140.08, 124.13,
110.57, 108.89, 55.89, 35.30, 29.40.
5.5.3.3. 5-Bromo-3-tert-butyl-2-hydroxybenzoic acid (9)
5-Bromo-3-tert-butyl-2-hydroxybenzaldehyde (5) (0.500 g, 1.95 mmol) and silver(I)
oxide (0.270 g, 1.17 mmol) was added to 12 mL of 3M aqueous NaOH solution and
heated to 80 'C for 4 hours, followed by stirring at room temperature for 10 hours. The
solution was then filtered. The collected filtrate was neutralized using HCI and the
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resulting precipitate was collected by filtration. The precipitate was washed with
deionized water (20 mL) to give the orange product (0.171 g, 32% yield). 1H NMR (500
MHz, CDCl3, 6): 11.24 (bs, 1H), 7.91 (d, J = 2.5 Hz, 1H), 7.57 (d, J = 2.5 Hz, 1H), 1.41
(s, 9H). '13C NMR (500 MHz, CDCl 3, 6): 174.60, 161.02, 140.95, 137.04, 130.94, 129.41,
110.95, 35.45, 29.30.
5.5.3.4. 3-tert-Butyl-2-hydroxy-5-nitrobenzoic acid (10)
3-tert-Butyl-2-hydroxy-5-nitrobenzaldehyde (6) (0.300 g, 1.34 mmol) and silver(I) oxide
(0.187 g, 0.81 mmol) were added to 5 mL of 3M aqueous NaOH and heated to 80 'C for
4 hours and then stirred at room temperature for 12 hours. The solution was then filtered
over Celite. The collected filtrate was neutralized using HC1 and refiltered to collect the
resulting colorless precipitate. The filtrate was extracted with 2 x 10 mL of diethyl ether,
and the organic portions combined with the previously collected precipitate and purified
by column chromatograph (silica gel, 90:10 dichloromethane: methanol) to elute the
product (0.276 g, 86% yield). 1H NMR (500 MHz, CDCl3, 6): 12.05 (bs, 1H), 8.77 (d, J
= 3 Hz, 1H), 8.41 (s, IH), 3.53 (bs, 1H), 1.47 (s, 9H).
5.5.3.5. N-(2-Aminocyclohexane)-3,5-di-tert-butyl-2-hydroxybenzamide (11)
3,5-Di-tert-butylsalicylic acid (1.80 g, 6.81 mmol) (0.460 g, 1.74 mmol), (1R,2R)-(-)-
1,2-diaminocyclohexane, 1 -[3-(dimethylamino)propyl]-3-ethylcarbodiimine hydrochloric
acid (0.367 g, 1.91 mmol) and N-methylmorpholine (0.76 mL, 6.96 mmol) were added to
6 mL of dry dichloromethane and stirred at room temperature for 12 hours. The solution
was washed with dilute NaOH, dried over MgSO 4, and the solvent removed by rotary
evaporation. The residue was purified by column chromatography (silica gel, 5:5
pentane: dichloromethane, followed by dichloromethane, followed by 98:1:1
dichloromethane: methanol: triethylamine) to elute the product (0.239 g, 40% yield). 'H
NMR (500 MHz, CDC13, 6): 7.42 (d, J = 2 Hz, 1H), 7.32 (d, J = 2 Hz, 1H), 7.01 (bs,
1H), 3.62 (bs, 1H), 2.54 (bs, 1H), 1.97 (d, J = 2 Hz, 1H), 1.87 (bs, 1H), 1.62 (d, J = 6 Hz,
2H), 1.38 (s, 9H), 1.26 (s, 9H), 1.24 (m, 2H), 1.11 (t, J - 9 Hz, 2H). 13C NMR (500 MHz,
CDCl 3, 6): 171.79, 158.88, 140.00, 138.16, 128.92, 119.61, 113.50, 56.10, 55.05, 35.53,
35.32, 34.47, 32.42, 31.65, 29.52, 25.12, 25.10.
5.5.3.6. N-(2-Aminocyclohexane)-2-hydroxybenzamide (12)
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Salicyclic acid (0.300 g, 2.17 mmol), (1R,2R)-(-)-1,2-diaminocyclohexane (0.250 g, 2.17
mmol), 1-[3-dimethylamino)propyl)-3-ethylcarbodiimide hydrochloric acid (0.458 g,
2.39 mmol), and N-methylmorpholine (0.96 mL, 8.68 mmol) were added to 12 mL of dry
dichloromethane in an oven-dried flask and stirred for 36 hours. The reaction was then
washed with a dilute aqueous sodium carbonate solution and the organic portion dried
with MgSO4. The solvent was removed by rotary evaporation and the residue was
purified by column chromatography (silica gel, 98:1:1 dichloromethane: methanol:
triethylamine followed by 89:10:1 dichloromethane: methanol: triethylamine) to elute the
product (0.203 g, 40% yield). 'H NMR (500 MHz, CDCl3 , 6): 7.52 (dd, J = 8 Hz, 1.5 Hz,
IH), 7.50 (bs, 1H), 7.36 (dt, J = 8 Hz, 1.5 Hz, 1H), 6.89 (dd, J = 8 Hz, 1 Hz, IH), 6.85
(dt, J = 8 Hz, 1.5 Hz, 1H), 3.99 (bs, 1H), 3.68 (t, J = 4.5 Hz, 2H), 2.40 (bs, 2H), 2.27 (s,
2H), 2.24 (s, IH), 1.85 (d,J= 6.5 Hz, 1H), 1.45 (m, 2H).
5.5.3.7. N-(2-Amino-cyclohexane)-3-tert-butyl-2-hydroxybenzamide (13)
3-tert-Butyl-2-hydroxybenzoic acid (7) (0.160 g, 0.824 mmol) was heated to 70 'C in
neat thionyl chloride (2 mL) for about one hour, or when evolution of gas from the
reaction ceased. The excess thionyl chloride was removed under reduced pressure and
100 mL of dry dichloromethane was added to the residue. A solution of (IR,2R)-(-)-1,2-
diaminocyclohexane (0.114 g, 0.989 mmol) in 100 mL of dry dichloromethane was
slowly added to the acyl chloride solution in 15 mL aliquots, followed by neat
triethylamine (0.115 mL, 0.824 mmol). After stirring at room temperature for 12 hours,
the solution was filtered and the filtrate was reduced by rotary evaporation to give the
crude product, which was purified by column chromatography (silica gel, 98:1:1
dichloromethane: methanol: triethylamine) to give the product (0.091 g, 38% yield). 'H
NMR (500 MHz, CDCl 3, 6): 7.40 (t, J = 6.5 Hz, 1H), 6.78 (m, 2H), 3.80 (bs, IH), 3.00
(bs, 1H), 3.07 (m, 2H), 2.75 (bs, 2H), 2.19 - 2.05 (m, 2H), 1.75 (d, J = 11 Hz, 2H). 1.42
(s, 9H). 171.52, 161.23, 138.95, 131.31, 123.88, 117.82, 114.24, 55.82, 55.05, 35.25,
35.17, 34.68, 32.46, 29.46, 25.06. 13C NMR (500 MHz, CDCl3, 6): 171.52, 161.23,
138.95, 131.31, 123.88, 117.82, 114.24, 59.01, 55.82, 55.05, 45.98, 35.17, 32.46, 29.46,
25.06.
5.5.3.8. N-(2-Aminocyclohexane)-3-tert-butyl-2-hydroxy-5-methoxybenzamide
(14)
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3-tert-Butyl-2-hydroxy-5-methoxybenzoic acid (8) (0.100 g, 0.446 mmol) was heated to
70 'C in neat thionyl chloride (2 mL) for about one hour. The excess thionyl chloride was
removed under reduced pressure and 100 mL of dry dichloromethane was added to the
residue. A solution of (lR,2R)-(-)-l,2-diaminocyclohexane (0.061 g, 0.535 mmol) in
100 mL of dry dichloromethane was slowly added to the acyl chloride solution in 15 mL
aliquots, followed by neat triethylamine (0.061 mL, 0.446 mmol). After stirring at room
temperature for 12 hours, the solution was filtered and the filtrate was reduced by rotary
evaporation to give the crude product, which was purified by column chromatography
(silica gel, 98:1:1 dichloromethane: methanol: triethylamine followed by 89:10:1
dichloromethane: methanol: triethylamine) to give the product (0.061 g, 43% yield). 1H
NMR (500 MHz, CDCl 3, 5): 7.04 (t, J = 3 Hz, 1H), 6.97 (bs, 1H), 3.81 (s, 3H), 3.53 (bs,
1H), 3.34 (bs, 1H), 3.07 (m, 2H), 2.8 (bs, IH), 2.40 (d, J = 12 Hz, 1H), 2.18 - 2.03 (m,
2H), 1.74 (d, J = 8.5 Hz, 2H), 1.40 (s, 9H). "3C NMR (500 MHz, CDCl 3, 5): 171.53,
155.58, 150.92, 140.22, 119.98, 113.77, 107.13, 56.21, 55.20, 54.26, 46.00, 35.29, 32.19,
29.38, 24.93, 24.75.
5.5.3.9. N-(2-Aminocyclohexane)-5-bromo-3-tert-butyl-2-hydroxybenzamide (15)
5-Bromo-3-tert-butyl-2-hydroxybenzoic acid (6) (0.120 g, 0.439 mmol) was heated to 70
'C in neat thionyl chloride (2 mL) for about one hour. The excess thionyl chloride was
removed under reduced pressure and 100 mL of dry dichloromethane was added to the
residue. A solution of (1R,2R)-(-)-1,2-diaminocyclohexane (0.061 g, 0.535 mmol) in
100 mL of dry dichloromethane was slowly added to the acyl chloride solution in 15 mL
aliquots, followed by neat triethylamine (0.061 mL, 0.446 mmol). After stirring at room
temperature for 12 hours, the solution was filtered and the filtrate was reduced by rotary
evaporation to give the crude product, which was purified by column chromatography
(silica gel, 98:1:1 dichloromethane: methanol: triethylamine followed by 89:10:1
dichloromethane: methanol: triethylamine) to give the product (0.078 g, 48% yield). 1H
NMR (500 MHz, CDC13, 5): 7.64 (d, J = 2.5 Hz, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.02 (bs,
1H), 3.70 (bs, 1H), 3.51 (m, 2H), 2.72 (m, 2H), 2.67 (bs, 1H), 2.09 (bs, 1H), 2.00 (bs,
1H), 1.74 (min, 2H), 1.35 (s, 9H). "3C NMR (500 MHz, CDCl 3, 6): 170.53, 160.31, 141.06,
133.96, 127.33, 115.86, 109.91, 55.22, 53.93, 52.93, 35.35, 32.12, 29.26, 24.86, 24.82.
5.5.3.10. N-(2-Aminocyclohexane)-3-tert-butyl-2-hydroxy-5-nitrobenzamide (16)
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3-tert-Butyl-2-hydroxy-5-nitrobenzoic acid (10) (0.040 g, 0.167 mmol) was heated to 70
'C in neat thionyl chloride (2 mL) for about one hour. The excess thionyl chloride was
removed under reduced pressure and 50 mL of dry dichloromethane was added to the
residue. A solution of (1R,2R)-(-)-1,2-diaminocyclohexane (0.023 g, 0.201 mmol) in 50
mL of dry dichloromethane was slowly added to the acyl chloride solution in 15 mL
aliquots, followed by neat triethylamine (0.023 mL, 0.167 mmol). After stirring at room
temperature for 12 hours, the solution was filtered and the filtrate was reduced by rotary
evaporation to give the crude product, which was purified by column chromatography
(silica gel, 89:10:1 dichloromethane: methanol: triethylamine) to give the product (0.013
g, 23% yield). tH NMR (500 MHz, CDCI3, 8): 8.98 (s, 1H), 8.11 (s, 1H), 4.12 (bs, 1H),
3.80 (bs, IH), 3.25 (m, IH), 2.35 (d, J = 12 Hz, IH), 2.15 (d, J = 9 Hz, IH), 1.96 (m,
2H), 1.88 (d,J= 7 Hz, 1H), 1.75 (bs, 2H), 1.39 (s, 9H).
5.5.3.11. 3,5-Di-tert-butyl-N-{2-[(3,5-di-tert-butyl-2-hydroxybenzylidene)amino]-
cyclohexane}-2-hydroxybenzamide (17)
N-(2-Aminocyclohexane)-3,5-di-tert-butyl-2-hydroxybenzamide (11) (0.250 g, 0.721
mmol) and 3,5-di-tert-butyl-2-hydroxybenzaldehyde (0.169 g, 234.23 mmol) were added
to 6 mL of ethanol and heated to reflux for 12 hours. The reaction was then cooled to 0
'C and filtered. The bright yellow precipitate was washed with cold ethanol (2 mL) to
give the product (0.300 g, 74% yield). IR (KBr) vmax: 1628 cmn-1 (C=O), 1587 cn -1
(C=N). 'H NMR (500 MHz, CDC13, 8): 13.42 (s, 1H), 12.54 (s, 1H), 8.40 (s, 1H), 7.38
(d, J = 2.5 Hz, IH), 7.32 (d, J= 2.5 Hz, 1H), 7.03 (m, 2H), 6.11 (d,J= 7.5 Hz, IH), 4.19
(bs, 1H), 3.25 (dt, J = 10.5 Hz, 4 Hz, 1H), 2.19 (bs, 1H), 1.96 - 1.73 (m, 4H), 1.55 - 1.50
(m, 3H), 1.38 (s, 9H), 1.34 (s, 9H), 1.25 (s, 9H), 1.22 (s, 9H). '3 C NMR (500 MHz,
CDC13, 8): 171.16, 165.60, 158.74, 158.26, 140.25, 139.83, 138.28, 137.10, 128.81,
127.50, 126.01, 119.05, 117.75, 113.79, 54.06, 35.34, 35.22, 34.35, 34.29, 33.84, 31.66,
31.58, 31.53, 31.31, 29.62, 29.53, 24.85, 24.33. HRESI-MS ([M + H]) C36H54N2 0 3 m/z,
Calcd. 563.4207 Found 563.4202.
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Figure 5.2. 'H NMR of compound 17.
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5.5.3.12. Mn[3,5-di-tert-butyl-N-{2-[(3,5-di-tert-butyl-2-hydroxybenzylidene)-
amino] cyclohexane}-2-hydroxybenzamide] (18)
The ligand 3,5-di-tert-butyl-N-{2-[(3,5-di-tert-butyl-2-hydroxybenzylidene)amino]-
cyclohexane}-2-hydroxybenzamide (17) (15.0 mg, 0.027 mmol) was added to
manganese(II) acetate tetrahydrate (6.5 mg, 0.027 mmol) in 2 mL of ethanol and refluxed
in air for 4 hours. Upon cooling, the solvent was removed under reduced pressure. The
residue was washed with methanol and the insoluble portion dissolved in
dichloromethane and washed with 2 x 10 mL of deionized water. The organic portion
was dried with MgSO 4 and the solvent removed by rotary evaporation to give the brown
product (8.0 mg, 49% yield). IR (KBr) vmax: 1624 cm'- 1 (C=O), 1535 cm- ' (C=N).
HRESI-MS ([M + Na]÷) NaC36H51MnN 20 3 m/z, Calcd. 637.3178 Found 637.3204.
5.5.3.13. 2,7-Di-tert-butyl-5-(3-{ [2-(3,5-di-tert-butyl-2-hydroxybenzoylamino)-
cyclohexaneimino]methyl}-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid (19)
N-(2-Aminocyclohexane)-3,5-di-tert-butyl-2-hydroxybenzamide (11) (25.0 mg, 0.072
mmol) was added to 2,7-di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid (35.1 mg, 0.072 mmol) in 3 mL of methanol. The mixture
was refluxed for 12 hours and then cooled to 0 'C and filtered. The precipitate was
washed with 4 mL of cold methanol to leave the bright yellow product (26 mg, 44%
yield). IR (KBr) vmax: 1638 cm - ' (C=O), 1588 cm - 1 (C=N). 'H NMR (500 MHz, CDCl3,
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6): 8.45 (s, IH), 7.95 (d, J = 2.5 Hz, lh), 7.69 (d, J = 2.5 Hz, 1H), 7.46 (d, J = 2.5 Hz,
IH), 7.39 (m, 2H), 7.17 (d, J = 2.5 Hz, 1H), 7.07 (d, J = 2.5 Hz, 1H), 7.03 (d, J = 9 Hz,
IH), 6.19 (d, J = 9 Hz, 1H), 4.22 (d, J = 6 Hz, IH), 3.42 (s, 1H), 3.37 (dt, J = 11.5 Hz,
4.5 Hz, 1H), 2.18 (bs, 1H), 2.01 (d,J= 13.5 Hz, 1H), 1.89 - 1.76 (m, 3H), 1.54 - 1.48 (m,
2H), 1.34 (s, 9H), 1.21 (s, 9H). "3C NMR (500 MHz, CDC13, 6): 171.47, 160.92, 159.00,
146.06, 145.64, 145.13, 139.99, 137.81, 130.33, 128.75, 128.57, 128.40, 128.02, 126.08,
125.85, 124.62, 124.47, 124.32, 124.15, 121.77, 121.58, 120.64, 120.47, 118.35, 117.13,
116.90, 113.88, 69.9, 53.93, 53.70, 50.74, 50.57, 44.26, 35.30, 35.05, 34.68, 31.74, 31.65,
31.60, 31.51, 29.63, 29.55, 29.51. HRESI-MS ([M + H]f) C 52H 66 N20 6 m/z, Caled.
815.4994 Found 815.5028.
Figure 5.3. 1H NMR spectra of compound 19.
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5.5.3.14. Mn[2,7-di-tert-butyl-5-(3-{ [2-(3,5-di-tert-butyl-2-hydroxybenzoylamino)-
cyclohexaneimino]methyl}-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid] (20)
2,7-Di-tert-butyl-5-(3- {[2-(3,5-di-tert-butyl-2-hydroxybenzoylamino)cyclohexaneimino]-
methyl}-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-carboxylic acid (19) (26.0 mg,
0.032 mmol) was added to manganese(II) acetate tetrahydrate (7.8 mg, 0.032 mmol) in 2
mL of ethanol and refluxed in air for 4 hours. Upon cooling, the solvent was removed
under reduced pressure, and the residue was washed with methanol. The insoluble portion
was dissolved in dichloromethane and washed with 2 x 10 mL of deionized water. The
organic portions were dried with MgSO 4 and the solvent was removed by rotary
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evaporation to leave the product (14 mg, 52% yield). IR (KBr) vmax: 1626 cm- 1 (C=O),
1531 cm-1 (C=N). ESI-MS ([M + Na] ) NaC 52H63MnN 20 6 m/z, Calcd. 889.40 Found
889.56.
5.5.4. Epoxidation Measurements
The epoxidation measurement was performed as follows: 0.75 mL of 0.05 M Na 2HPO4
was added to 2 mL of commercial bleach (Clorox) and cooled to 0 oC. This solution of
oxidant was added to a solution of Mn[2,7-di-tert-butyl-5-(3- {[2-(3,5-di-tert-butyl-2-
hydroxybenzoylamino)-cyclohexaneimino]methyl}-4-hydroxyphenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid] (20) (6.7 mg, 0.008 mmol) and 1,2-dihydronapthalene (100
mg, 0.768 mmol) in 1 mL of dichloromethane, also cooled to 0 'C. Upon stirring for 12
hours, the layers were separated and the aqueous layer was extracted with 2 x 6 mL of
dichloromethane. The combined organic layers were washed with 10 mL of water and 10
mL of a saturated sodium chloride solution and dried over MgSO 4. After solvent removal
by rotary evaporation the crude product was purified to by column chromatography
(silica gel, 98:2 petane: ethyl acetate) to yield the epoxide product (36 mg, 32% yield).
The ee of 0% was determined by use of a chiral GC calibrated using a pure racemic
epoxide sample. The ee measurements were performed using a chiral GC housed in
Professor Gregory Fu's laboratory by Shih-Yuan Liu.
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Chapter 6
Synthesis of Cofacial Pacman Salen
Architectures and Their Iron Complexes
171
6.1. Motivation and Specific Aims
Our interest in multi-electron reactivity has led us to synthesize a series of bimetallic
cofacial Pacman salen architectures with different inter-metal distances. A general
synthetic methodology is developed for the construction of the ligands with two different
pillars, which can be assembled and isolated in the absence of a metal ion template. This
Chapter focuses on the synthesis of diferric, diferrous, and the p-oxo diferric salen
Pacman complexes and their reactivity; the ensuing Chapter captures the diversity of
metal Pacman complexes that can be made from the ligands described here. We attempt
to photolytically activate the p-oxo bond in an attempt to expose a high-valent iron oxo
that can perform enantioselective oxygen atom transfer chemistry to electron rich
substrates, as displayed in the diiron Pacman porphyrin analogues.
6.2. Background
The design of ligand architectures capable of arranging two metal sites in a cofacial
fashion has been explored with a variety of porphyrin' -26 and other macrocyclic 275 2
frameworks for a variety of reasons, including modeling enzymatic active sites, exploring
multi-electron reactivity, and studying host-guest chemistry. Schiff-base macrocycles
have been used in several of these architectures as they can support a wide range of
transition metals in many oxidation states. The facile incorporation of enantioselective
features into the salen macrocycles makes them interesting templates for assembling
bimetallic ligands that form a chiral cleft between the metal centers. Moreover, Lewis-
acid-assisted epoxide ring opening reactions are catalyzed by metallosalens and the
mechanism is believed to involve a bimetallic intermediate. Therefore, a cofacial disalen
construct that can pre-organize the transition state is a logical approach to improve
catalytic activity though ligand design (this will be discussed further in Chapter 7).
The features of oxidative stability and construction of a chiral cleft are the primary
motivations in extending the chemistry that has been performed with cofacial "Pacman"
ligands. One of the intriguing reactions performed by the diiron p-oxo bonded complexes
is photocatalytic oxidation of electron rich substrates.22 6'5  The overall catalytic cycle
is shown in Scheme 5.1. The g-oxo bonds, formed upon oxidation of the diferrous
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Scheme 6.1
0.5
subf0l sub
species with molecular oxygen, is thermally unreactive. However, transient absorption
spectroscopy has shown that the Fe-O bond can be photolytically cleaved, generating an
iron(IV) oxo capable of performing oxygen atom transfer (OAT) chemistry. 24 These
studies reveal that the geometrically splayed dibenzofuran pillar directs substrate
approach to the oxidizing intermediate, favoring oxidation of substrate instead of the
reverse reaction, re-clamping to reform the g-oxo bond. Additionally, functionalizing the
porphyrins with electron-withdrawing groups shifts the excitation wavelength into the
visible and increases the electrophilicity of the iron(IV) oxo intermediate sufficiently to
oxidize more challenging substrates such as hydrocarbons. 25' 26
We were motivated to extend this photocatalytic oxidation chemistry using molecular
oxygen as the oxidant to Pacman salen architectures. Using these architectures, we could
potentially expand the utility of this reaction to the oxidation of prochiral substrates.
Although no efforts that we are aware of have been made to photoactivate a diiron salen
g-oxo bond, there is chemical precedent for the last two steps of the catalytic cycle.
Firstly, iron salens have shown catalytic oxygen atom transfer to olefins56 and sulfides57
using the oxidants sodium hypochlorite and iodosylbenzene, respectively, although the
nature of the oxidizing iron intermediate is still under debate.58-60 The subsequent reaction
of the diferrous species with molecular oxygen to oxidize the metals by one electron and
reform the g-oxo bridge is also well known in the iron salen literature. 6 1-72 Therefore, a
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catalytic cycle using diiron Pacman salens may be constructed provided that the Fe-O
bond may be cleaved photolytically.
The synthesis of cofacial salens has been demonstrated in the literature using a variety of
linkers, such as naphthalene, 47  methylene, 50,5 1  1,2-ethanediol, 50 ' 51  and 9,9-
dimethylxanthene. 48 The cofacial geometry is enforced by bridging the salens on both
ends of the phenolic arms via the synthetically accessible 3 and 3' or 5 and 5' positions.
In all of these examples, the complexes were synthesized in the presence of a metal
ion46 ,4 8,50 ,51 or boric acid,52 which is believed to be critical in templating the formation of
the ligand. This requirement complicates the synthesis of other bimetallic complexes;
only M2+ ions (specifically Mn, Ni, and Zn) have successfully been used as templates for
ligand assembly. Consequently, in our synthesis of diiron and diiron p-oxo Pacman salen
complexes, we sought to synthesize and isolate the free ligands in the absence of a
templating agent.
6.3. Results and Discussion
6.3.1. Ligand Design
Chart 6.1
DSX DSD
Xanthene and dibenzofuran were used as the rigid pillars to bridge the two macrocycles
to form the ligands DSX and DSD, respectively, shown in Chart 5.1. Because the imine
bonds on the salen macrocycle are easily hydrolyzed, 73-76 resulting in exchange, 77 salens
with unique salicylaldehydes are difficult to isolate and extremely sensitive to water. To
avoid this issue, we once again turned to using two pillars to form salen macrocycles that
were symmetric across the diamine bridge. The (lR,2R)-(-)-1,2-diaminocyclohexane
enantiomer was used as the diamine bridge for complexes that we hoped to effect
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enantioselective chemistry; the racemic version was used for the other Pacman
complexes. The xanthenes are expected to hold the salens roughly parallel, whereas the
dibenzofuran pillars enforces a more splayed geometry, as they do in the porphyrin
Pacman complexes. Thus, the two pillars provide geometric endpoints for molecular cleft
sizes of Pacman salens.
6.3.2. Synthesis of DiSalen Xanthene Ligand (DSX)
The synthesis of the DSX ligand is outlined in Scheme 6.1. The formation of the
xanthene-to-salicylaldehyde aryl-aryl bonds of ligand 4 required the precursor 4,5-di(5-
salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3), which was approached from
two different synthetic pathways. In the first, 7-di-tert-butyl-9,9-dimethyl-4-
dihydroxyborane-5-(4,4,5,5-tetramethyl-[ 1,3,2]dioxaborolan-2-yl)-9H-xanthene (1) was
synthesized from Rebek's xanthene dibromide (procedure described in Chapter 3).
Suzuki coupling of 1 directly with 5-bromosalicylaldehyde gave 3, with an overall yield
of 13%. Alternatively, the xanthene dibromide is already equipped with the electrophilic
Scheme 6.1
t-Bu t-Bu
V\ 1-0Br OMe
0 C0
-0Br -OMe
t-Bu t-Bu
2
a d
t-Bu
-0
OH
b 0. e00
- OH
t-Bu
(a) bis(pinacolato)diboron, Pd(dppf)C12, KOAc, DMSO, (b) 5-bromosalicylaldehyde,
Na2 CO 3, Pd(dppf)C12, DME: H20 (3:1) (c) 3-formyl-4-methoxyphenylboronic acid,
Na2 CO 3, Pd(dppf)C12, DME: H20 (3:1), (d) BBr 3, CH 2Cl2, (e) 1,2-
diaminocyclohexane, EtOH
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3
aryl carbons necessary for palladium catalyzed coupling. Under Suzuki coupling
conditions, the commercially available 3-formyl-4-methoxyphenylboronic acid was
joined to the xanthene dibromide to furnish 4,5-di-(3-formyl-4-methoxyphenyl)-2,7-di-
tert-butyl-9,9-dimethylxanthene (2). The methyl ether was then deprotected using boron
tribromide to give 3 in 53% overall yield. Both pathways to 3 require two steps from the
xanthene starting material. The modest yield is limited by the consecutive application of
two palladium catalyzed cross-coupling steps, which are typically low yielding.
The precursor 4,5-di(5-salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3) was
refluxed with one equivalent of 1,2-diaminocyclohexane to give the DSX ligand (4).
Unlike previous attempts by other groups to synthesize a disalen ligand, we were able to
isolate the ligand 4 without using a metal ion template. The isolated ligand was
characterized by high-resolution mass spectrometry and elemental analysis was used to
determine purity. The 'H NMR spectra at room temperature of 4 was poorly resolved and
broad (see Figure 6.1). The spectra of different isomers were resolved at lower
temperatures. Head-to-head or head-to-tail orientations will be obtained with rotation of
the salen macrocycles about the bond connecting the macrocycle to the xanthene.
Insight into the geometry disposition of the cofacial macrocycles was provided from the
X-ray analysis. Single crystals of 4 suitable for X-ray diffraction were grown from the
slow evaporation of a pentane-dichloromethane solution. The structure, shown in Figure
6.2 indicates considerable flexibility of the ligand salen macrocycle. They can twist along
the aliphatic diamine bridge to break the square planar ligand arrangement and form the
bent orientation observed in the crystal structure. We believe that insertion of a metal ion
is expected to enforce the planar orientation of the ligand and provides the cofacial
parallel construction desired of this architecture.
The DSX ligand was also characterized by infrared spectroscopy. The most notable
feature is the imine bond stretch, found at 1589 cm ~. This is a useful diagnostic in
characterizing the subsequent DSX complexes as it blue shifted when coordinated to a
metal.
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Figure 6.1. Variable temperature IH NMR spectra of DiSalen Xanthene ligand (4)
from room temperature (20 'C) to -60 'C, taken in 10 'C intervals.
8 6 4 2 0
ppm
Figure 6.2. X-Ray crystal structure of DiSalen Xanthene (4). Crystals were grown
from slow evaporation of a pentane-dichloromethane solution. Carbons are depicted
as gray, oxygens as red, and nitrogens as blue. H atoms are omitted for clarity.
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6.3.3. Synthesis of DiSalen Dibenzofuran Ligand (DSD)
Scheme 6.2
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(a) bis(pinacolato)diboron, Pd(dppf)Cl 2, KOAc, DMSO, (b) BBr3, CH2Cl2 , (c) 3-
formyl-4-methoxyphenylboronic acid, Na2CO3, Pd(dppf)Cl2, DME: H20 (3: 1), (d) 5-
bromosalicylaldehyde, Na2CO 3, Pd(dppf)C12, DME: H20 (3: 1) (e) 1,2-
diaminocyclohexane, EtOH
The synthesis of the disalen dibenzofuran ligand (DSD) is outlined in Scheme 5.2.
Dibenzofuran (5) is not commercially available but can be produced in a one-pot
synthesis by treating dibenzofuran successively with sec-butyllithium, followed by
elemental bromine. We initially synthesized the diboronate (6) using palladium catalyzed
cross-coupling conditions with bis(pinacolato)diboron, followed by its reaction with 5-
bromosalicylaldehyde under Suzuki coupling conditions to give the desired precursor 8.
The low overall yield along this path led us to synthesize 2-hydroxy-5-(4,4,5,5-
tetramethyl-[ 1,3,2]dioxaborolan-2-yl)-benzaldehyde as a precursor, but this was also met
with disappointing yields (this synthesis is presented in Appendix B2). A few years into
this work, 3-formyl-4-methoxyphenylboronic acid became commercially available,
which can be coupled directly to dibromodibenzofuran (5). Attempted Suzuki coupling
conditions resulted in the monocatenated product (also discussed in Appendix B2), but
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proper conditions were eventually found to give 7 in good yields. The methyl ethers were
deprotected using boron tribromide to give 8 in 62% overall yield.
The DSD ligand (9) is produced upon refluxing 8 with one equivalent of 1,2-
diaminocyclohexane. Unlike the DSX ligand, the 1H NMR spectrum of DSD is well
resolved; the splayed pillar may strain the salens enough to prevent rotation in solution.
The product was analyzed using high-resolution mass spectrometry and elemental
analysis. The infrared spectra of the ligand contained a peak at 1586 cm-1, assigned to the
imine bond stretch. X-ray quality crystals grown from pentane-dichloromethane solutions
gave the surprising structure shown in Figure 6.3. Diamine couples to the
salicylaldehydes on the same dibenzofuran spacers instead of bridging between two
dibenzofurans. The 1H NMR clearly shows the existence of only one isomer in solution,
and the mass spectrum proves it to be the heavier disalen dibenzofuran (DSD) ligand.
Because the imine bonds in salen ligands are in equilibrium with their hydrolysis
products, we believe that impurity shown in Figure 6.3 is formed in small concentrations
from the fluxional nature of the imine bonds in our ligand. Solutions left under conditions
for crystallization typically form large single crystals of the impurity, which is less
soluble. The impurity appears to be in equilibrium with the disalen. When the crystals are
Figure 6.3. X-Ray crystal structure of DSD impurity. Crystals were grown out of a
pentane-dichloromethane solution. Carbons are depicted as gray.
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isolated and redissolved into solution, their mass spectrum is again composed primarily
of the disalen dibenzofuran ligand. Therefore we believe the desired product DSD is the
major component of our condensation reaction, and the impurity crystallizes out of
solution as a minor product. As the impurity is less soluble, crystallizing conditions
drives the equilibrium to the undesired product. Although present in small amounts in
solutions of the ligand, metalation of the salen prevents hydrolysis and thus stabilizes the
formation of the disalen ligand; the impurity may easily be separated from the metallated
ligand. We have not observed an analogous impurity in the synthesis of disalen xanthene
(DSX). The aldehydes are likely too close to bridge a cyclohexanediamine bridge.
5.3.4. Synthesis of Ferric Chloride Complexes
Chart 6.2
10: M = FeCI 13
16 : M = Fe
11 : M = FeCI
17: M = Fe
t ou*t-Bu - 0M' t-Bu
t-Bu t-Bu
12: M = FeCI
18 : M = Fe
t-Bu
t-Bu
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The iron salen and Pacman salen complexes shown in Chart 6.2 were prepared. Iron(III)
insertion into the Pacman ligands was achieved by the reaction of two equivalents of
ferric chloride in ethanol; the procedure is analogous to the preparation of monomeric
iron salen compounds. 78 Anhydrous reactions conditions and workup were required to
prevent the formation of pt-oxo-bridged impurities.79,80 This is particularly important as
elemental analysis is not sensitive enough to distinguish between a partially aquated
species and pt-oxo bridged impurities. This metalation method was also successful in
producing the iron salen complex monomer 12 cleanly and in good yield. The purity of
the ferric complexes 10 - 12 was determined by elemental analysis and their molecular
formula by mass spectrometry. The infrared spectrum of the Pacman complexes also
possessed the blue-shifted imine peaks of 1540 cm for 10 and 1538 cm ' for 11
(compared to the free ligand), diagnostic of metal coordination.
5.3.5. Synthesis of Diiron p-Oxo Complexes
The diiron p-oxo complexes 13 - 15 (as shown in Chart 6.2) were prepared using a
method similar to a procedure used for other salen ligands.81,'82 Ferric chloride
hexahydrate was added to the ligand, followed by slow addition of excess triethylamine.
The iron(III) centers are expected to be paramagnetic, but coupling through the p-oxo can
result in ferromagnetic or antiferromagnetic coupling, depending on the angle of the Fe-
O-Fe bond. A crystal of the unpillared 15 was grown out of a tetrahydrofuran solution
Figure 6.4. X-Ray crystal structure of the unpillared Fe 2(salen) 20 (15). Crystals were
grown from a pentane-dichloromethane solution. The angle of the Fe-O-Fe bond
is 165.2(7)0, and the salens are by rotated 124.5' with respect to each other.
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Figure 6.5. Infrared spectra displaying the fingerprint region of Fe 2DSXO (13),
Fe2DSDO (14), and Fe 2(salen)20 (15), highlighting the imine (C=N, blue) and Fe-
O-Fe bond (purple) stretch.
1 UU00
80
E
S60
C
40
Z
20
1600 1400 1200 1000 800 600 400
Wavenumber (cm 1)
and the structure is shown in Figure 6.4. The Fe-O-Fe bond of 1650 (it should be
noted that the quality of the crystal data was poor). The structure is shown in Figure 5.4.
This observed angle is more linear than the related diiron R-oxo
bis(disalicylalethylenediamine) complex, which displays an Fe-O-Fe of 144.6(7)0,83
but within the 139'-1750 range expected with a variety for four-coordinate macrocycles,
The more linear geometry may indicate more a-bonding character in the Fe--O-Fe.72
Additionally, the Fe-O bond distances of 1.773(9) and 1.754(9) are expected for a
diiron t-oxo bridge, as opposed to the longer distances indicative of a hydroxyl bridged
species. We expect the restricted geometry of the Pacman complexes to alter the angle of
the diiron t-oxo coordination, although we have yet to determine this parameter using
crystallographically. The imine stretch was again diagnostic of metal coordination in the
infrared spectra, coming in at 1536 cm - 1 for both 13 and 14 and 1533 cm -n for 15. The
Fe-O-Fe asymmetric bond stretch was also identified (based on published literature
values), coming in at 833 cm - 1n, 830 cm - 1 and 837 cm l for 13, 14 and 15, respectively
(see Figure 6.5). In additional to 'H NMR spectroscopy, the compounds were
characterized by mass spectroscopy and their purity determined by elemental analysis.
5.3.6. Synthesis of Ferrous Complexes
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Previous preparations of iron(II) salen compounds have used ferrous acetate to insert the
metal ion in dimethylformamide. 62 We found the air-sensitive ferrous complexes 16 - 18
could be cleanly synthesized with this starting material using tetrahydrofuran instead,
which is more convenient to remove during product isolation. The purity of the products
was determined by elemental analysis.
6.3.7. 5 7sFe Mossbauer Spectroscopy of Iron Complexes
57Fe Mossbauer spectra were recorded for all of the iron compounds 10 - 18 in the solid
state at 4.2K. The parameters from the data fit are given in Table 6.1. The data for the
iron salen compounds, along with the fit, are shown in Figures 6.6, 6.7 and 6.8, and a
summary of the parameters found is listed in Table 6.1.
The Fe(III) chloride salen complexes (Figure 6.6) have similar isomer shifts (8) (0.428,
0.435, and 0.447 mm/s for 10, 11, and 12 respectively), indicating that the chemical
environment around the irons are comparable. These values fall within the range of an
Fe(III) high spin S = 5/2 species, typically listed as between 0.25 and 0.60 mm/s. 84-86 This
Figure 6.6. Fitted 57Fe M6ssbauer spectra of (a) Fe 2DSXCl2 (10), (b) Fe 2DSDC12
(11), (c) Fe(salen)Cl (12) at 4.2 K. Gray dots represent the experimental data points
and the black solid line represents the fit. The vertical axis is an arbitrary
transmission scale.
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Figure 6.7. Fitted 57Fe Massbauer spectra of (a) Fe2DSXO (13), (b) Fe2DSDO (14),
(c) Fe 2(salen)20 (15) at 4.2 K. Gray dots represent the experimental data points and
the black solid line represents the fit. The vertical axis is an arbitrary transmission
scale.
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Table 6.1. Summary of M6ssbauer parameters for compounds 10 - 18
K. 6 is relative to elemental iron. All samples were measured in
(powdered). F is the half-width at half-maximum of the peaks, and the
is the same for both peaks.
recorded at 4.2
the solid state
value presented
Complex 6 (mm/s) AEQ (mm/s) F
Fe 2DSXC12 (10) 0.428 1.03 0.387
Fe2(DSD)C12 (11) 0.435 1.23 0.617
Fe(salen)C1 (12)a 0.447 1.18 0.219
Fe2(DSX)O (13) 0.439 0.90 0.259
Fe2(DSD)O (14) 0.490 0.97 0.498
Fe2(salen)20 (15)" 0.441 0.73 0.275
Fe 2(DSX) (16) 0.472 0.94 0.372
Fe2(DSD) (17) 0.416 0.87 0.581
Fe(salen) (18)a 0.578 1.08 1.362
a salen = (1R, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)].
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Figure 6.8. Fitted 57Fe MSssbauer spectra of (a) Fe2DSX (16), (b) Fe 2DSD (17),
(c) Fe(salen) (18) at 4.2 K. Gray dots represent the experimental data points and
the solid black line represents the fit. The vertical axis is an arbitrary transmission
scale.
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spin state is supported by magnetic data on the related Fe(salen)Cl compounds (with
ethylenediamine and phenylenediamine bridges) in the literature. 78' 79 The similar
quadrupole splitting value AEQ of the diiron Pacman complexes (1.03 for 13 and 1.23 for
14) compared to the monomeric compound 12 (AEQ = 1.18 mm/s) suggests the
tetradendate salen ligand geometry is probably not distorted from its normal square
planar geometry by incorporation in the Pacman framework. The F values are the same
for both peaks.
The diiron t-oxo-bridged species (data shown in Figure 6.7) have 6 values of 0.439,
0.490, and 0.447 mm/s for 13, 14 and 15, respectively. These values are consistent with
other unbound Fe(III) t-oxo bridged salen complexes, which display isomer shifts of
0.47 to 0.56 mm/s (at 77 K).72'87-90 The slightly higher quadrupole splitting (AEQ) seen in
the Pacman complexes (0.90 and 0.97 mm/s for the Pacmans 13 and 14 compared to 0.73
mmn/s for the monomer 15) could be due to a more acute FeO---Fe angle due to ligand
constraints, although this is a tentative conclusion in the absence of more structural
evidence.
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The Fe(II) salen complexes (Figure 6.8) display isomer shifts (8) of 0.472, 0.416, and
0.578 mm/s for 16, 17 and 18 respectively. These shifts for 16 and 17 are consistent with
a low spin Fe(II) environment. As mentioned previously, the ferrous compounds are
subject to oxidation in the presence of air. Although the samples were prepared under an
inert atmosphere, and brought to the instrument immersed in liquid nitrogen, they may
have been exposed to air during the manipulation into the sample holder. This may
explain the poor data quality of 18, and 8 values that are on the high end for low-spin
Fe(II) complexes (approaching the range observed for high-spin Fe(III) complexes).
However, the isomer shifts we measured are below the range expected for high spin
Fe(II) complexes, which generally fall between 6 = 0.8 - 1.5 mm/s.86
6.3.8. Photolysis Studies of Iron Complexes
The diiron t-oxo salen photo-oxidation studies were performed under conditions similar
to those used in the analogous porphyrin systems. We examined the Pacman complexes
bridged with xanthene (13), dibenzofuran (14), and the species lacking a pillar, 15.
Dimethyl sulfide and dibutyl sulfide used as OAT substrates, and dodecane was used as
the internal standard for product analysis via GC/MS. Excess substrate was used (10
Figure 6.9. UV-vis absorption profiles of 30 jmol solutions of Fe 2DSXC12 (13)(---
), Fe 2DSDCl2 (14) ("'), and Fe 2(salen) 20 (15) (-) in acetonitrile. The spectra is
scaled to molar absorbtivity.
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equivalents) and the reactions were photolyzed for 20 hours; the wavelength was tailored
using long-wavelength-pass filters. Unlike the porphyrin complexes, the diiron It-oxo
salens do not absorb strongly above 300 nm. In the Pacman salen complexes 13 and 14,
there is only a tail above 350 nm that extends into the visible, as shown in Figure 6.9. The
disalen complex 15 exhibits a broad shoulder at about 380 nm. Photolysis using kexcc >
400 nm gave no oxidation products. When kXxec was shifted into the ultraviolet (295 nm
and 324 nm), there were no sulfoxide or sulfone products obtained above the background
level, as determined by control experiments in the absence of catalysts. (Trace oxidation
of sulfides occurs upon aerobic photolysis with ultraviolet light). In the context of the
previous studies with the Pacman porphyrin catalytic cycle we can make a few
observations about the lack of reactivity from the diiron pt-oxo salens. Transient
absorption spectroscopy of the Pacman porphyrins shows that photon absorption results
in cleavage of the Fe-O bond to give the ferrous and ferryl oxo species. Oxidation of
substrate competes with reclamping to reform the g-oxo diiron bridge. The double-
pillared structure of the Pacman salens would appear to facilitate the reclamping and
prevent exposure of any photolytically generated ferryl oxo. However, the unbridged
complex also does not display any oxidation chemistry. This leads us to believe that the
lack of photocatalytic activity is likely due to the low absorptive qualities of the diiron t-
oxo complexes. The Pacman porphyrin complexes are excited in the LMCT (k =360 nm,
S105). The salen compounds, however, lack any pronounced absorption peaks in k >
350 with lower molar absorptivity. In an effort to elucidate the LMCT bands, the
absorption spectra was taken in solvents of varying dielectric constants 9' (specifically
benzene, acetonitrile, and propylene carbonate), but no notable changes were observed.
6.4. Concluding Remarks
We have developed a synthetic methodology to synthesize cofacial salen ligands using
dibenzofuran and xanthene pillars in the absence of a templating agent. As a result, we
were able to isolate and characterize the unmetallated ligands, and easily synthesize
several diiron compounds. We tested the pt-oxo diiron complexes for the same
photocatalytic oxidation chemistry that is observed in the porphyrin analogues, but did
not see any activity. This is likely due to the lack of prominent absorption features that
are present in the porphyrin complexes.
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6.5. Experimental Section
6.5.1. Materials
Silica gel 60 (70 - 230 and 230 - 400 mesh) was used for column chromatography.
Analytical thin layer chromatography was performed using F254 silica gel (pre-coated
sheets, 0.2 mm thick). Solvents for synthesis were reagent grade or better and used as
received from Aldrich or dried according to standard methods. 92 4,5-Dibromo-2,7-di-tert-
butyl-9,9-dimethylxanthene, boron tribromide, (1R,2R)-(-)-1,2-diaminocyclohexane,
triethylamine, and (LR, 2R)-(-)-(1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-
butylsalicylidene)] were also used as received from Aldrich. Bis(pinacolato)diboron and
3-formyl-4-methoxyphenylboronic acid were used as received from Frontier Scientific.
Sodium carbonate, potassium acetate, anhydrous iron(III) chloride, iron(III) chloride
hexahydrate, anhydrous iron(II) acetate, and dichloro[1,1'-
bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct were used as
received from Strem Chemicals. The following compound was obtained using published
protocols and its purity confirmed by iH NMR: 4,6-dibromodibenzofuran (5). The
synthesis for 2,7-di-tert-butyl-9,9-dimethyl-4-dihydroxyborane-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-9H-xanthene (1) was presented in Chapter 3 (as compound 13).
The synthesis of 4,5-di(5-salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3) via
(1) can be found in Appendix B2.
6.5.2. Physical Measurements
1H NMR and 'C NMR spectra were collected in CDC13 (Cambridge Isotope
Laboratories) at the MIT Department of Chemistry Instrumentation Facility (DCIF) using
an Inova 500 Spectrometer at 25 'C. All chemical shifts are reported using the standard 6
notation in parts-per-million relative to tetramethylsilane and spectra have been internally
calibrated to the monoprotio impurity of the deuterated solvent used. High-resolution
mass spectral analyses were carried out by the MIT Department of Chemistry
Instrumentation Facility on a Bruker APEXIV47e.FT-ICR-MS using an Apollo ESI
source. Infrared spectrum were taken on a Perkin-Elmer Model 2000 FTIR using KBr
pellets prepared using a high pressure press. Mdssbauer absorption data were recorded at
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4.2 K on an MS1 spectrometer (WEB Research Co.) equipped with a 57Co source and a
Janus cryostat, and referenced to elemental iron. UV-visible absorption spectra were
recorded on a Spectral Instruments 440 spectrophotometer. Molar absorptivity
coefficients were determined on solutions of sub-mM concentrations of the respective
compounds.
6.5.3. Synthesis
6.5.3.1. 4,5-Di-(3-formyl-4-methoxyphenyl)-2,7-di-tert-butyl-9,9-
dimethylxanthene (2)
Under nitrogen, a mixture of 4,5-dibromo-2,7-di-tert-butyl-9,9-dimethylxanthene (2.00 g,
4.17 mmol), 3-formyl-4-methoxyphenylboronic acid (1.65 g, 9.17 mmol), sodium
carbonate (1.33 g, 12.5 mmol), dichloro[1,1'-bis(diphenylphosphino)ferrocene]-
palladium(II) dichloromethane adduct (0.367 g, 0.500 mmol), 1,2-dimethoxyethane (45
mL), and deionized water (15 mL) was heated to 90 'C for 48 hours. Upon cooling, the
mixture was extracted with 4 x 100 mL of dichloromethane. The organic portions were
combined and dried over MgSO 4 and the solvent removed by rotary evaporation. The
crude solid was purified by column chromatography (silica gel, 2: 8 hexane:
dichloromethane) to elute the colorless product (1.671 g, 69 % yield). 'H NMR (500
MHz, CDCl3, 6): 10.35 (s, 2H), 7.73 (d, J = 2.5 Hz, 2H), 7.44 (d, J = 2.5 HZ, 2H), 7.39
(dd, J = 8.5 Hz, 2 Hz, 2H), 7.13 (d, J = 2 Hz, 2H), 6.61 (d, J= 8.5 Hz, 2H), 3.94 (s, 6H),
1.74 (s, 6H), 1.35 (s, 18H). 13C NMR (500 MHz, CDC13, 6): 189.53, 160.46, 145.71,
137.57, 131.12, 130.37, 129.97, 127.81, 125.54, 124.28, 122.07, 121.93, 111.95, 55.68,
35.26, 34.71, 32.03, 31.72. HRESI-MS ([M + Na] ) NaC39H420 5 m/z, Calcd. 613.2924
Found 613.2925.
6.5.3.2. 4,5-Di(5-salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3)
4,5-Di-(3-formyl-4-methoxyphenyl)-2,7-di-tert-butyl-9,9-dimethylxanthene (2) (1.01 g,
1.63 mmol) was added to 55 mL of dry dichloromethane and cooled to 0 'C. A solution
of boron tribromide (7.0 mL, 1.0 M in dichloromethane) was added and upon stirring for
3 hours, 40 mL of water was added. The aqueous layer was separated and extracted with
3 x 50 mL of dichloromethane. The combined organic layers were washed with 25 mL
of water, and dried over MgSO 4. The solvent was evaporated and the residue was eluted
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by column chromatography (silica gel, dichloromethane) and further purified by
recrystallization in hot ethanol (0.748 g, 77% yield). 'H NMR (500 MHz, CDC13, 8):
10.86 (s, 2H), 9.38 (s, 2H), 7.50 (d, J = 3 Hz, 2H), 7.47 (t, J = 3 Hz, 2H), 7.40 (d, J = 2.5
Hz, 2H), 7.17 (d, J = 2.5 Hz, 2H) 6.84 (d, J = 8.5 Hz, 2H), 1.76 (s, 6H), 1.37 (s, 18). 13C
NMR (500 MHz, CDCl3 , 6): 195.84, 160.47, 146.07, 145.27, 145.26. 138.01, 135.35,
130.01, 127.38, 125.60, 122.53, 122.40, 120.20, 117.35, 35.24, 34.81, 32.56, 31.76.
HRESI-MS ([M + Na] ) NaC37H3805 m/z, Calcd. 585.2617 Found 585.2605.
6.5.3.4. DSX (4)
4,5-Di(5-salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3) (500 mg, 0.841
mmol) and (lR,2R)-(-)-l,2-diaminocyclohexane (96 mg, 0.841 mmol) was added to 8
mL of anhydrous ethanol and heated to reflux overnight. The solution was then cooled in
a freezer and filtered. The bright yellow solid collected was washed with an additional 4
mL of cold ethanol to give the product (504 mg, 94% yield). X-Ray quality crystals were
grown from slow evaporation of a pentane-dichloromethane solution. IR (KBr) Vmax :
1589 cm - ' (C=N). HRESI-MS ([M + H] ) C86H96N40 6 m/z, Calcd. 1281.7403 Found
1281.7405. UV-vis (CH 2C 2 ) Xmax, nm (F): 307 (31,924), 336 (14,984). Anal. Calcd for
C 86H 96N4 0 6 : C, 80.59; H, 7.55; N, 4.37. Found: C, 80.65; H, 7.38; N, 4.29.
6.5.3.5. 4,6-(4,4,5,5-Tetramethyl-[1,3,2] dioxaborolan-2-yl)-dibenzofuran (6)
Under nitrogen, a mixture of 4,6-dibromodibenzofuran (5) (2.00 g, 6.14 mmol),
bis(pinacolato)diboron (4.67 g, 18.4 mmol), potassium acetate (4.22 g, 43.0 mmol),
dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct
(0.450 g., 0.613 mmol), dimethyl sulfoxide (30 mL), was heated to 90 'C for 48 hours.
Upon cooling, the mixture was extracted with 4 x 200 mL of dichloromethane. The
organic portions were combined and washed with 5 x 100 mL of water and dried over
MgSO4 and the solvent removed by rotary evaporation. 2 x 500 mL of hexanes was
stirred into the residue and filtered. The filtrate was reduced by rotary evaporation to
give a crude solid, which was recrystallized by hot ethanol to give the colorless product
(2.253 g, 87 % yield). Subsequent synthetic procedure to produce 8 from 6 is presented in
Appendix B2. 1H NMR (500 MHz, CDC13, 8): 8.02 (d, J = 7.5 Hz, 2H), 7.85 (d, J = 7.5
Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 1.46 (s, 12H). 13C NMR (500 MHz, CDCl3, 8): 160.83,
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134.00, 123.58, 123.39, 122.16, 122.16, 120.05, 83.94, 83.62, 25.25, 25.16, 25.09.
HRESI-MS ([M + Na]+) NaC24H30B2Os m/z, Calcd. 443.2195 Found 443.2192.
Figure 6.10. X-Ray crystal structure of 4,6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-
2-yl)-dibenzofuran (6).
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6.5.3.6. 4,6-Di(3-formyl-4-methoxyphenyl)-dibenzofuran (7)
Under nitrogen, a mixture of 4,6-dibromodibenzofuran (5) (1.00 g, 3.07 mmol), 3-
formyl-4-methoxyphenylboronic acid (1.22 g, 6.75 mmol), sodium carbonate (0.948 g,
9.20 mmol), tetrakis(triphenylphosphine)palladium (0.425 g, 0.368 mmol),
dimethylformamide (27 mL), and deionized water (3 mL) was heated to 90 'C for 48
hours. Upon cooling, the mixture was extracted with 4 x 100 mL of dichloromethane.
The organic portions were combined and dried over MgSO 4 and the solvent removed by
rotary evaporation. The crude solid was purified by column chromatography (silica gel,
dichloromethane) to elute the colorless product (1.02 g, 76% yield). IH NMR (500 MHz,
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CDC13, 8): 10.58 (s, 2H), 8.48 (d, J = 2.5 Hz, 2H), 8.28 (d, J = 7.5 Hz, 2H), 7.97 (dd, J=
2.5 Hz, 1 Hz, 2H), 7.68 (dd, J = 7.5 Hz, 1 Hz, 2H), 7.25 (m, 4H), 4.04 (s, 6H).
6.5.3.7. 4,6-Di(5-salicylaldehyde)dibenzofuran (8)
4,6-Di(3-formyl-4-methoxyphenyl)dibenzofuran (7) (1.02 g, 2.34 mmol) was added to 50
mL of dry dichloromethane and cooled to 0 'C. A solution of boron tribromide (10 mL,
1.0 M in dichloromethane) was added and upon stirring for 3 hours, 30 mL of water was
added. The aqueous layer was separated and extracted with 3 x 50 mL of
dichloromethane. The combined organic layers were washed with 25 mL of water, and
dried over MgSO 4. The solvent was evaporated and the residue was eluted by column
chromatography (silica gel, dichloromethane) and further purified by recrystallization in
hot ethanol (0.773 g, 81% yield). 'H NMR (500 MHz, CDCl3, 8): 11.11 (s, 2H), 9.97 (s,
2H), 8.17 (m, 4H), 8.01 (dd, J = 7.5 Hz, 1 Hz, 2H), 7.66 (dd, J = 2.5 Hz, 1 Hz, 2H), 7.51
(d, J = 7.5 Hz, 1H), 7.15 (d, J = 7.5 Hz, 2H). 13C NMR (500 MHz, CDC13, 6): 196.73,
161.20, 153.14, 137.18, 135.35, 133.78, 131.73, 128.36, 126.31, 125.14, 123.93, 120.97,
120.21. HRESI-MS ([M + Na]+) NaC26H160 5 m/z, Calcd. 431.0890 Found 431.0893.
6.5.3.8. DSD (9)
4,6-Di(5-salicylaldehyde)dibenzofuran (8) (0.400 g, 0.980 mmol) and (1R,2R)-(-)-1,2-
diaminocyclohexane (0.112 g, 0.980 mmol) was added to 12 ml of anhydrous ethanol and
heated to reflux overnight. The solution was then cooled in a freezer and filtered. The
bright yellow solid collected was washed with an additional 8 mL of cold ethanol to give
the product (0.416 g, 87% yield). 'H NMR (500 MHz, CDC13, 8): 13.96 (s, 4H), 8.20 (s,
4H), 8.17 (d, J = 2.5 Hz, 4H), 7.92 (dd, J = 7.5 Hz, 1 Hz, 4H), 7.71 (dd, J = 8 Hz, I H,
4H), 7.63 (dd, J = 8.5 Hz, 2 Hz, 4H), 7.56 (t, J = 8 Hz, 4H), 7.14 (d, J = 8.5 Hz, 4H),
3.24 (m, 4H), 2.35 (d, J = 10.5 Hz, 4H), 1.93 (m, 8H), 1.50 (m, 4H). 13C NMR (500
MHz, CDCI3, 8): IR (KBr) vmax : 1586 cn - 1 (C=N). HRESI-MS ([M + H]+) C 6 4H 5 3N 40 6
m/z, Calcd. 943.3960 Found 973.3957. UV-vis (CH 2C12) kmax, nm (e): 297 (sh, 37,096),
318 (sh, 30,396), 327 (sh, 32,334). Anal. Calcd for C 64H 52N 4 0 6: C, 78.99; H, 5.39; N,
5.76. Found: C, 78.76; H, 5.26; N, 5.68.
6.5.3.9. Fe2(DSX)CI 2 (10)
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Under a nitrogen atmosphere, anhydrous ferric chloride (7.6 mg, 0.047 mmol) was added
to 5 mL of anhydrous ethanol. The ligand DSX (4) (30.0 mg, 0.023 mmol) was added and
the solution turned reddish-brown with precipitate. Upon stirring for 18 hours the now
purple-red solution was filtered, and the precipitate was washed with an additional 10 mL
of ethanol. The combined filtrates were reduced under vacuum and the resulting residue
was recrystallized from hot acetone to give the dark purple product (27 mg, 82% yield).
IR (KBr) Vmax : 1540 cm -' (C=N). ESI-MS ([M - Cl] ) C86H92N4 0 6C1Fe 2 m/z, Calcd.
1423.53 Found 1423.61. Anal. Calcd for C86H92C12Fe2N4 0 6 : C, 70.73; H, 6.35; N, 3.84.
Found: C, 70.63; H, 6.39; N, 3.88.
6.5.3.10. Fe2(DSD)CI2 (11)
Under a nitrogen atmosphere, anhydrous ferric chloride (55.6 mg, 0.206) was added to 10
mL of anhydrous methanol. The ligand DSD (9) was added and the solution was heated
to reflux overnight. Upon cooling, the green solution was cooled in an ice bath and
filtered. The precipitate was washed with 1 mL of cold methanol to give the dark purple
product (45 mg, 75% yield). IR (KBr) Vmax: 1538 cm -n (C=N). HRESI-MS ([M - Cl]-)
C64H4 8N40 6C1Fe 2 m/z, Calcd. 1115.1976 Found 1115.1973. Anal. Calcd for
C64H4 8N40 6Cl2Fe2 : C, 66.74; H, 4.20; N, 4.86. Found: C, 66.68; H, 4.28; N, 4.81.
6.5.3.11. Fe[(1R, 2R)-(-)-(1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicyli
dene))jCl (12)
This compound has previously been prepared using different reagents and conditions. 58' 93
Under a nitrogen atmosphere, anhydrous ferric chloride (14.8 mg, 0.091 mmol) was
added to (1R, 2R)-(-)-(1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)
(50.0 mg, 0.091 mmol) in 4 mL of anhydrous ethanol. Upon stirring at room temperature
for 12 hours, the reaction was filtered and the precipitate was washed with cold ethanol
and recrystallized from hot acetone to give (42 mg, 72 % yield). HRESI-MS ([M - Cl] )
C36H52N2 0 2Fe m/z, Calcd. 600.3378 Found 600.3379. Anal. Calcd for C36H52C1FeN 202:
C, 67.97; H, 8.24; N, 4.40. Found: C, 67.75; H, 8.05; N, 4.46.
6.5.3.12. pi-oxo-(Fe 2DSX) (13)
Ferric chloride hexahydrate (84.5 mg, 0.312 mmol) was slowly added to the ligand DSX
(4) (200.0 mg, 0.156 mmol) in 8 mL of methanol. After 5 minutes, triethylamine (0.44
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mL, 3.12 mmol) was added dropwise to the dark red solution and precipitate formed. The
mixture was stirred for an additional 3 hours, then cooled in an ice bath and filtered. The
precipitate was taken up in dichloromethane and filtered through a 0.45 ptm
polypropylene syringe filter. The filtrate was reduced by rotary evaporation to leave the
reddish-brown product (173 mg, 80% yield). IR (KBr) Vmax : 1536 cm' (C=N), 834 cm - 1
(Fe-O-Fe). ESI-MS ([M + H] ) C86H93N40 7Fe 2 m/z, Calcd. 1405.57 Found 1405.61.
Anal. Calcd for C86H92Fe 2N407: C, 73.50; H, 6.60; N, 3.99. Found: C, 73.42; H, 6.62; N,
4.06.
6.5.3.13. g-oxo-(Fe 2DSD) (14)
Ferric trichloride hexahydrate (44.4 mg, 0.164 mmol) was added slowly to a solution of
the ligand DSD (9) (80.0 mg, 0.082 mmol) in 2 mL of methanol, which turned dark olive
green. After 10 minutes, triethylamine 0.23 mL, 1.64 mmol) was added dropwise and the
solution was stirred for an additional 2 hours, then cooled in an ice bath. The red mixture
was filtered using 0.22 pm polypropylene filter paper, and the precipitate was washed
with 20 mL of methanol. The solid was then taken up in dichloromethane and filtered.
The dark red filtrate was reduced by rotary evaporation to leave the reddish- orange
product (53 mg, 59% yield). IR (KBr) vmax: 1536 cm - ' (C=N), 830 cm -1 (Fe-O-Fe).
Anal. Calcd for C64H48Fe2N40 7: C, 70.09; H, 4.41; N, 5.11. Found: C, 69.84; H, 4.30; N,
4.96.
6.5.3.14. p-oxo-[Fe(1R, 2R)-(-)-(1,2-cyclohexanediamino-NN'-bis(3,5-di-tert-butyl
salicylidene))]2 (15)
Ferric trichloride hexahydrate (24.7 mg, 0.091 mmol) was added slowly to a solution of
(1R, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene)] (50.0 mg,
0.091 mmol) in 4 mL of methanol. After 5 minutes, triethylamine (0.13 mL, 0.914 mmol)
was added dropwise to the purplish brown solution, which turned orange with precipitate.
This was stirred for an additional 3 hours, then filtered washed with 2 mL of methanol.
The precipitate was then taken up in dichloromethane and refiltered. The filtrate was
reduced by rotary evaporation to leave the orange product (35 mg, 64% yield). X-Ray
quality crystals were grown from a pentane-dichloromethane solution. IR (KBr) Vmax :
1533 cm 1 (C=N), 837 cm 1. HRESI-MS ([M + H]t) C72H1o05N4OsFe 2 m/z, Caled.
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1217.6872 Found 1217.6902. Anal. Calcd for C72HIO04Fe2N4Os: C, 71.04; H, 8.61; N,
4.60. Found: C, 71.15; H, 8.40; N, 4.55.
6.5.3.15. Fe2(DSX) (16)
Under a nitrogen atmosphere, ferrous acetate (27.2 mg, 0.156 mmol) was added to the
ligand DSX (4) (50.0 mg, 0.078) in 6 mL of anhydrous tetrahydrofuran. The solution
went from red to dark purple upon stirring for 24 hours. The solvent was removed under
reduced pressure and the residue was washed with 2 mL of anhydrous ether to leave the
dark purple product (100 mg, 92% yield). Anal. Calcd for C86H92Fe 2N40 6: C, 74.34; H,
6.67; N, 4.03. Found: C, 74.26; H, 6.74; N, 3.91.
6.5.3.16. Fe2(DSD) (17)
Under a nitrogen atmosphere, ferrous acetate (18.0 mg, 0.103 mmol) was added to the
ligand DSD (9) (50.0 mg, 0.051 mmol) in 10 miL of anhydrous tetrahydrofuran. The
solution turned red and was stirred for 24 hours. The solvent was removed under reduced
pressure and the remaining residue was washed with 4 mL of anhydrous ether to leave
the reddish-purple product (48 mg, 88% yield). Anal. Calcd for C64H4 8Fe2 N40 6 : C, 71.12;
H, 4.48; N, 5.18. Found: C, 70.94; H, 4.58; N, 5.08.
6.5.3.17. Fe[(1R, 2R)-(-)-[1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicyli
dene)] (18)
Under a nitrogen atmosphere, ferrous acetate (31.8 mg, 0.183 mmol) was added to (1R,
2R)-(-)-[ 1,2-cyclohexanediamino-N,N'-bis(3,5-di-tert-butylsalicylidene) (100.0 mg,
0.183 mmol) in 10 mL of anhydrous tetrahydrofuran and stirred at room temperature for
24 hours. The solvent was removed under reduced pressure and the remaining residue
was washed with 2 mL of anhydrous ether to give the purple product (72.5 mg, 66%
yield). Anal. Calcd for C36H52FeN 20 2: C, 71.99; H, 8.73; N, 4.66. Found: C, 69.55; H,
8.46; N, 3.88.
6.5.4. Photolysis Studies
Representative Procedure. 100 mL of a 3.13 mM substrate (dibutyl sulfide or methyl
sulfide) and 74.9 mM dodecane solution of acetonitrile or benzene was prepared. 4.0 mL
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of this solution was added to separate matching cells containing 5.4 mg of Fe 2DSXO
(13), 2.1 mg of Fe 2DSDO (14), 2.4 mg of Fe 2(salen)20 (15), or no catalyst. Each of these
reactions was then photolyzed for 20 hours and the solutions were then analyzed using
GC/MS. Using light through a 400 nm long wavelength pass (LWP) filter, there were no
oxidation products observed. Using light through a 295 nm and 324 nm LWP there were
trace amounts of sulfoxide and sulfone produced, all in quantities similar to that observed
for the control solution with no catalyst.
6.5.5. X-Ray Crystal Data Collection and Refinement Parameters
Data collection and reduction
Crystals were coated with Paratone N oil and mounted on a glass fiber. X-ray diffraction
data were collected at -80 'C on a Siemens three-circle diffractometer equipped with a
CCD detector, using the Mo Kcc radiation, selected by a graphite monochromator. The
data were integrated to hke-intensity and the final unit cell calculated using the SAINT
v.4.050 program from Siemens. Solution and refinement were performed with the
SHELXTL v.5.03 suite of programs developed by G. M. Sheldrick and Siemens
Industrial Automation, 1995. No absorption correction was performed. The structure was
solved by direct methods; the least-squares refinement converged normally (with
hydrogen atoms placed at calculated positions using a standard riding model and refined
isotropically).
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Table 6.2 Crystal data and structure refinement for DSX (4).
Identification code c05035 ortho
Empirical formula C96H1 19N40 6
Formula weight 1424.95
Temperature 100(2) K
Wavelength 0.71073
Crystal system Orthorhombic
Space group P2(1)2(1)2(1)
Unit cell dimensions a = 16.2351(5) A
b = 18.8877(6) A
c = 28.0461(8) A
Volume 8600.2(5) A3
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 23.260
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
4
1.101 Mg/m 3
0.068 mm-'
3084
0.30 x 0.18 x 0.12 mm3
1.65 to 23.260.
-16<=h<=18, -20<=k<=20, -
27<=1<=3 1
41819
12323 [R(int) = 0.0502]
99.8 %
None
0.9919 and 0.9800
Full-matrix least-squares on F2
12323 / 2 / 1001
1.059
R1 = 0.0473, wR2 = 0.1160
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Table 6.3 Crystal data and structure refinement for 4,6-(4,4,5,5-Tetramethyl-
[1,3,2]dioxaborolan-2-yl)-dibenzofuran (6).
Identification code 002220m
Empirical formula C24 H30 B2 05
Formula weight 420.10
Temperature 193(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2(1)/c
Unit cell dimensions a = 23.2735(18) A
b = 8.2995(7) A f= 100.3650(10).
c = 12.2614(10) A
Volume 2329.7(3) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 20.00'
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
1.198 Mg/m 3
0.081 mm - 1
896
0.48 x 0.31 x 0.07 mm 3
2.61 to 20.00'.
-22<=h<=22, -7<=k<=7, -6<=1<=11
6450
2157 [R(int) = 0.0555]
99.6 %
None
Full-matrix least-squares on F2
2157 / 0 / 289
1.077
R1 = 0.0551, wR2 = 0.1321
R1 = 0.0584, wR2 = 0.1345
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Table 6.4. Crystal data and structure refinement for structure shown in Figure 6.3.
Identification code c04085m
Empirical formula C3 2 H26 N2 03
Formula weight 486.55
Temperature 150(2) K
Wavelength 0.71073
Crystal system Orthorhombic
Space group P2, 2 12,
Unit cell dimensions a = 11.269(3) A
b = 13.507(3) A
c = 16.031(4) A
Volume 2440.2(11) A3
Z 4
Density (calculated) 1.324 Mg/m 3
Absorption coefficient 0.085 mm-1
F(000) 1024
Crystal size 0.09 x 0.07 x 0.07 mm3
Theta range for data collection 1.97 to 23.34'.
Index ranges -12<=h<= 12, -14<=k<= 15, -17<=1<= 13
Reflections collected 11313
Independent reflections 3528 [R(int) = 0.0624]
Completeness to theta = 23.34' 99.8 %
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
None
Full-matrix least-squares on F2
3528 / 0 / 341
1.044
R1 = 0.0413, wR2 = 0.0922
R1 = 0.0517, wR2 = 0.0982
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Table 6.5. Crystal data and structure refinement for structure shown in Figure 6.4.
Identification code C04060
Empirical formula C 36 H52 Fe 2 N4 05
Formula weight 732.52
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 13.75(3) A a= 105.76(3)0.
b = 17.69(3) A 83= 102.39(3)0.
c = 17.73(4) A y = 107.99(4).
Volume 3731(13) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 20.000
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
1.304 Mg/m3
0.822 mm-
1552
0.16 x 0.10 x 0.10 mm3
1.26 to 20.000.
-12<=h<=13, -15<=k<=17, -
15<=1<=17
7468
5781 [R(int) = 0.0389]
83.2 %
None
Full-matrix least-squares on F2
5781 / 1321 / 1034
2.956
R1 = 0.2492, wR2 = 0.5434
RI = 0.2760, wR2 = 0.5732
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Chapter 7
Synthesis of Bimetallic Cofacial Pacman
Salens
207
7.1. Motivation and Specific Aims
The untemplated synthesis of cofacial Pacman ligands using the rigid pillars xanthene
(DSX) and dibenzofuran (DSD) was presented in Chapter 6. In many cases, metalation
can proceed under conditions similar to those established for monomeric salens, allowing
easy synthetic access to a diverse metallosalen library of complexes. This metalation
chemistry is explored here to generate bimetallic complexes of copper, chromium,
manganese, cobalt, and zinc. Initial studies into catalytic Lewis-acid assisted epoxide
ring-opening chemistry is also explored.
7.2. Background
An avenue of reactivity we sought to explore with our Pacman salens was the ring-
opening of epoxides. The intrinsic ring-strain of epoxides can be coupled with
coordination of the oxygen to a Lewis acid to induce ring opening. This reaction has been
catalyzed with a variety of chiral metallosalens with a host of nucleophiles. 1-25 The ring
opening reactions are significant because of their high selectivity; this reaction produces
produces two adjacent stereocenters from an achiral precursor. Additionally, several of
the catalysts (notably the chromium-azide nucloephile and and cobalt/water nucleophile
systems) are able to efficiently kinetically resolve racemic mixtures of epoxides, an
important strategy in asymmetric synthesis.26
Scheme 7.1
6M
Nuc
The mechanism of epoxide ring-opening reaction is believed to involve two metals; one
metal is utilized for epoxide coordination while the second metal poises the nucelophile
for attack at the a-carbon, as shown in Scheme 7.1.23-25 Non-rigid oligomeric
multinuclear salens exhibit marked improvements in reaction rates as compared to their
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monomeric counterparts for the asymmetric ring opening (e.g., chromium/azide
system)," as well as the hydrolytic kinetic resolution of epoxides (e.g., dicobalt).27-3 We
set out to explore whether analogous reactivity enhancements would be achieved with the
more rigid cofacial Pacman architectures.
7.3. Results and Discussion
7.3.1. Ligand Characteristics and Synthesis
Metallo complexes of the DSX ligand 1 were prone to oil in crystallization attempts. We
therefore synthesized the DSX ligand lacking the tert-butyl functionalities on the
xanthene pillar to produce the slightly less soluble 2 (shown in Chart 7.1). This ligand
was prepared in similar fashion to 1, as discussed in Chapter 6. Other complexes of note
in this Chapter are also listed in Chart 7.1.
Chart 7.1
1: M =2H,R= t-Bu
2: M = 2H, R= H
5 : M = CrCI, R = t-Bu
7 : M = Cu, R = t-Bu
3:M=2H
6: M = CrCI
9: M = Cu
13 : M = MnCI
15: M= Co
8: M = Cu, R=H
12 : M = MnCl, R = t-Bu
14: M = Co, R = t-Bu
16: M = Zn, R = t-Bu
4: M = 2H, R1 =H, R2 = Ph
10: :M=Cu,R 1 =H,R 2 = Ph
R, O" "O0 R2 11 :M= Cu, R= R2 = t-Bu
R2 RM
17: M = Zn, R1 = H, R2 = Ph
7.3.2. Synthesis of Chromium Pacman Salen Complexes
Dichromium Pacman complexes Cr2DSXCI2 (5) and Cr2DSDC12 (6) were synthesized by
procedures adapted from the literature. 9 The divalent metal ions were inserted by stirring
two equivalents of anhydrous chromium(II) chloride in dry tetrahydrofuran under an inert
atmosphere. Upon exposure to air, the metal was oxidized to chromium(III); addition of
ammonium chloride forms the chloride salt. The yield was quantitative for DSX but only
11% for DSD, possibly due to its lower solubility in tetrahydrofuran. The compounds
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were characterized by mass spectrometry and their purity was established by elemental
analysis. Small hexagonal crystals of Cr2DSXC12 could be grown from the evaporation of
concentrated tetrahydrofuran solutions, but none diffracted well enough for X-ray
crystallographic analysis. In an effort to improve the diffraction intensity, an attempt was
made to synthesize the bromide salt of [Cr2DSX]2+, but the Pacman complex could not be
obtained cleanly.
7.3.3. Epoxide Ring Opening Reactivity with Chromium Pacman Complexes
The chromium Pacman complexes were explored for their activity towards the catalytic
ring-opening of cyclohexene oxide. The conditions used were similar to those described
as successful for Cr(salen)Cl and meso-epoxide substrates. 9 Cr2DSDCl 2 (6) was not
sufficiently soluble in diethyl ether, so the study was only performed with Cr 2DSXCI2 (5)
and Cr(salen)CI was employed as the control. Trimethylsilyl azide was used to deliver the
nucleophile in diethyl ether. The reaction was monitored using GC/MS (with dodecane as
the internal standard). The amount of substrate consumed per equivalent of catalyst was
found to be the same for both compounds.
7.3.4. Synthesis of Cu Pacman Salen Complexes
The copper(II) Pacman salen complexes were synthesized using a procedure similar to
that described for the monomeric salens.32 The disalen ligands DSX (1), DSX ^ (2) and
DSD (3) were refluxed with two equivalents of copper(II) acetate hydrate in ethanol for 1
- 2 hours. (Another method used to metallate salen monomers using aqueous sodium
hydroxide to deprotonate the salens followed by addition of copper(II) nitrate trihydrate
did not give any product). The yields ranged from 36 - 93% for the various Pacman
ligands. The copper salen monomers 10 and 11 were also synthesized using sodium
hydroxide and the copper nitrate salt as described above.
The 7 - 11 compounds were characterized by mass spectrometry and elemental analysis
was used to determine the purity. We had hoped it would be easier to grow crystals of the
xanthene Pacman lacking the di-tert-butyl groups on the pillar, Cu2DSX ^ (8), since this
210
Figure 7.1 EPR spectra of compound 11 taken a chloroform-ethanol frozen solution at
4.5 K.
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was the case for the analogous porphyrin Pacman complexes. But we found that this was
not the case. With Cu 2DSX (7), small needle-like crystals could be grown, but none were
large or high quality enough for X-ray structural determination. The EPR spectrum of the
copper complex 11 was taken in a frozen chloroform-ethanol solution (Figure 7.1). The
g-values of, g1l = 2.283 and gi- = 2.094 are within a range that is observed for monomeric
copper salens.33-38 Frozen solutions of 7 - 11 were also recorded, but the spectra was
poorly resolved and the g values were not obtained.
7.3.5. Synthesis of Manganese, Cobalt, and Zinc Pacman Salen Complexes
Manganese Pacman salens 12 and 13 were synthesized under conditions similar to that
used to prepare manganese salen monomeric compounds. The ligands were refluxed in
ethanol with manganese(II) acetate tetrahydrate in air and worked up with aqueous
sodium chloride to give the chloride compounds. The compounds were analyzed by mass
spectrometry.
The air-sensitive dicobalt(II) Pacman salens 14 and 15 were synthesized by adding a
solution of the ligand in dichloromethane to a solution of cobalt(II) acetate tetrahydrate in
methanol under an inert atmosphere. The product was isolated by collecting the bright red
(14) or orange (15) product that precipitates. Co 2(DSX) (14) was identified as the positive
ion in the high resolution mass spectra, suggesting some of the sample may have been
singly oxidized to Co(III) during data collection. This does not appear to be an issue with
the obtained product; Co2(DSX) (14) was analytically pure by elemental analysis. The
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Co2DSD (15) product was also identified in the high resolution mass spectra and
analyzed for purity.
Preparation of the zinc Pacman salens was pursued on several fronts. Metal ion
incorporation was attempted by refluxing the ligand with: (i) refluxing zinc(II) chloride
and triethylamine; (ii) diethylzinc in tetrahydrofuran; and (iii) refluxing with zinc acetate
in ethanol. For the DSX (1) and (R,R)-N,N'-bis(5-phenylsalicylidene)-l,2-
cyclohexanediamine (4) ligand, the latter reaction showed the desired compound in the
mass spectra. But the isolated product was not analytically pure, and a suitable solvent for
recrystallization could not be found. The zinc complexes of the DSD (3) ligand escaped
preparation.
7.4. Concluding Remarks and Future Work
We were able to establish the generality of the Pacman salen ligands by synthesis of a
variety of metallocomplexes. For most of the Pacman complexes, particularly DSX,
synthetic procedures for the introduction of the metal into the macrocycle follows from
those typically used for metallosalen monomers. From these established methods we
were able to cleanly prepare the copper, manganese, and cobalt (DSX only) Pacman
salens. A preliminary study was done on the catalytic ring-opening of cyclohexene oxide
by the Cr2DSXCl 2, although no enhancement of activity was observed. Zinc Pacman
salens, and could not be prepared in a straightforward manner and we were unable to
isolate pure products.
7.5. Experimental Section
7.5.1. Materials
Solvents for synthesis were reagent grade or better and used as received from Aldrich or
dried according to standard methods.3 9 (IR,2R)-(-)-l,2-diaminocyclohexane, and
manganese acetate tetrahydrate, and cyclohexene oxide were also used as received from
Aldrich. Copper(II) acetate monohydrate, anhydrous chromium(II) chloride, cobalt(II)
acetate tetrahydrate, and zinc(II) acetate dihydrate were used as received from Strem
Chemicals. Tetramethylsilyl azide was used as received from Alfa Aesar. The following
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compound was obtained using published protocols and its purity confirmed by 1H NMR:
4,5-di(5-salicylaldehyde)-9,9-dimethylxanthene (5).40 The following compounds were
obtained as described previously: DiSalen Xanthene (DSX), compound 4 in Chapter 6;
DiSalen Dibenzofuran (DSD), compound, compound 9 in Chapter 6; (R,R)-N,N'-bis(5-
phenylsalicylidene)-l1,2-cyclohexanediamine, compound 12 in Chapter 4.
7.5.2. Physical Measurements
iH NMR spectra were collected in CDCl3 (Cambridge Isotope Laboratories) at the MIT
Department of Chemistry Instrumentation Facility (DCIF) using an Inova 500
Spectrometer at 25 oC. All chemical shifts are reported using the standard 6 notation in
parts-per-million relative to tetramethylsilane and spectra have been internally calibrated
to the monoprotio impurity of the deuterated solvent used. High-resolution mass spectral
analyses were carried out by the MIT Department of Chemistry Instrumentation Facility
on a Bruker APEXIV47e.FT-ICR-MS using an Apollo ESI source. Infrared spectrum
were taken on a Perkin-Elmer Model 2000 FTIR using KBr pellets prepared using a high
pressure press. UV-visible absorption spectra were recorded on a Spectral Instruments
440 spectrophotometer. X-band EPR measurements were carried out on frozen
chloroform-ethanol solutions on a Bruker EMX spectrometer; the cavity was maintained
at 4.5 K by an Oxford liquid helium cryostat. The spectrum was not fitted and the g
values presented in the text correspond to zeros of the first or second derivative of the
signal with respect to the field.
7.5.3. Synthesis
7.5.3.1. DSX ^ (2)
4,5-Di(5-salicylaldehyde)-9,9-dimethylxanthene (5) (250 mg, 0.56 mmol) and (1R,2R)-
(-)-1,2-diaminocyclohexane (63 mg, 0.56 mmol) were added to 9 mL of anhydrous
ethanol and heated to reflux overnight. The solution was then cooled in a freezer and
filtered. The bright yellow solid collected was washed with an additional 2 mL of cold
ethanol to give the product (266 mg, 88% yield). HRESI-MS ([M + H] ) C 70H 65N 40 6
m/z, Calcd. 1057.4899 Found 1057.4903.
7.5.3.2. Cr(DSX)C12 (5)
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In an inert atmosphere, the ligand DSX (8) (250.0 mg, 0.195 mmol) was dissolved in 6
mL of dry tetrahydrofuran. Anhydrous chromium(II) chloride (72.0 mg, 0.586 mmol)
was added and the solution rapidly turned greenish-brown. Upon stirring overnight, the
reaction was exposed to air and 6 mL of aqueous saturated ammonium chloride was
added. After stirring in air for 6 hours, the organic layer was washed with 6 mL of
additional aqueous saturated ammonium chloride, followed by 2 x 6 mL of aqueous
saturated sodium chloride. The organic layer was dried with MgSO 4 and the solvent
reduced by rotary evaporation to leave the brown product in quantitative yield (293 mg).
HRESI-MS ([M - Cl]) C86H92Cr 2N406 m/z, Calcd. 1411.5621 Found 1411.5668. Anal.
Calcd for C86H92C12CrzN 4 06: C, 71.11; H, 6.38; N, 3.86. Found: C, 71.18; H, 6.44; N,
3.78.
7.5.3.3. Cr(DSD)C12 (6)
In an inert atmosphere, the ligand DSD (13) (100.0 mg, 0.103 mmol) was dissolved in 4
mL of dry tetrahydrofuran. Anhydrous chromium(ll) chloride (38.0 mg, 0.308 mmol)
was added. Upon stirring overnight, the olive green solution was exposed to air and 2 mL
of aqueous saturated ammonium chloride was added. After stirring in air for 6 hours, the
organic layer was washed with 2 mL of additional aqueous saturated ammonium
chloride, followed by 2 x 2 mL of aqueous saturated sodium chloride. The organic layer
was dried with MgSO 4 and the solvent reduced by rotary evaporation to leave the green
product (14 mg, 11% yield). Anal. Calcd for C64H48C12Cr2N406: C, 67.19; H, 4.23; N,
4.90. Found: C, 67.38; H, 4.25; N, 4.78.
7.5.3.4. Cu 2(DSX) (7)
The disalen xanthene (DSX) ligand (8) (145 mg, 0.113 mmol) was added to copper(II)
acetate monohydrate (45.2 mg, 0.226 mmol) and 10 mL of ethanol was added. The
mixture was heated to reflux for 1 hour, during which the solution turned rose red with
precipitate. The reaction was then cooled to 0 'C, filtered, and the solid washed with cold
ethanol and deionized water. The precipitate was taken up in dichloromethane and
filtered through a 0.45 ýtm polypropylene syringe filter. The solvent was removed from
the filtrate using rotary evaporation to give the dark purple product (139 mg, 87% yield).
HRESI-MS ([M + H] ) C86H 93CU2N 40 6 m/z, Calcd. 1403.5682 Found 1403.5598. UV-vis
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(CH 2C12) kax, nm (c): 310 (96,170), 379 (26,210), 553 (2178). Anal. Calcd for
C86H92 Cu2N406: C, 73.48; H, 6.67; N, 3.99. Found: C, 73.41; H, 6.68; N, 3.87.
7.5.3.5. Cu2(DSX ^) (8)
The ligand 7 (50.0 mg, 0.047 mmol) was added to copper(II) acetate monohydrate (19.0
mg, 0.095 mmol) and 4 mL of ethanol was added. The mixture was heated to reflux for 1
hour and then cooled to 0 'C and filtered. The precipitate was taken up in
dichloromethane and filtered. The solvent was removed from the filtrate under reduced
pressure to reveal the light reddish-purple product (20 mg, 36% yield). HRESI-MS ([M +
H]+) C70H61Cu2N40 6 m/z, Calcd. 1179.3178 Found 1179.3153.
7.5.3.6. Cu 2(DSD) (9)
The disalen dibenzofuran (DSD) ligand (13) (50.0 mg, 0.051 mmol) was added to
copper(II) acetate monohydrate (20.4 mg, 0.102 mmol) and 4 mL of ethanol was added.
The mixture was heated to reflux for 2 hours, during which the solution turned into a rust
brown suspension. Upon cooling to 0 'C, the mixture was filtered, and washed with cold
ethanol. The precipitate was taken up in dichloromethane and filtered through a 0.45 tm
polypropylene syringe filter. The solvent was removed by rotary evaporation to give the
dark red product (35 mg, 62% yield). HRESI-MS ([M + H]+) C 64H 49Cu 2N4 0 6 m/z, Calcd.
1095.2444 Found 1095.1977. UV-vis (CH2CI 2) Xax, nm (F): 330 (55,960), 387 (20,130),
474 (sh, 2,667).
7.5.4.7. Cu(5-phsalen) (10)
The ligand (R,R)-N,N'-bis(5-phenylsalicylidene)-1,2-cyclohexanediamine (50.0 mg,
0.105 mmol) was added to 5 mL of ethanol and 0.211 mL of an aqueous sodium
hydroxide solution (0.9967 M). This was stirred until the ligand dissolved completely,
about 5 minutes. Copper(II) nitrate trihydrate was then added, and the solution heated to
reflux for 2 hours, during which the solution turned rust colored with precipitate. Upon
cooling to 0 'C, the solution was filtered and the precipitate was washed with cold
ethanol. The precipitate was then taken up in dichloromethane and filtered. The solvent
was removed from the filtrate under vacuum to give the dark purple product (53.0 mg,
93% yield). This compound can also be synthesized using copper(II) acetate hydrate as
the precursor, analogous to the procedure described above for the copper Pacman
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complexes. IR (KBr) vmax : 1540 cmn- (C-N). HRESI-MS ([M + H] +) C32H2 9CuN20 2 m/z,
Calcd. 536.1520 Found 536.1539. UV-vis (CH 2C12) max, nm (E): 381 (20,075), 564
(1,098). Anal. Caled for C32H2sCuN 20 2: C, 71.69; H, 5.26; N, 5.23. Found: C, 71.66; H,
5.38; N, 5.17.
7.5.3.8. Mn 2(DSX)CI 2 (12)
The ligand DSX (8) (50.0 mg, 0.039 mmol) was added to manganese(II) acetate
tetrahydrate (28.7 mg, 0.117 mmol) in 4 mL of ethanol and heated to reflux for 2 hours
and cooled to room temperature. 1 mL of aqueous saturated sodium chloride solution was
added and stirred for 1 minute. The mixture was extracted with 3 x 4 mL of
dichloromethane, and the organic layers were combined and washed with 10 mL of
deionized water, followed by drying using MgSO 4. The solvent was removed by rotary
evaporation to leave the brown product in quantitative yield (57 mg). ESI-MS ([M -
Cl] ) C86H92C1Mn 2N40 6 m/z, Calcd. 1421.55 Found 1421.57.
7.5.3.9. Mn 2(DSD)CI2 (13)
The ligand DSD (13) (50.0 mg, 0.051 mmol) was added to manganese(II) acetate
tetrahydrate (37.8 mg, 0.154 mmol) in 4 mL of ethanol and then heated to reflux for 2
hours. Upon cooling, 1 mL of aqueous saturated sodium chloride solution was added and
stirred for 1 minute. The mixture was extracted with 3 x 25 mL of dichloromethane, and
the organic layers were combined and washed with 10 mL of deionized water, followed
by drying using MgSO 4. The solvent was removed by rotary evaporation to leave the
brown product (48 mg, 81% yield). HRESI-MS ([M - Cl] ) C64 H4 8C1Mn 2N40 6 m/z,
Calcd. 1113.20 Found 1113.20.
7.5.3.10. Co 2DSX (14)
Under nitrogen, the ligand DSX (8) (60.0 mg, 0.047 mmol) was dissolved in 8 mL of
degassed dichloromethane. Cobalt(II) acetate tetrahydrate (28.0 mg, 0.112 mmol) was
dissolved in 6 mL of degassed methanol and this solution was added dropwise to the
dichloromethane DSX solution, which turned orange. After stirring for about 1 hour
under nitrogen, the solution turned red with precipitate. The solvent was removed under
reduced pressure, and the residue was washed with cold methanol to leave the bright red
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product (21 mg, 78% yield). HRESI-MS ([M] +) C86H 92Co 2N 406 m/z, Calcd. 1394.5675
Found 1394.5668. Anal. Calcd for C86H92Co 2N4 0 6 : C, 74.04; H, 6.61; N, 4.02. Found: C,
73.88; H, 6.73; N, 3.88.
7.5.3.11. Co 2DSD (15)
Under nitrogen, the ligand DSD (60.0 mg, 0.062 mmol) was dissolved in 8 mL of
degassed dichloromethane. Cobalt(II) acetate tetrahydrate was dissolved in 8 mL of
degassed methanol, which was added dropwise to the dichloromethane DSD solution.
After stirring for about 1 hour, the solution was reddish-brown with precipitate. The
solvent was removed under reduced pressure, and the residue was washed with cold
methanol to give the brown crude product (63 mg). HRESI-MS ([M + H]')
C64H49Co 2N4 06 m/z, Calcd. 1087.2311 Found 1087.2322. Anal. Calcd for
C64H48Co 2N4 0 6-(H20) 5: C, 65.31; H, 4.93; N, 4.76. Found: C, 65.04; H, 4.87; N, 4.36.
7.5.3.12. Zn 2DSX (16)
The ligand DSX (8) (50.0 mg, 0.039 mmol) was added to zinc(II) acetate dihydrate (17.2
mg, 0.078 mmol) and 8 mL of ethanol and refluxed for 6 hours. Upon cooling, the
solvent was removed by rotary evaporation, and the residue was washed with deionized
water to leave the bright yellow crude product (48 mg). IR (KBr) Vmax : 1540 cm - 1 (C=N).
ESI-MS ([M + H] ) C86H93Zn2 N40 6 m/z, Calcd. 1405.57 Found 1409.58.
7.5.3.13. Zn(5-phsalen) (17)
(R,R)-N,N'-Bis(5-phenylsalicylidene)-1,2-cyclohexanediamine (50.0 mg, 0.105 mmol)
was added to zinc(II) acetate dihydrate (23.1 mg, 0.105 mmol) in 8 mL of ethanol and
refluxed for 8 hours. Upon cooling, the solvent was removed by rotary evaporation, and
the residue was washed with deionized water to leave the bright yellow crude product (52
mg). ESI-MS ([M + H]+) C32H29ZnN20 2 m/z, Calcd. 537.15 Found 537.15.
7.5.4. Epoxide Ring Opening Studies
The following procedures were used to study the catalytic ring-opening of an epoxide by
Cr 2DSXCI2 (5) and Cr(salen)C1. A solution of Cr2DSXCI 2 (5) (12.0 mg, 0.008 mmol) and
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substrate cyclohexene oxide (95.4 mg, 0.756 mmol), and 1 mL of diethyl ether was
prepared. As the control, a solution of chromium (IR, 2R)-(-)-[1,2-cyclohexanediamino-
N,N'-bis(3,5-di-tert-butylsalicylidene) chloride (5.2 mg, 0.008 mmol), cyclohexene oxide
(96.2 mg, 0.762 mmol), and 1 mL of diethyl ether was also prepared. To each solution,
triemethylsilyl azide (457 gL, 5.6 mmol) and dodecane the internal standard was added.
The solutions were sampled after 26 hours of stirring at room temperature. The
concentration of substrate and product produced was determined using GC/MS and
compared to the initial solutions.
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Figure A.1. Reaction setup for measuring catalase activity.
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Appendix B.1: Alternate Synthetic Pathways from Chapter 3
2,7-Di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid methyl ester (4) from (3), as shown in Scheme 3.1
Under nitrogen, 2,7-di-tert-butyl-5-(3-formyl-4-hydroxy-phenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid methyl ester (3) (0.250 g, 0.590 mmol), 5-
bromosalicylaldehyde (0.119 g, 0.590 mmol), sodium carbonate (0.092 g, 0.884 mmol),
dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct
(0.026 g, 0.035 mmol), 14 mL of 1,2-dimethoxyethane, and 6 mL of deionized water and
heated to 90 'C for 48 hours. Upon cooling, 25 mL of dichloromethane was added and
the solution was washed with 2 x 25 mL of deionized water. The aqueous portions were
extracted with 10 mL of dichloromethane. The combined organic portions were dried
under MgSO4 and the solvent was removed by rotary evaporation; the resulting residue
was purified by column chromatography (silica gel, 99:1 dichloromethane: methanol) to
elute the product as a colorless solid (0.118 g, 40% yield). Characterization data is
provided in Chapter 4.5.3.1.
2,7-Di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid (5) via deprotection of (4), as shown in Scheme 3.1
2,7-Di-tert-butyl-5-(3-fonrmyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-carboxylic
acid methyl ester (4) (0.050 g, 0.10 mmol) was added to 8 mL of dichloromethane and
cooled to 0 'C. A solution of boron tribromide (1.2 mL, 1.0 M in dichloromethane) was
added and the reaction was warmed to room temperature and stirred for 4 hours, after
which 4 mL of water was added. The organic layer was separated, washed with 10 mL of
water, and dried over MgSO 4. The solvent was evaporated and the residue was purified
by column chromatography (silica gel, 99:5 dichloromethane: methanol) to elute the
product (0.014 g, 28 % yield). Characterization data is provided in Chapter 3.5.3.6.
2,7-Di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthene-4-
carboxylic acid (5) via deprotection of (8), as shown in Scheme 3.2
Under nitrogen, 2,7-di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-
xanthene-4-carboxylic acid benzyl ester (8) (0.100 g, 0.174 mmol) was added to 20 mL
of ethyl acetate and palladium (5% on activated carbon, 0.015 g) and placed under a
hydrogen balloon overnight at room temperature. The mixture was then filtered over
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Celite and the filtrate was reduced by rotary evaporation and the residue purified by
column chromatography (silica gel, 95:5 dichloromethane: methanol) to elute the desired
product (0.061 g, 72%) yield. Characterization data is provided in Chapter 3.5.3.6.
4-[2,7-Di-tert-butyl-5-(3-formyl-4-hydroxyphenyl)-9,9-dimethyl-9H-xanthen-4-ylJ]-
benzoic acid methyl ester (17) via (16), as shown in Scheme 3.4.
Under nitrogen, 5-(5-bromo-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-2-hydroxy-
benzaldehyde (16) (0.37 g, 0.071 mmol), 4-methoxycarbonylphenylboronic acid (0.013
g, 0.071 mmol), sodium carbonate (0.012 g, 0.112 mmol), and dichloro[1,1'-
bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.002 g, 0.002
mmol), and 6 mL of 1,2-dimethoxyethane and 2 mL of deionized water. This was heated
to 90 'C for 24 hours and upon cooling, the solution was extracted with 2 x 50 mL of
dichloromethane. The organic layers were combined and washed with water and dried
using MgSO 4. The solvent was removed by rotary evaporation and purified by column
chromatography (silica gel, dichloromethane) to give the product (0.025 g, 61% yield).
Characterization data are provided in Chapter 4.5.3.4.
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Appendix B.2: Alternate Synthetic Pathways from Chapter 5.
4,5-Di(5-salicylaldehyde)-2,7-di-tert-butyl-9,9-dimethylxanthene (3) via (1) as shown
in Scheme 6.1
Under nitrogen, 2,7-di-tert-butyl-9,9-dimethyl-4-dihydroxyborane-5-(4,4,5,5-tetramethyl-
[1,3,2]dioxaborolan-2-yl)-9H-xanthene (1) (0.600 g, 1.22 mmol), 5-
bromosalicylaldehyde (0.490 g, 2.44 mmol), sodium carbonate (0.377 g, 3.66 mmol),
dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct
(0.107 g, 0.146 mmol), 1,2-dimethoxyethane (12 mL), and deionized water (4 mL) was
heated to 90 'C for 48 hours. Upon cooling, the mixture was extracted with 3 x 50 mL of
dichloromethane. The organic portions were combined dried over MgSO 4 and the solvent
removed by rotary evaporation. The residue was purified by column chromatography
(silica gel, dichloromethane) and recrystallized in hot ethanol to obtain the colorless
product (0.310 g, 43%). Characterization data are provided in Chapter 6.5.3.2.
4,6-di(5-salicylaldehyde)-dibenzofuran (8) via (6) as shown in Scheme 6.2
Under nitrogen, 4,6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-dibenzofuran (10)
(0.750 g, 1.78 mmol), 5-iodosalicylaldehyde (0.885 g, 3.57 mmol), sodium carbonate
(0.551 g, 5.35 mmol), dichloro[ 1,1 '-bis(diphenylphosphino)ferrocene]palladium(II)
dichloromethane adduct (0.157 g, 0.214 mmol), dimethoxyethane (9 mL), and deionized
water (3 mL) was heated to 90 'C for 48 hours. Upon cooling, the mixture was extracted
with 3 x 100 mL of dichloromethane. The organic portions were combined dried over
MgSO 4 and the solvent removed by rotary evaporation. The residue was purified by
column chromatography (silica gel, dichloromethane) and recrystallized in hot ethanol to
obtain the colorless product (0.206 g, 28%). Characterization data are provided in
Chapter 6.5.3.5.
Synthetic Procedures as shown in Scheme B2.1
5-(6-Bromo-dibenzofuran-4-yl)-2-methoxy-benzaldehyde (19)
Under nitrogen, 4,6-dibromodibenzofuran (5) (0.500 g, 1.54 mmol), 3-formyl-4-
methoxyphenylboronic acid (0.611 g, 3.40 mmol), sodium carbonate (0.477 g, 4.63
mmol), and dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloro-
methane adduct (0.226 g, 0.39 mmol) was added to 9 mL of degassed 1,2-
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Scheme B2.1
o -+ o o
19 • R1 = Me0 0
Br-
0 0
Br . Br -
bE19 RI =Me20 : R =H 21 : R2 = Me
d
22: R2 = H
(a) 3-formyl-4-methoxyphenylboronic acid, Na2CO 3, Pd(dppf)Cl 2, DME: H20 (3: 1),
(b) BBr3, CH 2CI2, (c) 3-formyl-4-methoxyphenylboronic acid, Na2CO3, Pd(PPh3)4,
DMF: H20 (9: 1), (d) BBr3, CH 2C12.
dimethoxyethane and 3 mL of deionized water and heated to 90 'C for 24 hours. Upon
cooling, the reaction mixture was extracted with 3 x 20 mL of dichloromethane. The
organic portions were combined and dried over MgSO 4, the solvent removed by rotary
evaporation and the residue was purified via column chromatography (silica gel, 5: 5
pentane: dichloromethane) to give the product (0.481 g, 82 % yield). 1H NMR (500 MHz,
CDC13, 8): 10.58 (s, 1H), 8.40 (d, J= 2.5 Hz, 1H), 8.34 (dd, J= 9 Hz, 2.5 Hz, 1H), 7.92
(dt, J= 7.5 Hz, 1 Hz, 2H), 7.70 (dd, J= 7.5 Hz, 1 Hz, 1H), 7.64 (dd, J= 7.5 Hz, 1 Hz,
1H), 7.46 (t, J = 8 Hz, 1H), 7.26 (t, J = 8 Hz, 1H), 7.22 (d, J= 9 Hz, 1H), 4.05 (s, 3H).
13C NMR (500 MHz, CDCI3, 8): 189.91, 189.87, 161.67, 153.48, 153.18, 136.41, 130.37,
128.75, 128.72, 127.01, 125.74, 125.22, 124.59, 124.35, 124.09, 120.29, 119.94, 112.28,
104.87, 56.12. HRESI-MS ([M + Na] ) NaC2oH13BrO3 m/z, Calcd. 402.9940 Found
402.9946.
5-(6-Bromodibenzofuran-4-yl)-2-hydroxybenzaldehyde (20)
5-(6-Bromo-dibenzofuran-4-yl)-2-methoxybenzaldehyde (19) (0.481 g, 1.26 mmol) was
added to 30 mL of dry dichloromethane and cooled in an acetone/dry ice bath and boron
tribromide was added via syringe (6.0 mL of 1.0 M in dichloromethane). The reaction
was warmed to room temperature and stirred for 2 hours. 20 mL of deionized water was
added and the mixture extracted with 2 x 30 mL of dichloromethane. The organic
portions were combined dried over MgSO 4 , the solvent removed by rotary evaporation
and the residue eluted via column chromatography (silica gel, 3: 7 hexane:
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dichloromethane) to give the product (0.400 g, 87% yield). 1H NMR (500 MHz, CDCI 3,
8): 11.13 (s, 1H), 10.05 (s, 1H), 8.28 (d,J= 2.5 Hz, 1H), 8.13 (dd, J= 7.5 Hz, 3 Hz, 1H),
7.92 (t, J= 7.5 Hz, 2H), 7.65 (d, J= 8 Hz, 2H), 7.46 (t, J= 7.5 Hz, 1H), 7.28 (t, J= 3 Hz,
1H), 7.18 (d, J = 8 Hz, 1H). 13C NMR (500 MHz, CDCl3, 8): 197.09, 197.03, 161.51,
153.45, 153.09, 137.13, 134.18, 130.49, 128.03, 126.76, 124.47, 124.28, 124.16, 120.40,
120.02, 118.38, 104.85.
(21)
Under nitrogen, 5-(6-bromo-dibenzofuran-4-yl)-2-hydroxybenzaldehyde (15) (0.300 g,
0.82 mmol), 3-formyl-4-methoxyphenylboronic acid (0.176 g, 0.98 mmol), sodium
carbonate (0.126 g, 1.22 mmol), and (triphenylphosphine)palladium (0.057 g, 0.049
mmol) were added to 9 mL of degassed dimethylformamide and 1 mL of deionized water
and heated to 90 'C for 24 hours. Upon cooling, the mixture was extracted with 2 x 30
mL of dichloromethane. The organic portions were combined dried over MgSO 4, the
solvent removed by rotary evaporation and the residue purified via column
chromatography (silica gel, 2: 8 hexane: dichloromethane) to elute the product (0.275 g,
80% yield). 'H NMR (500 MHz, CDCI3, 8): 11.15 (s, IH), 10.59 (s, IH), 10.00, (s, 1H),
8.51 (d, J= 2.5 Hz, 1H), 8.22 (d, J= 2 Hz, I H), 8.15 (dd, J= 9 Hz, 2 Hz, IH), 8.10 (dd, J
= 8.5 Hz, 2.5 Hz, 1H), 7. 99 (dd, J= 2 Hz, 1.5 Hz, 1H), 7.97 (dd, J= 2 Hz, 1.5 Hz, 1H),
7.65 (dd, J= 3.5 Hz, 1 Hz, 1H), 7.63 (dd, J= 3.5 Hz, 1 Hz), 7.47 (m, 2H), 7.19 (d, J= 8.5
Hz, 1H), 7.12 (d, J= 8.5 Hz, 1H).
4,6-di(5-salicylaldehyde)-dibenzofuran (22)
(16) (0.361 g, 0.85 mmol) was dissolved in 50 mL of dry dichloromethane cooled in an
ice water bath. After boron tribromide (2 mL, 1.0 M in dichloromethane) was added via
syringe, the solution was warmed to room temperature and stirred for 3 hours. 20 mL of
deionized water was added and the mixture was extracted with 3 x 25 mL of
dichloromethane. The organic portions were combined dried over MgSO 4, the solvent
removed by rotary evaporation and the residue purified via column chromatography
(silica gel, dichloromethane) to elute the product (0.319 g, 92 %yield). Characterization
data are provided in Chapter 6.5.3.7.
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Appendix C.1. Input File for the hydroperoxide complex of Mn(HSX*)
#! /bin/csh
$ADFBIN/adf-n 12 << eor
TITLE Jenny's DPX pacman MnOOH
MAXMEMORYUSAGE 512
GEOMETRY
GO
Iterations 400
END
OCCUPATIONS KeepOrbitals 100
SCF
Iterations 1000
END
XC
GGA Becke PW9 Ic
END
UNRESTRICTED
CHARGE 04
ATOMS
C 10.581210 -3.430240 -3.355240
C 9.725230 -2.665780 -2.563120
C 8.347830 -2.771270 -2.766220
C 7.812850 -3.638630 -3.738880
C 8.709320 -4.391440 -4.507120
C 10.081570 -4.294210 -4.324620
O 7.457180 -2.031580 -1.994730
C 7.913340 -0.931240 -1.272500
C 9.273180 -0.752590 -1.020600
C 10.266530 -1.786790 -1.470090
C 6.944120 -0.047350 -0.769220
C 7.394000 1.049590 -0.023320
C 8.748170 1.264210 0.214990
C 9.680120 0.361610 -0.283890
C 5.484320 -0.232080 -0.945340
C 4.857720 -0.194750 -2.212370
C 3.485760 -0.247540 -2.349740
C 2.624240 -0.341690 -1.226150
C 3.272009 -0.426770 0.066080
C 4.676359 -0.351890 0.175500
O 1.333210 -0.344740 -1.376430
Mn -0.133390 -0.886810 -0.190950
O -0.614281 -2.577590 0.377280
O -1.999151 -3.001679 0.271980
C 2.450379 -0.582370 1.201720
N 1.129731 -0.796132 1.382537
C 0.403721 -0.811071 2.661647
C -0.697689 0.238309 2.560427
N -1.389039 0.055509 1.275786
C -2.697689 0.316937 1.071853
C -3.483009 0.115707 -0.103617
C -2.894748 -0.293243 -1.347807
C -3.756078 -0.462473 -2.451497
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-5.124598
-5.712188
-4.876199
-1.373512
-7.203888
-7.953678
-9.344938
-10.003459
-9.288049
-7.896759
-7.123790
-7.699340
-9.088591
-9.978600
-6.853641
-7.444852
-8.820092
-9.632971
-5.356401
-4.781290
6.348870
5.432940
-4.735112
6.002080
-3.811620
5.885800
8.277440
10.760480
11.657750
10.540340
11.188020
10.745030
9.073070
6.649400
-6.773132
-9.256953
-10.717101
-11.092839
-9.913147
-7.424587
-10.884540
-10.308460
-3.306667
-5.768888
-5.292579
3.021960
5.476390
5.126119
1.087734
-0.035929
-0.279480
-1.408601
-2.121011
2.897574
-0.300783
0.040578
0.274638
-0.496915
0.116678
0.960398
0.993828
0.178788
-0.665142
-0.688542
-1.506112
-2.538532
-2.612432
-1.520311
-3.525172
-4.576262
-4.667702
-3.685361
-3.606803
-2.548463
-3.856760
-3.261980
-4.565693
-4.555090
-2.741873
-2.725180
-5.054320
-4.892280
-3.349640
-2.418650
-1.291600
0.506400
2.134570
1.754100
-5.327252
-5.499641
-3.739551
0.199259
1.660418
1.605268
-1.967741
-0.880511
-0.705898
-0.475752
0.556648
-0.214450
-0.100201.
-0.403030
-0.600591
-1.813904
1.259101
0.114588
-3.076139
-0.647606
-2.322648
-1.091138
-0.012048
-1.552018
-0.958719
-1.783809
-1.706920
-0.790810
0.061320
-0.032419
0.766422
1.461532
1.624281
1.088290
2.017752
2.729292
2.886251
2.327780
1.908193
1.299633
-4.053790
-3.259950
2.342444
-4.985560
1.209664
-2.569500
-5.256110
-4.932860
-3.192370
-0.603000
-1.813710
-0.092870
0.785910
0.350380
3.143492
3.438901
2.445410
-0.721801
-2.356500
-2.487589
0.648510
1.929340
-3.416220
-3.187218
0.954092
-3.336590
-3.107110
1.168040
3.496055
2.775416
2.593446
3.390619
-0.704260
2.192518
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H -3.180732 0.586810 2.009808
END
BASIS
C $ADFRESOURCES/DZP/C. Is
O $ADFRESOURCES/TZP/O. 1s
N $ADFRESOURCES/TZP/N. Is
H $ADFRESOURCES/DZP/H
Mn $ADFRESOURCES/TZ2P/Mn.2p
END
END INPUT
eor
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Table C.1. Cartesian coordinates from the DFT calculated energy minimized structure of
the hydroperoxide complex of Mn(HSX*). The structure is shown in Figure 4.4.
x y z
1.C 10.54703 -3.38522 -3.3624
2.C 9.68632 -2.64592 -2.55441
3.C 8.311687 -2.76836 -2.75099
4.C 7.783106 -3.63145 -3.72707
5.C 8.682754 -4.36068 -4.51001
6.C 10.05356 -4.24241 -4.33893
7.0 7.416122 -2.0485 -1.96717
8.C 7.862076 -0.94236 -1.24597
9.C 9.218721 -0.75202 -0.9971
10.C 10.21893 -1.77446 -1.45312
11.C 6.884345 -0.0688 -0.7487
12.C 7.324951 1.027343 0.001137
13.C 8.675675 1.254335 0.240083
14.C 9.615952 0.364363 
-0.26163
15.C 5.427121 -0.25561 -0.94458
16.C 4.814239 -0.16331 -2.2162
17.C 3.44543 -0.20198 
-2.36716
18.C 2.57427 -0.34933 -1.24733
19.C 3.203745 -0.47449 0.049393
20.C 4.608608 
-0.41023 0.159554
21.0 1.287077 -0.34475 
-1.42562
22.Mn 
-0.16069 -0.86555 
-0.23384
23.0 
-0.6646 
-2.5896 0.3577
24.0 
-2.07419 
-2.96625 0.295007
25.C 2.429979 
-0.60886 1.24072
26.N 1.137132 
-0.75186 1.294269
27.C 0.434907 
-0.76124 2.575628
28.C 
-0.67066 0.304545 2.506114
29.N 
-1.35727 0.138633 1.233124
30.C 
-2.63639 0.283297 1.136077
31.C 
-3.39444 0.07964 
-0.06945
32.C 
-2.80265 
-0.30302 
-1.316
33.C 
-3.66507 -0.45679 
-2.42489
34.C 
-5.03447 
-0.30466 
-2.30187
35.C 
-5.62856 0.015866 -1.0648
36.C 
-4.79101 0.222814 0.020031
37.0 
-1.51506 
-0.5233 
-1.49761
38.C 
-7.09904 0.10156 
-0.94635
39.C 
-7.83231 0.931162 
-1.80171
40.C 
-9.22335 0.979313 
-1.7475
41.C 
-9.90188 0.188831 
-0.82458
42.C 
-9.20428 
-0.64331 0.053971
43.C 
-7.81255 
-0.67904 
-0.01552
44.0 
-7.0592 
-1.48972 0.813131
45.C 
-7.65478 
-2.53137 1.48274
46.C 9.04792 -2.58636 1.623098
47.C 
-9.91558 
-1.47852 1.081779
48.C 6.83248 
-3.54502 2.033475
49.C 
-7.45473 
-4.59552 2.719975
50.C 
-8.8336 
-4.66286 2.858963
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51.C
52.C
53.0
54.C
55.0
56.0
57.0
58.H
59.H
60.H
61.H
62.H
63.H
64.H
65.H
66.H
67.H
68.H
69.H
70.H
71.H
72.H
73.H
74.H
75.H
76.H
77.H
78.H
79.H
80.H
81.H
82.H
83.H
84.H
85.H
86.H
87.H
88.H
-9.62136
-5.33755
-4.73639
6.320222
5.401275
-4.73514
5.975872
-3.77078
5.849483
8.254883
10.73623
11.62155
10.49567
11.13619
10.67786
8.991218
6.575785
-6.8036
-9.29376
-10.7081
-10.992
-9.77516
-7.28691
-10.8272
-10.2388
-3.2148
-5.6749
-5.22411
2.988855
5.442582
5.059577
1.121107
-0.02263
-0.20891
-1.35302
-2.1853
2.982576
-3.65903
-3.66437
-2.61443
-3.86776
-3.2661
-4.64188
-4.58544
-2.82908
-2.71298
-5.0207
-4.81956
-3.29034
-2.41122
-1.27075
0.520843
2.126241
1.725685
-5.36913
-5.49536
-3.69612
0.218998
1.637244
1.557318
-1.91062
-0.82912
-0.72904
-0.47482
0.485137
-0.11889
-0.03236
-0.49095
-0.55949
-1.75599
1.308071
0.208945
-3.16188
-0.57186
0.563181
2.303248
1.922399
1.329674
-4.03141
-3.24738
2.338189
-4.94947
1.23245
-2.56649
-5.26105
-4.95944
-3.20684
-0.59286
-1.78935
-0.07428
0.809769
0.37136
3.125449
3.391576
2.401853
-0.77225
-2.41979
-2.5098
0.638539
1.918061
-3.38048
-3.1698
0.985485
-3.3517
-3.09736
1.149005
3.414924
2.701444
2.529538
3.369173
-0.66379
2.,192149
2.027737-3.22249
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Appendix C.2. Input File for the hydroperoxide complex of Mn(HphSX*) with
carboxylic acid dimers.
#! /bin/csh
$ADFBIN/adf-n12 << eor
TITLE Jenny's DPX-Ph pacman MnOOH w/ H-bonds to the -OOH
MAXMEMORYUSAGE 512
GEOMETRY
GO
Iterations 400
END
OCCUPATIONS KeepOrbitals 100
SCF
Iterations 1000
END
XC
GGA Becke PW91c
END
UNRESTRICTED
CHARGE 04
ATOMS
C 0.206290 5.777170 15.541860
C -1.104080 5.319360 15.735900
C -1.865980 4.961720 14.618090
C -1.334450 5.073740 13.335840
C -0.026700 5.535250 13.144920
C 0.736430 5.892040 14.262000
C -1.693370 5.327640 17.096570
C -2.154200 4.163720 17.732940
C -2.713520 4.197960 19.011450
C -2.803290 5.425240 19.670840
C -2.353810 6.595120 19.064790
C -1.804320 6.539740 17.785760
C -3.236710 2.925260 19.622910
C -2.596850 1.705240 19.013080
C -2.029390 1.788060 17.742070
O -2.019210 2.979730 17.034940
C -1.488590 0.662590 17.092390
C -1.538190 -0.565770 17.765610
C -2.090929 -0.667250 19.039680
C -2.607310 0.467440 19.658580
C -0.906400 0.750041 15.737530
C 0.051870 1.727791 15.400190
C 0.599670 1.799971 14.133270
C 0.216530 0.901201 13.114170
C -0.745400 -0.113499 13.453780
C -1.273380 -0.165110 14.758590
C -1.164180 -1.084019 12.494760
N -0.935319 -1.115507 11.164673
C -1.442799 -2.138447 10.241113
C -1.850569 -1.427837 8.958562
N -0.709569 -0.573297 8.571822
C 0.000764 -0.668447 7.427762
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1.174154
1.926223
3.053693
3.431333
2.755494
1.613774
3.340704
2.591734
3.202994
4.593584
5.363334
4.738124
2.368355
0.938464
0.431924
1.215234
-0.914536
-1.750396
-1.262276
0.079685
-1.443896
-0.816357
-1.290137
-2.404097
-3.069926
-2.593616
1.619843
-0.001377
0.821803
-2.809707
-2.036198
0.578760
0.112480
-1.622607
-1.550957
-3.694447
1.440020
-2.790946
-1.925426
0.472705
2.397395
2.803275
5.070174
6.449574
5.344194
-1.466590
-2.439230
-3.243860
-3.048020
-2.111569
-1.103090
-3.062550
-4.332660
1.342470
-0.081617
0.733124
1.409224
1.211994
0.322624
-0.295277
0.034794
-0.250637
-0.553176
-0.528146
-0.241576
0.018484
-0.960707
-0.520177
-0.179337
-0.225607
0.176862
0.161952
-0.165968
-0.494777
0.567362
1.570013
1.910373
1.256673
0.291782
-0.049028
0.870374
0.536423
1.002764
1.467073
2.378623
5.747020
4.979680
1.560253
2.714084
0.817203
6.581890
0.456212
-0.155478
-0.756798
-2.061977
-0.548747
-0.758896
-0.240816
0.184514
7.450810
7.551110
5.458840
0.396600
-1.628740
-1.441830
2.934350
2.873080
2.559691
6.933682
7.855342
7.311782
5.992312
5.120842
5.610822
3.792322
2.631332
1.415072
1.331333
2.451163
3.663023
0.231722
0.358292
1.607942
2.747472
1.786582
0.668662
-0.591598
-0.740408
3.109322
3.859202
5.118601
5.650701
4.887051
3.626202
9.112622
10.120382
11.750552
7.067671
7.686791
11.785090
10.770690
10.212212
11.113801
7.616641
11.588970
0.797252
-1.454258
-1.722138
0.139013
-0.689928
0.379363
2.388243
4.550723
17.288990
19.581810
20.669210
20.655170
19.553280
17.283520
20.710270
19.470270
13.888310
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H 0.377160 2.438841 16.159100
H -2.015640 -0.933060 14.977440
H 3.598633 2.094174 7.961962
H 4.282903 1.774524 5.613982
H 1.034104 -0.968577 4.988322
H -2.087217 -2.132363 8.149534
H -2.715443 -0.772082 9.135154
H -0.633719 -2.858757 10.035213
H -2.293609 -2.669127 10.691613
H -1.817437 2.315334 11.973352
H -2.106988 2.223033 8.677811
H -3.090286 -0.829058 3.046482
H -3.943766 -0.201338 5.313341
H 0.062153 2.074203 3.455602
H -0.775078 2.666823 5.708621
H -0.432770 4.220970 11.090030
H -1.970190 4.856350 12.476960
H -2.896740 4.632870 14.755020
H 0.807630 6.055880 16.410440
H 1.743770 6.279520 14.104250
H -1.883381 -1.851984 12.775652
H -0.599671 -1.310130 6.784612
END
BASIS
C $ADFRESOURCES/DZP/C. Is
O SADFRESOURCES/TZP/O. Is
N $ADFRESOURCES/TZPiN. Is
H SADFRESOURCES/DZP/H
Mn $ADFRESOURCES/TZ2P/Mn.2p
END
END INPUT
eor
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Table C.2. Cartesian coordinates from the DFT calculated energy minimized structure of
the hydroperoxide complex of Mn(HphSX*) with the xanthenes oriented so the carboxylic
acids can form a hydrogen bonded dimer. The structure is shown in Figure 4.5.
x y z
1.C -3.75165 4.546489 14.31793
2.C -3.38406 3.626824 15.30982
3.C -2.8434 2.395334 14.92456
4.C -2.68628 2.083854 13.58282
5.C -3.06025 3.004904 12.59827
6.C -3.58758 4.242615 12.97275
7.C -3.60206 3.958867 16.73365
8.C -2.56721 3.891009 17.68142
9.C -2.77102 4.23596 19.01614
10.C -4.04147 4.653395 19.41208
11.C -5.08914 4.71473 18.49963
12.C -4.86443 4.370164 17.17086
13.C -1.63375 4.113736 19.99311
14.C -0.29351 4.125105 19.30752
15.C -0.20586 3.78953 17.95878
16.0 -1.33477 3.477823 17.22283
17.C 1.021914 3.710811 17.27923
18.C 2.176114 3.978908 18.02141
19.C 2.115825 4.326536 19.3671
20.C 0.882194 4.40687 20.00279
21.C 1.11115 3.36242 15.84516
22.C 0.330315 4.025557 14.87198
23.C 0.413865 3.706708 13.53512
24.C 1.281166 2.691984 13.06558
25.C 2.13297 2.065424 14.03725
26.C 2.009736 2.405781 15.40133
27.C 3.137512 1.125374 13.65775
28.N 3.331359 0.699528 12.44032
29.C 4.394219 -0.26124 12.15586
30.C 3.868309 -1.22721 11.08788
31.N 3.242431 -0.423 10.04361
32.C 3.509082 -0.6284 8.784802
33.C 3.007294 0.125546 7.684865
34.C 2.209732 1.311089 7.875835
35.C 1.736861 1.958986 6.698018
36.C 2.071322 1.513461 5.438487
37.C 2.928479 0.399599 5.246521
38.C 3.364036 -0.27635 6.374625
39.C 3.459637 0.040274 3.909948
40.C 2.648788 -0.24499 2.794942
41.C 3.186567 -0.58831 1.553547
42.C 4.57522 -0.60557 1.405997
43.C 5.406733 -0.31751 2.483065
44.C 4.846457 -0.00795 3.720003
45.C 2.279383 -0.99611 0.421165
46.C 0.856353 -0.55775 0.641278
47.C 0.431035 -0.20078 1.921345
48.0 1.284142 -0.19645 3.002532
49.C -0.89868 0.185909 2.177049
236
Appendix C
50.C
51.C
52.C
53.C
54.C
55.C
56.C
57.C
58.C
59.0
60.Mn
61.0
62.C
63.0
64.C
65.0
66.0
67.0
68.0
69.0
70.H
71.H
72.H
73.H
74.H
75.H
76.H
76.H
77.H
78.H
79.H
80.H
81.H
82.H
83.H
84.H
85.H
86.H
87.H
88.H
89.H
90.H
91.H
92.H
93.H
94.H
95.H
96.H
97.H
98.H
99.H
100.H
101.H
102.H
-1.79941
-1.39444
-0.07203
-1.31587
-1.92146
-2.25587
-1.98531
-1.41963
-1.09142
1.932871
2.017818
1.273912
-2.24824
-2.774
-2.88906
-2.53684
0.535003
0.250044
-1.96951
-3.06877
-2.83754
-2.11176
0.252183
2.306334
2.655165
5.000639
6.4899
6.4899
5.487723
-5.67994
-6.08157
-4.20853
0.822128
3.03054
3.136077
-1.68326
-1.74167
-0.19761
-0.35209
2.633856
1.111855
1.697964
3.999387
4.684173
3.095807
5.264114
4.711448
-0.41679
-2.88509
-0.6426
-1.23114
-2.0949
-2.70507
-2.34413
0.201045
-0.15816
-0.5304
0.571328
1.812961
2.200459
1.343799
0.086463
-0.29527
1.80829
0.941913
2.407007
1.724205
2.917394
2.675209
1.425547
-0.20666
-0.84851
0.937607
3.51929
0.474442
-0.15753
-0.81884
-2.09848
-0.57658
-0.85511
-0.31843
-0.31843
0.252168
4.39356
5.022087
4.91942
4.681388
4.549584
3.953563
4.932077
3.168577
4.225949
4.813256
1.880058
2.843248
2.051326
-1.15685
-1.8534
-1.88001
0.286524
-0.81151
-0.22796
3.120288
-1.2716
-0.58331
2.494781
3.176113
1.271822
1.107698
-0.17648
-0.40197
3.542132
3.783046
5.077877
6.154086
5.90944
4.619417
9.040583
10.83467
11.78954
7.56468
7.745202
11.16074
10.95134
11.02656
9.744538
8.494387
10.25959
1.302656
-0.99779
-1.40393
0.319297
-0.52584
0.432238
2.358736
2.358736
4.563406
16.44961
18.8235
20.45552
21.05555
19.91288
17.50816
20.72549
20.55642
12.79949
15.18598
16.12387
6.830108
4.565478
6.253866
10.68829
11.53033
11.75112
13.059
9.366585
8.762245
4.439241
6.745625
2.94807
5.260958
9.951154
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13.28726
15.68419
14.61272
12.20067
8.5362
14.46404
103.H
104.H
105.H
106.H
107.H
108.H
-2.26015
-2.54897
-4.15206
-3.86272
4.190518
3.779046
1.128916
1.674658
5.516006
4.958224
-1.45728
0.736605
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Appendix C.3. Input File for the hydroperoxide complex of Mn(HSD*).
#!/bin/csh
$ADFBIN/adf-n 12 << eor
TITLE Jenny's HSD, no phenyl,
MAXMEMORYUSAGE 512
GEOMETRY
GO
Iterations 400
END
OCCUPATIONS KeepOrbitals 100
SCF
Iterations 1000
END
XC
GGA Becke PW9 Ic
END
UNRESTRICTED
CHARGE 04
ATOMS
C 1.372400 4.336910 -12.351861
C 0.975270 5.543420 -11.777121
C 0.567690 6.667260 -12.511201
C 0.532130 6.596010 -13.904851
C 0.913570 5.404000 -14.511341
C 1.326340 4.304700 -13.752591
O 0.945420 5.789520 -10.424451
C 0.509640 7.092370 -10.285101
C 0.265380 7.685390 -11.530611
C -0.180180 9.006830 -11.585691
C -0.375050 9.673530 -10.381911
C -0.137401 9.048520 -9.150501
C 0.318840 7.726990 -9.058711
C 0.635940 7.083380 -7.773371
C -0.179941 7.241030 -6.629171
C 0.179179 6.720770 -5.390821
C 1.415439 6.004579 -5.222381
C 2.206999 5.804839 -6.404410
C 1.793679 6.341259 -7.636741
C 3.454799 5.120939 -6.380580
N 4.050639 4.671469 -5.315729
Mn 3.409979 4.747139 -3.460570
O 3.076319 2.817999 -3.568699
O 3.343189 2.000131 -2.398729
O 1.760019 5.574599 -4.045881
C 1.777750 3.156620 -11.567391
C 5.340839 3.988739 -5.407769
C 6.220399 4.565900 -4.301479
N 5.396789 4.653639 -3.091149
C 5.959439 4.587610 -1.922659
C 5.273419 4.668470 -0.667879
C 3.855269 4.854559 -0.570689
C 3.280229 4.887250 0.727900
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C
C
C
C
C
C
C
C
C
C
C
O
C
C
C
C
C
O
H
H
H
H -
H -
H -
H
H
H
H
H
H
H
H
H
H -
H -
H
H
H
H
H
H
H
H
O
O
H
O
O
H
END
4.058588
5.448508
6.034029
6.215948
5.799538
6.438548
7.592278
8.055988
7.381298
5.648118
4.619978
4.696458
5.711288
4.696580
4.468650
4.485910
4.086770
3.008700
2.586879
3.258950
4.318301
4.726130
1.481569
1.315570
2.238670
0.617419
1.848841
1.759791
0.506841
2.964171
3.747160
4.920030
5.340070
4.564131
3.402781
5.412120
4.474770
3.460650
6.512770
4.742698 -0.378941 6.633270
3.728988 -0.516471 5.676440
3.644478
2.621288
3.060699
1.579650
0.877450
0.207550
0.363470
0.707260
0.268231
0.322610
0.127740
4.961411
3.373460
5.313730
7.445590
9.502280
10.712280
9.616820
4.558040
3.514950
-1.611159
-14.256031
-15.595281
-14.502140
-12.536811
-10.388771
-8.230361
3.004238 -1.326351 5.770749
4.776558 -1.064671 7.480030
6.502468
8.115248
8.951608
7.748477
2.205129
3.587048
7.102089
0.460691
1.127350
2.443949
5.802559
5.166720
6.547309
7.112129
3.027659
7.050279
3.954130
1.788809
1.732898
1.142217
2.114113
2.869011
2.997173
0.716909
2.966560
4.858891
5.584990
5.048429
4.693070
4.276140
6.839110
7.770840
6.200779
4.127500
2.915489
5.583250
3.937909
2.585191
4.450520
4.978459
-0.756036
1.163984
0.878896
2.131625
3.237589
2.397870
7.257370
6.250861
4.872901
2.838421
0.803510
2.832671
0.413171
-4.516481
-6.722301
-8.497001
-6.399519
-5.226419
-4.581539
-4.138859
-1.670199
-1.872159
-7.346879
3.634607
3.203567
2.516310
-12.137168
-10.694125
-10.268749
BASIS
C $ADFRESOURCES/DZP/C. Is
0 $ADFRESOURCES/TZP/O. I s
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N $ADFRESOURCES/TZP/N. Is
H $ADFRESOURCES/DZP/H
Mn SADFRESOURCES/TZ2P/Mn.2p
END
END INPUT
eor
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Table C.3. Cartesian coordinates from the DFT calculated energy minimized structure of
the hydroperoxide complex of Mn(HSD*). The structure is shown in Figure 4.7.
x y z
1.C 1.3724 4.33691 -12.3519
2.C 0.97527 5.54342 -11.7771
3.C 0.56769 6.66726 -12.5112
4.C 0.53213 6.59601 -13.9049
5.C 0.91357 5.404 -14.5113
6.C 1.32634 4.3047 -13.7526
7.0 0.94542 5.78952 -10.4245
8.C 0.50964 7.09237 -10.2851
9.C 0.26538 7.68539 -11.5306
10.C -0.18018 9.00683 -11.5857
1 l.C -0.37505 9.67353 -10.3819
12.C -0.1374 9.04852 -9.1505
13.C 0.31884 7.72699 -9.05871
14.C 0.63594 7.08338 -7.77337
15.C -0.17994 7.24103 -6.62917
16.C 0.179179 6.72077 -5.39082
17.C 1.415439 6.004579 -5.22238
18.C 2.206999 5.804839 -6.40441
19.C 1.793679 6.341259 -7.63674
20.C 3.454799 5.120939 -6.38058
21.N 4.050639 4.671469 -5.31573
22.Mn 3.409979 4.747139 -3.46057
23.0 3.076319 2.817999 -3.5687
24.0 3.343189 2.000131 -2.39873
25.0 1.760019 5.574599 -4.04588
26.C 1.77775 3.15662 -11.5674
27.C 5.340839 3.988739 -5.40777
28.C 6.220399 4.5659 -4.30148
29.N 5.396789 4.653639 -3.09115
30.C 5.959439 4.58761 -1.92266
31.C 5.273419 4.66847 -0.66788
32.C 3.855269 4.854559 -0.57069
33.C 3.280229 4.88725 0.7279
34.C 4.058588 4.69658 1.848841
35.C 5.448508 4.46865 1.759791
36.C 6.034029 4.48591 0.506841
37.C 6.215948 4.08677 2.964171
38.C 5.799538 3.0087 3.74716
39.C 6.438548 2.586879 4.92003
40.C 7.592278 3.25895 5.34007
41.C 8.055988 4.318301 4.564131
42.C 7.381298 4.72613 3.402781
43.C 5.648118 1.481569 5.41212
44.C 4.619978 1.31557 4.47477
45.0 4.696458 2.23867 3.46065
46.C 5.711288 0.617419 6.51277
47.C 4.742698 -0.37894 6.63327
48.C 3.728988 -0.51647 5.67644
49.C 3.644478 0.32261 4.55804
50.C 2.621288 0.12774 3.51495
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51.0
52.H
53.H
54.H
55.H
56.H
57.H
58.H
59.H
60.H
61.H
62.H
63.H
64.H
65.H
66.H
67.H
68.H
69.H
70.H
71.H
72.H
73.H
74.H
75.H
76.H
77.0
78.0
79.H
80.0
81.0
82.H
3.060699
1.57965
0.87745
0.20755
-0.36347
-0.70726
-0.26823
3.004238
4.776558
6.502468
8.115248
8.951608
7.748477
2.205129
3.587048
7.102089
-0.46069
-1.12735
2.443949
5.802559
5.16672
6.547309
7.112129
3.027659
7.050279
3.95413
1.788809
1.732898
1.142217
2.114113
2.869011
2.997173
4.961411
3.37346
5.31373
7.44559
9.50228
10.71228
9.61682
-1.32635
-1.06467
0.716909
2.96656
4.858891
5.58499
5.048429
4.69307
4.27614
6.83911
7.77084
6.200779
4.1275
2.915489
5.58325
3.937909
2.585191
4.45052
4.978459
-0.75604
1.163984
0.878896
2.131625
3.237589
2.39787
-1.61116
-14.256
-15.5953
-14.5021
-12.5368
-10.3888
-8.23036
5.770749
7.48003
7.25737
6.250861
4.872901
2.838421
0.80351
2.832671
0.413171
-4.51648
-6.7223
-8.497
-6.39952
-5.22642
-4.58154
-4.13886
-1.6702
-1.87216
-7.34688
3.634607
3.203567
2.51631
-12.1372
-10.6941
-10.2687
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Appendix C.4. Input File for the hydroperoxide complex of Mn(HphSD*).
#! /bin/csh
$ADFBIN/adf-nl2 << eor
TITLE Jenny's HSD-phenyl
MAXMEMORYUSAGE 512
GEOMETRY
GO
Iterations 400
END
OCCUPATIONS KeepOrbitals 100
SCF
Iterations 1000
END
XC
GGA Becke PW91c
END
UNRESTRICTED
CHARGE 04
ATOMS
C 2.772680 2.341637 -11.875520
C 1.700776 3.143507 -11.469912
C 0.968351 2.783937 -10.333078
C 1.256879 1.605939 -9.657334
C 2.294132 0.788380 -10.101660
C 3.068625 1.172155 -11.194318
C 1.298681 4.292929 -12.279070
C 0.898427 5.499096 -11.722027
C 0.443153 6.590979 -12.476720
C 0.364369 6.480682 -13.866474
C 0.781361 5.289507 -14.450917
C 1.238532 4.220208 -13.673757
O 0.928713 5.785636 -10.385300
C 0.502843 7.084786 -10.263797
C 0.188083 7.634276 -11.515263
C -0.257046 8.955417 -11.582581
C -0.375004 9.675093 -10.395516
C -0.052161 9.096591 -9.163969
C 0.397850 7.775551 -9.058544
C 0.781332 7.185010 -7.777349
C 0.067199 7.469518 -6.589414
C 0.466381 6.982032 -5.379842
C 1.614825 6.195159 -5.242150
C 2.339450 5.885073 -6.436386
C 1.894614 6.371328 -7.676882
C 3.546784 5.143674 -6.394659
N 4.135893 4.751744 -5.307648
Mn 3.514344 4.879692 -3.492018
O 3.126305 2.993078 -3.636416
O 3.206992 2.240128 -2.442159
O 1.972671 5.775985 -4.068477
C 2.588769 -0.513190 -9.470311
0 3.509677 -1.237816 -9.802316
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5.366884
6.255640
5.419889
5.968316
5.292476
3.898498
3.302241
4.043721
5.423573
6.027011
6.162573
5.713463
6.298710
7.427155
7.922034
7.300473
5.503469
4.527304
4.645901
3.543170
3.550125
4.506678
5.489493
2.603438
1.261449
0.403917
0.883450
2.207488
3.061553
-0.043787
-1.213508
3.135146
1.726388
0.551181
1.502867
0.733903
0.005285
-0.500036
-0.701602
-0.096901
2.813765
4.480444
6.229306
7.917899
8.806830
7.680389
2.233607
3.564387
7.093782
-0.103933
-0.847663
2.468827
5.840460
5.116246
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3.990932 -5.388663
4.528230 -4.285478
4.628461 -3.098036
4.461600 -1.939333
4.554108 -0.687374
4.817591 -0.608719
4.859133 0.669181
4.621593 1.804460
4.357628 1.731412
4.338141 0.490142
4.040898 2.955941
3.013718 3.771624
2.656338 4.992567
3.353583 5.417466
4.368538 4.604762
4.712547 3.397462
1.556699 5.486011
1.341079 4.503478
2.221848 3.469161
0.370151 4.581407
-0.411601 5.735401
-0.229118 6.734450
0.755435 6.624989
0.131829 3.491289
-0.145528 3.761738
-0.499319 2.734980
-0.575524 1.428766
-0.251766 1.143935
0.108577 2.172043
-1.031682 0.378116
-1.305295 0.565653
4.959578 -1.668069
-0.822133 -8.506941
-1.138428 -0.828262
3.273077 -14.154098
5.175208 -15.537157
7.314814 -14.477332
9.420945 -12.541718
10.717725 -10.424339
9.703324 -8.253566
-1.214775 5.824825
-0.862295 7.624377
0.896301 7.417384
3.112437 6.364136
4.927507 4.921346
5.548990 2.802351
5.077586 0.720168
4.638246 2.787983
4.095692 0.416439
7.189405 -4.472617
8.068558 -6.657725
6.128270 -8.577976
4.085477 -6.382270
2.934044 -5.177534
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H 6.598291 5.545448 -4.555149
H 7.129489 3.875520 -4.111608
H 3.023492 2.945328 -1.753894
H 2.024401 -1.716263 -8.173067
H 3.383123 2.657563 -12.727341
H 3.892447 0.518518 -11.496886
H 0.138517 3.418734 -10.005155
H 0.660010 1.300357 -8.791693
H -0.175829 -1.447521 -1.438926
H 2.564894 -0.299433 0.111480
H 4.108292 0.346398 1.962759
H 0.893879 -0.056742 4.787997
H -0.651054 -0.727417 2.913311
H 7.047206 4.232872 -1.894439
H 4.019066 4.906830 -7.363068
END
BASIS
C $ADFRESOURCES/DZP/C.1s
O SADFRESOURCES/TZP/O. Is
N $ADFRESOURCES/TZP/N. 1s
H $ADFRESOURCES/DZP/H
Mn $ADFRESOURCES/TZ2P/Mn.2p
END
END INPUT
eor
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Table C.4. Cartesian coordinates from the DFT calculated energy minimized structure of
the hydroperoxide complex of Mn(HphSD*). The structure is shown in Figure 4.8.
x y z
1.C 2.77268 2.341637 -11.8755
2.C 1.700776 3.143507 -11.4699
3.C 0.968351 2.783937 -10.3331
4.C 1.256879 1.605939 -9.65733
5.C 2.294132 0.78838 -10.1017
6.C 3.068625 1.172155 -11.1943
7.C 1.298681 4.292929 -12.2791
8.C 0.898427 5.499096 -11.722
9.C 0.443153 6.590979 -12.4767
10.C 0.364369 6.480682 -13.8665
11.C 0.781361 5.289507 -14.4509
12.C 1.238532 4.220208 -13.6738
13.0 0.928713 5.785636 -10.3853
14.C 0.502843 7.084786 -10.2638
15.C 0.188083 7.634276 -11.5153
16.C -0.25705 8.955417 -11.5826
17.C -0.375 9.675093 -10.3955
18.C -0.05216 9.096591 -9.16397
19.C 0.39785 7.775551 -9.05854
20.C 0.781332 7.18501 -7.77735
21.C 0.067199 7.469518 -6.58941
22.C 0.466381 6.982032 -5.37984
23.C 1.614825 6.195159 -5.24215
24.C 2.33945 5.885073 -6.43639
25.C 1.894614 6.371328 -7.67688
26.C 3.546784 5.143674 -6.39466
27.N 4.135893 4.751744 -5.30765
28.M 3.514344 4.879692 -3.49202
29.0 3.126305 2.993078 -3.63642
30.0 3.206992 2.240128 -2.44216
31.0 1.972671 5.775985 -4.06848
32.C 2.588769 -0.51319 -9.47031
33.0 3.509677 -1.23782 -9.80232
34.C 5.366884 3.990932 -5.38866
35.C 6.25564 4.52823 -4.28548
36.N 5.419889 4.628461 -3.09804
37.C 5.968316 4.4616 -1.93933
38.C 5.292476 4.554108 -0.68737
39.C 3.898498 4.817591 -0.60872
40.C 3.302241 4.859133 0.669181
41.C 4.043721 4.621593 1.80446
42.C 5.423573 4.357628 1.731412
43.C 6.027011 4.338141 0.490142
44.C 6.162573 4.040898 2.955941
45.C 5.713463 3.013718 3.771624
46.C 6.29871 2.656338 4.992567
47.C 7.427155 3.353583 5.417466
48.C 7.922034 4.368538 4.604762
49.C 7.300473 4.712547 3.397462
50.C 5.503469 1.556699 5.486011
51.C 4.527304 1.341079 4.503478
52.0 4.645901 2.221848 3.469161
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53.C
54.C
55.C
56.C
57.C
58.C
59.C
60.C
61.C
62.C
63.C
64.0
65.0
66.0
67.0
68.H
69.H
70.H
71.H
72.H
73.H
74.H
75.H
76.H
77.H
78.H
79.H
80.H
81.H
82.H
83.H
84.H
85.H
86.H
87.H
88.H
89.H
90.H
91.H
92.H
93.H
94.H
95.H
96.H
97.H
98.H
99.H
100.H
101.H
102.H
3.54317
3.550125
4.506678
5.489493
2.603438
1.261449
0.403917
0.88345
2.207488
3.061553
-0.04379
-1.21351
3.135146
1.726388
0.551181
1.502867
0.733903
0.005285
-0.50004
-0.7016
-0.0969
2.813765
4.480444
6.229306
7.917899
8.80683
7.680389
2.233607
3.564387
7.093782
-0.10393
-0.84766
2.468827
5.84046
5.116246
6.598291
7.129489
3.023492
2.024401
3.383123
3.892447
0.138517
0.66001
-0.17583
2.564894
4.108292
0.893879
-0.65105
7.047206
4.019066
0.370151
-0.4116
-0.22912
0.755435
0.131829
-0.14553
-0.49932
-0.57552
-0.25177
0.108577
-1.03168
-1.3053
4.959578
-0.82213
-1.13843
3.273077
5.175208
7.314814
9.420945
10.71773
9.703324
-1.21478
-0.8623
0.896301
3.112437
4.927507
5.54899
5.077586
4.638246
4.095692
7.189405
8.068558
6.12827
4.085477
2.934044
5.545448
3.87552
2.945328
-1.71626
2.657563
0.518518
3.418734
1.300357
-1.44752
-0.29943
0.346398
-0.05674
-0.72742
4.232872
4.90683
4.581407
5.735401
6.73445
6.624989
3.491289
3.761738
2.73498
1.428766
1.143935
2.172043
0.378116
0.565653
-1.66807
-8.50694
-0.82826
-14.1541
-15.5372
-14.4773
-12.5417
-10.4243
-8.25357
5.824825
7.624377
7.417384
6.364136
4.921346
2.802351
0.720168
2.787983
0.416439
-4.47262
-6.65773
-8.57798
-6.38227
-5.17753
-4.55515
-4.11161
-1.75389
-8.17307
-12.7273
-11.4969
-10.0052
-8.79169
-1.43893
0.11148
1.962759
4.787997
2.913311
-1.89444
-7.36307
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